
<html lang="en"     class="pb-page"  data-request-id="574d43f1-30b5-4b4b-a4a8-24e621d90bb6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01725;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-4;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors" /></meta><meta name="dc.Creator" content="Jeffrey&#xA;T.  Bagdanoff" /></meta><meta name="dc.Creator" content="Zhouliang  Chen" /></meta><meta name="dc.Creator" content="Michael  Acker" /></meta><meta name="dc.Creator" content="Ying-Nan  Chen" /></meta><meta name="dc.Creator" content="Homan  Chan" /></meta><meta name="dc.Creator" content="Michael  Dore" /></meta><meta name="dc.Creator" content="Brant  Firestone" /></meta><meta name="dc.Creator" content="Michelle  Fodor" /></meta><meta name="dc.Creator" content="Jorge  Fortanet" /></meta><meta name="dc.Creator" content="Murphy  Hentemann" /></meta><meta name="dc.Creator" content="Mitsunori  Kato" /></meta><meta name="dc.Creator" content="Robert  Koenig" /></meta><meta name="dc.Creator" content="Laura R.  LaBonte" /></meta><meta name="dc.Creator" content="Shumei  Liu" /></meta><meta name="dc.Creator" content="Movarid  Mohseni" /></meta><meta name="dc.Creator" content="Rukundo  Ntaganda" /></meta><meta name="dc.Creator" content="Patrick  Sarver" /></meta><meta name="dc.Creator" content="Troy  Smith" /></meta><meta name="dc.Creator" content="Martin  Sendzik" /></meta><meta name="dc.Creator" content="Travis  Stams" /></meta><meta name="dc.Creator" content="Stan  Spence" /></meta><meta name="dc.Creator" content="Christopher  Towler" /></meta><meta name="dc.Creator" content="Hongyun  Wang" /></meta><meta name="dc.Creator" content="Ping  Wang" /></meta><meta name="dc.Creator" content="Sarah L.  Williams" /></meta><meta name="dc.Creator" content="Matthew J.  LaMarche" /></meta><meta name="dc.Description" content="SHP2 is a nonreceptor protein tyrosine phosphatase within the mitogen-activated protein kinase (MAPK) pathway controlling cell growth, differentiation, and oncogenic transformation. SHP2 also parti..." /></meta><meta name="Description" content="SHP2 is a nonreceptor protein tyrosine phosphatase within the mitogen-activated protein kinase (MAPK) pathway controlling cell growth, differentiation, and oncogenic transformation. SHP2 also parti..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 28, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01725" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01725" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01725" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01725" /></link>
        
    
    

<title>Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01725" /></meta><meta property="og:title" content="Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0012.jpeg" /></meta><meta property="og:description" content="SHP2 is a nonreceptor protein tyrosine phosphatase within the mitogen-activated protein kinase (MAPK) pathway controlling cell growth, differentiation, and oncogenic transformation. SHP2 also participates in the programed cell death pathway (PD-1/PD-L1) governing immune surveillance. Small-molecule inhibition of SHP2 has been widely investigated, including in our previous reports describing SHP099 (2), which binds to a tunnel-like allosteric binding site. To broaden our approach to allosteric inhibition of SHP2, we conducted additional hit finding, evaluation, and structure-based scaffold morphing. These studies, reported here in the first of two papers, led to the identification of multiple 5,6-fused bicyclic scaffolds that bind to the same allosteric tunnel as 2. We demonstrate the structural diversity permitted by the tunnel pharmacophore and culminated in the identification of pyrazolopyrimidinones (e.g., SHP389, 1) that modulate MAPK signaling in vivo. These studies also served as the basis for further scaffold morphing and optimization, detailed in the following manuscript." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01725"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01725">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01725&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01725&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01725&amp;href=/doi/10.1021/acs.jmedchem.8b01725" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1781-1792</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01679" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01726" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.9b00435"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jeffrey T. Bagdanoff</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffrey T. Bagdanoff</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey%0AT.++Bagdanoff">Jeffrey T. Bagdanoff</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Zhouliang Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhouliang Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhouliang++Chen">Zhouliang Chen</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Michael Acker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Acker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Acker">Michael Acker</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ying-Nan Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying-Nan Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying-Nan++Chen">Ying-Nan Chen</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Homan Chan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Homan Chan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Homan++Chan">Homan Chan</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Michael Dore</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Dore</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Dore">Michael Dore</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Brant Firestone</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brant Firestone</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brant++Firestone">Brant Firestone</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Michelle Fodor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michelle Fodor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology & Therapeutics, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Fodor">Michelle Fodor</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jorge Fortanet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jorge Fortanet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jorge++Fortanet">Jorge Fortanet</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Murphy Hentemann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Murphy Hentemann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Murphy++Hentemann">Murphy Hentemann</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mitsunori Kato</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mitsunori Kato</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mitsunori++Kato">Mitsunori Kato</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Robert Koenig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Koenig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Koenig">Robert Koenig</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Laura R. LaBonte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura R. LaBonte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura+R.++LaBonte">Laura R. LaBonte</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Shumei Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shumei Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shumei++Liu">Shumei Liu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Movarid Mohseni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Movarid Mohseni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Movarid++Mohseni">Movarid Mohseni</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Rukundo Ntaganda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rukundo Ntaganda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rukundo++Ntaganda">Rukundo Ntaganda</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Patrick Sarver</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Sarver</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Sarver">Patrick Sarver</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Troy Smith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Troy Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Troy++Smith">Troy Smith</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Martin Sendzik</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Sendzik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Sendzik">Martin Sendzik</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Travis Stams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Travis Stams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology & Therapeutics, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Travis++Stams">Travis Stams</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Stan Spence</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stan Spence</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stan++Spence">Stan Spence</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Christopher Towler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Towler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Towler">Christopher Towler</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hongyun Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongyun Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongyun++Wang">Hongyun Wang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ping Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ping Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology Disease Area, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ping++Wang">Ping Wang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sarah L. Williams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah L. Williams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+L.++Williams">Sarah L. Williams</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Matthew J. LaMarche</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew J. LaMarche</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#dcb1bda8a8b4b9abf2b0bdb1bdaebfb4b99cb2b3aabdaea8b5aff2bfb3b1"><span class="__cf_email__" data-cfemail="a5c8c4d1d1cdc0d28bc9c4c8c4d7c6cdc0e5cbcad3c4d7d1ccd68bc6cac8">[emailÂ protected]</span></a>. Tel: 617-871-7729.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+J.++LaMarche">Matthew J. LaMarche</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6588-2302" title="Orcid link">http://orcid.org/0000-0002-6588-2302</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01725&amp;href=/doi/10.1021%2Facs.jmedchem.8b01725" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1781â1792</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 28, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 November 2018</li><li><span class="item_label"><b>Published</b> online</span>28 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 February 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01725" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01725</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ec-1612971054143.svg" alt="ACS Editorsâ Choice" /></img><span>ACS Editorsâ Choice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01725"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">10994</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">27</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01725" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jeffrey\nT.&quot;,&quot;last_name&quot;:&quot;Bagdanoff&quot;},{&quot;first_name&quot;:&quot;Zhouliang&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Acker&quot;},{&quot;first_name&quot;:&quot;Ying-Nan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Homan&quot;,&quot;last_name&quot;:&quot;Chan&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Dore&quot;},{&quot;first_name&quot;:&quot;Brant&quot;,&quot;last_name&quot;:&quot;Firestone&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Fodor&quot;},{&quot;first_name&quot;:&quot;Jorge&quot;,&quot;last_name&quot;:&quot;Fortanet&quot;},{&quot;first_name&quot;:&quot;Murphy&quot;,&quot;last_name&quot;:&quot;Hentemann&quot;},{&quot;first_name&quot;:&quot;Mitsunori&quot;,&quot;last_name&quot;:&quot;Kato&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Koenig&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;R. LaBonte&quot;},{&quot;first_name&quot;:&quot;Shumei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Movarid&quot;,&quot;last_name&quot;:&quot;Mohseni&quot;},{&quot;first_name&quot;:&quot;Rukundo&quot;,&quot;last_name&quot;:&quot;Ntaganda&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Sarver&quot;},{&quot;first_name&quot;:&quot;Troy&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Sendzik&quot;},{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;Stams&quot;},{&quot;first_name&quot;:&quot;Stan&quot;,&quot;last_name&quot;:&quot;Spence&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Towler&quot;},{&quot;first_name&quot;:&quot;Hongyun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ping&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;L. Williams&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;J. LaMarche&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;1781-1792&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01725&quot;},&quot;abstract&quot;:&quot;SHP2 is a nonreceptor protein tyrosine phosphatase within the mitogen-activated protein kinase (MAPK) pathway controlling cell growth, differentiation, and oncogenic transformation. SHP2 also participates in the programed cell death pathway (PD-1/PD-L1) governing immune surveillance. Small-molecule inhibition of SHP2 has been widely investigated, including in our previous reports describing SHP099 (2), which binds to a tunnel-like allosteric binding site. To broaden our approach to allosteric inhibition of SHP2, we conducted additional hit finding, evaluation, and structure-based scaffold morphing. These studies, reported here in the first of two papers, led to the identification of multiple 5,6-fused bicyclic scaffolds that bind to the same allosteric tunnel as 2. We demonstrate the structural diversity permitted by the tunnel pharmacophore and culminated in the identification of pyrazolopyrimidinones (e.g., SHP389, 1) that modulate MAPK signaling in vivo. These studies also served as the basis for further s&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01725&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01725" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01725&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01725" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01725&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01725" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01725&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01725&amp;href=/doi/10.1021/acs.jmedchem.8b01725" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01725" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01725" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01725%26sid%3Dliteratum%253Aachs%26pmid%3D30688462%26genre%3Darticle%26aulast%3DBagdanoff%26date%3D2019%26atitle%3DOptimization%2Bof%2BFused%2BBicyclic%2BAllosteric%2BSHP2%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D4%26spage%3D1781%26epage%3D1792%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/jmcmar.2019.62.issue-4/20190228/jmcmar.2019.62.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">SHP2 is a nonreceptor protein tyrosine phosphatase within the mitogen-activated protein kinase (MAPK) pathway controlling cell growth, differentiation, and oncogenic transformation. SHP2 also participates in the programed cell death pathway (PD-1/PD-L1) governing immune surveillance. Small-molecule inhibition of SHP2 has been widely investigated, including in our previous reports describing SHP099 (2), which binds to a tunnel-like allosteric binding site. To broaden our approach to allosteric inhibition of SHP2, we conducted additional hit finding, evaluation, and structure-based scaffold morphing. These studies, reported here in the first of two papers, led to the identification of multiple 5,6-fused bicyclic scaffolds that bind to the same allosteric tunnel as 2. We demonstrate the structural diversity permitted by the tunnel pharmacophore and culminated in the identification of pyrazolopyrimidinones (e.g., SHP389, 1) that modulate MAPK signaling in vivo. These studies also served as the basis for further scaffold morphing and optimization, detailed in the following manuscript.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Activation of SHP2 phosphatase, encoded by the gene PTPN11, is genetically associated with multiple cancer types, including juvenile myelomonocytic leukemia, B-cell acute lymphoblastic leukemia, and acute myeloid leukemia.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> SHP2 activating mutations also occur in solid tumors, including lung adenocarcinoma, colon cancer, neuroblastoma, melanoma, and hepatocellular carcinoma.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) composed of a C-terminal domain, a PTP domain, and two N-terminal Src homology 2 (SH2) domains. In its basal state, SHP2 adopts an autoinhibited conformation, which associates the SH2 and PTP domains and restricts substrate access to the catalytic site. Activation of SHP2 occurs via binding of bis-phosphotyrosyl peptides (e.g., IRS-1) to the SH2 domains, disrupting the SH2-PTP association. The resulting conformational change exposes the catalytic site and activates the enzyme by relieving autoinhibition, promoting cancer-dependent phosphatase activity.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">SHP2 is involved in numerous oncogenic cell-signaling cascades, including the canonical rat sarcoma protein (RAS)âextracellular signal-regulated kinase (ERK), phosphoinositide 3-kinase (PI3K)âprotein kinase B (AKT), and Janus kinase (JAK)âsignal transducer and activator of transcription protein (STAT) pathways.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The role of SHP2 in growth signaling via RAS/ERK/mitogen-activated protein kinase (MAPK) is more precisely defined, as SHP2 was reported to bind with dephosphorylate RAS and increase RASâRAF association, activating downstream proliferative signaling.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Furthermore, the role of SHP2 in the T-cell programmed cell death/checkpoint pathway (PD-L1/PD-1) contributing to immune evasion is under investigation.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> The PD-1/SHP2/STAT1/T-bet signaling axis mediates the suppressive effects of PD-1 on Th1 tumor immunity. Inhibition of PD-1 or SHP2 is therefore expected to restore Th1 immunity and T-cell activation, countering immunosuppression within the tumor microenvironment. Given recent clinical success of anti-PD-1 and PD-L1 therapeutics,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> small-molecule SHP2 inhibitors for cancer immunotherapy are highly desired clinical assets.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Previously, we reported the identification of two new allosteric binding sites for SHP2 inhibition.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Initial medicinal chemistry efforts identified a moderately potent, selective, and orally bioavailable inhibitor, SHP099 (<b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><b>2</b> stabilizes an inactive conformation by concurrent binding to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains. The SHP099-inhibited conformation of SHP2 resembles the published inactive apo structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> in which the N-terminal SH2 domain blocks the active site, resulting in autoinhibition of PTP activity. The continued optimization of the aminopyrazines will be described at a later time, separately from our published patent applications.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> We have also described a second allosteric binding modality and found that dual small-molecule allosteric binding via both mechanisms was possible.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Taken together, these pivotal publications and patent application disclosures have stimulated wide interest from the scientific community.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Both academic institutions<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and biopharmaceutical companies<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> have disclosed drug discovery programs, exploiting related chemical matter that utilizes the initial allosteric modality. In this, the first of two articles, we report the design rationale and structureâactivity relationship (SAR) studies that led to the identification of inhibitors across multiple fused bicyclic chemical series, including the potent and selective pyrazolopyrimidinones, e.g., SHP389 (<b>1</b>). These studies also served as the basis for continued scaffold evolution and optimization.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SHP2 binding interactions with (a) <b>2</b>, (b) <b>3</b>, and (c) <b>4</b>. PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD9">6MD9</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDA">6MDA</a>, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As part of a comprehensive program directed at allosteric SHP2 inhibitors, we conducted a structure-based prioritization of chemical matter identified through high-throughput screening.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Comparison of the binding pose of our previously disclosed SHP2 inhibitor <b>2</b> with the SHP2-cocrystal structure of HTS hits <b>3</b> and <b>4</b> (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD9">6MD9</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDA">6MDA</a>, respectively) revealed several conserved proteinâligand interactions (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). For example, all three ligands engage a Piâcation interaction between the haloarene and the guanidinium of R111. The haloarene of each ligand is also framed by Van der Waals interactions with the lipophilic sidechains P491 and L254. In the case of pyrazolopyridine <b>4</b>, the pendant carboxylate accesses an additional water-mediated interaction with R111 and a direct polar interaction with N217. Both <b>2</b> and <b>4</b> individually form an additional polar interaction with the backbone carbonyl of E250 with aniline and pyrazole proton donors, respectively, whereas <b>3</b> lacks the required H-bond donor. Of the three structures, only <b>2</b> contained a hydrogen bond donor contacting the F113 backbone carbonyl.</div><div class="NLM_p">A pharmacophore model adopted from <b>2</b>, <b>3</b>, and <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a) broadly characterized SHP2 allosteric pocket ligands as being composed of the following: an H-bond donor to the backbone carbonyl of E250; an H-bond acceptor to the guanidinium<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> of R111; an H-bond donor to F113; a Piâcation interaction with R111; and van der Waals interactions between the pendant arene and lipophilic residues P491 and L254. Accounting for all interactions implied by this model, pyrazolopyrimidinone <b>5</b> was envisioned, which combines the chloroarene and amine features of <b>2</b>, the 5,6-fused, bicyclic core of <b>3</b> and <b>4</b>, and the E250 binding NâH donor present in <b>2</b> and <b>4</b>. Consistent with our design hypothesis, pyrazolopyrimidinone <b>5</b> was found to potently inhibit the biochemical activity of SHP2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b, IC<sub>50</sub> = 0.067 Î¼M) and inhibited SHP2-mediated phosphorylation of ERK kinase (IC<sub>50</sub> = 0.746 Î¼M) and demonstrated a modest antiproliferative effect in a KYSE520 cell line (IC<sub>50</sub> = 4.76 Î¼M). Analysis of the cocrystal structure of <b>5</b> in the SHP2 allosteric binding pocket (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c) confirmed engagement of all interactions implicated in the pharmacophore model (vide supra). In addition to these predicted interactions, the pyrimidinone carbonyl participated in a water-mediated interaction with N127 and T219 whereas the tertiary amine donated a proton in an H bond to E249. Compound <b>5</b> also had an acceptable pharmacokinetic (PK) profile in mouse (Cl 34 mL/min/kg, 25% oral bioavailability), supporting the further optimization of the pyrazolopyrimidinone class for improved potency and selectivity over the human ether-a-go-go related gene (hERG) channel (IC<sub>50</sub> = 0.200 Î¼M).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Pharmacophore model derived from <b>2</b>, <b>3</b>, and <b>4</b>. Blue is H-bond donor. Red is H-bond acceptor. Green is lipophilic. (b) In vitro profile of designed ligand <b>5</b>. (c) Cocrystal of <b>5</b> in SHP2 allosteric pocket (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of pyrazolopyrimidinones (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) began with the reaction of 6-chlorouracil <b>6</b> with hydrazine hydrate to provide intermediate <b>7</b> after condensation with 4-methoxybenzaldehyde. Alternatively, the benzyl-protected intermediate <b>8</b> was accessed by a similar sequence using benzaldehyde. Piperidine-catalyzed cyclocondensation of <b>7</b> with an aromatic aldehyde completed the carbon framework present in intermediate <b>9</b>. Intermediate <b>8</b> was derivatized by parallel synthetic strategies, one of which required generation of the halide <b>10</b>. Intermediates <b>8</b>, <b>9</b>, and <b>10</b> were further advanced by installation of aliphatic amines under peptide coupling or SnAr conditions to provide after deprotection, final pyrazolopyrmidinone products <b>11</b>â<b>25</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyrazolopyrimidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>NNH<sub>2</sub>âH<sub>2</sub>O, EtOH, 80 Â°C; (b) 4-methoxybenzaldehyde, MeOH; (c) R<sup>1</sup>COH, piperidine, dimethylformamide (DMF), <i>i</i>-PrOH, 90 Â°C; (d) R<sup>2</sup>R<sup>3</sup>NH<sub>2</sub>, (benzotriazol-1-yl-oxy)tris(dimethylamino)phosphonium hexafluorophosphate, DMF (e) trifluoroacetic acid (TFA), 1,2-dichloroethene (DCE), 70 Â°C; (f) benzaldehyde, MeOH; (g) <i>t</i>-BuONa, dimethyl sulfoxide (DMSO), O<sub>2</sub>; (h) POCl<sub>3</sub>, Me<sub>4</sub>N<sup>+</sup>I<sup>â</sup>, 100 Â°C; and (i) R<sup>2</sup>R<sup>3</sup>NH<sub>2</sub>, <i>N</i>,<i>N</i>-diisopropylethylamine, <i>N</i>-methyl-2-pyrrolidone, Î¼-wave, 120 Â°C.</p></p></figure><div class="NLM_p">We observed water with variable weak density across cocrystal structures in the vicinity of the basic amine of <b>5</b> (e.g., <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). Elaboration of the amine substituent<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> provided a handle for modulating the biochemical and cellular potency of prototype <b>5</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Extending the basic amine to displace the proposed water returned a modest improvement in SHP2 biochemical inhibition with improvement of hERG selectivity (e.g., compound <b>11</b>). However, the modest biochemical improvement did not clearly benefit either the <i>p</i>-ERK or KYSE proliferation cellular assays. Cyclization to the spiro[4.5]-amine (<b>12</b>) provided little additional benefit to SHP2 biochemical potency but provided a >10-fold improvement in the <i>p</i>-ERK and KYSE antiproliferation cellular assays. This was likely due to an increase in affinity, as the biochemical IC<sub>50</sub> ranged from 0.009 to 0.045 Î¼M (the average of three experiments shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, 0.031 Î¼M). Tetrahydrofuran analog <b>13</b> was designed to mitigate amine basicity but was less potent than <b>12</b> by all measures. <b>13</b> presented an improved lipophilic efficiency (LipE), owing to a one log reduction in lipophilicity. The expected reduction in lipophilicity and basicity provided by ether <b>13</b> produced only a minor benefit to hERG inhibition. In an attempt to restore cellular potency by rebalancing lipophilicity, the spirocyclic ether was methylated to provide <b>14</b>. This maneuver improved both the <i>p</i>-ERK modulation (IC<sub>50</sub> = 0.012 Î¼M) and enhanced by 10-fold the antiproliferative activity against KYSE520 cells (IC<sub>50</sub> = 0.167 Î¼M).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Optimization of the Spirocyclic Amine for Potency and hERG Selectivity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0008.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">In light of the promising biochemical and cellular data, we sought to mitigate the hERG liability initially observed in the dofetilide binding assay and later confirmed by Q-Patch (<b>14</b>: IC<sub>50</sub> = 0.70 Î¼M). Bearing in mind our SHP2 allosteric pocket pharmacophore model (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a), we modeled potential binding interactions for various alternative heterocyclic cores within the SHP2 allosteric pocket. Our structural analysis indicated that retraction of the H-bond acceptor carbonyl presented by the pyrazolopyrimidinone core, as exemplified by pyrazolopyrazine <b>15</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), would retain the native donorâacceptor SHP2 interactions. A docking analysis of <b>15</b> in the SHP2 allosteric pocket further supported this hypothesis; the pyrazine nitrogen modeled within Van der Waals radius for interaction with R111 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Consistent with the elevated lipophilicity, <b>15</b> was not only a remarkably potent SHP2 inhibitor (biochemical IC<sub>50</sub> = 0.006 Î¼M) with substantial cellular potency (<i>p</i>-ERK IC<sub>50</sub> = 0.031 Î¼M, KYSE520 antiproliferative IC<sub>50</sub> = 0.46 Î¼M) but also potently inhibited the hERG channel (IC<sub>50</sub> = 0.004 Î¼M). Whereas the pyrazole NâH of the pyrazolopyrimidine heterocycle was deemed important due to the E250 backbone carbonyl contact, other heteroatoms in the core formed no H-bond acceptor interactions and were removed. The resulting pyrrolopyrazine, <b>16</b>, was moderately potent in biochemical (IC<sub>50</sub> = 0.039 Î¼M) and <i>p</i>-ERK KYSE520 cellular (IC<sub>50</sub> = 0.473 Î¼M) assays. Unfortunately, neither <b>15</b> nor <b>16</b> improved the selectivity over the hERG channel.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>15</b> modeled into the SHP2 allosteric binding pocket preserves R111 interaction. (Docking model built from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Core 5,6-Fused Bicycle SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0010.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">After optimizing the spirocyclic amine for biochemical and cellular potency and deprioritizing core heterocycle modifications as a means for improving hERG inhibition, we next focused our SAR study at the pendant chloroarene. Substituting the dichlorophenyl subunit in <b>11</b>â<b>16</b> with dichloropyridine <b>17</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) moderately mitigated hERG inhibition (IC<sub>50</sub> = 1.2 Î¼M). The heteroatom insertion substantially reduced lipophilicity by â¼1.5 log units (vs matched pair <b>14</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), resulting in improved lipophilic efficiency (<b>17</b>: LipE = 4.9). Compound <b>17</b> had moderate <i>p</i>-ERK cellular potency (<i>p</i>-ERK IC<sub>50</sub> = 0.093 Î¼M), and the antiproliferative effects were blunted (antiproliferative IC<sub>50</sub> = 2.6 Î¼M). The net benefits of tuning polarity and lipophilicity via the pendant arene prompted further investigation.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of the Pyridine Substituent for Potency and hERG Selectivity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0009.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0011.gif" alt="" id="fx5" /></img><div></div></div><div class="NLM_p">The unsubstituted pyridine <b>18</b> delivered superior biochemical potency (IC<sub>50</sub> = 0.008 Î¼M) with no discernable hERG signal and high lipE (5.9). However, <b>18</b> did not deliver a concomitant improvement in cellular potency, presumably due to the lower membrane permeability resulting from a log unit reduction in lipophilicity relative to dichloropyridine <b>17</b>. Replacement of the 2,3-dichloropyridine motif with 2-amino, 3-chloro aminopyridine <b>19</b> significantly reduced hERG activity and provided a new vector for synthetic elaboration. Appending small lipophilic groups, including methyl (<b>20</b>) and cyclopropyl (<b>1</b>), improved SHP2 biochemical and cellular potency in trend with increasing lipophilicity. Cyclobutane analog <b>21</b> resulted in a steep reduction in biochemical and cellular potency, presumably due to increased steric bulk. Overall, we observed that hERG IC<sub>50</sub> roughly tracked lipophilicity, wherein progressively lipophilic molecules displayed an increasingly severe hERG liability.</div><div class="NLM_p">Although the collection of heteroatoms presented by 2-amino, 3-chloropyridine might conceivably access specific interactions within the SHP2 allosteric pocket, our SAR suggested otherwise. For example, reconfiguration of the heteroatom presentation, as in regioisomeric aminoyridine <b>22</b>, also delivered promising biochemical potency that was robustly reproduced in cells. That <b>22</b> was sufficiently permeable for cellular potency was unexpected given the low <i>c</i>âlogâ<i>P</i>. For comparison, <b>22</b> was substantially less lipophilic than <b>1</b> (<i>c</i>âlog<i>âP</i> = 1.2 vs 2.0, respectively), yet delivered equivalent cellular potency. However, the lower lipophilicity of <b>22</b> did not fully relieve hERG promiscuity (IC<sub>50</sub> = 6.6 Î¼M).</div><div class="NLM_p">More dramatic variations of the pyrazolopyrimidinone substructure were also anticipated to bind the SHP2 allosteric tunnel. For example, a docking study (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) supported the hypothesis that substitution of the ArâAr bond present in <b>19</b> with the ArâSâAr motif, as present in the HTS screening hit <b>24</b>, could satisfy the pharmacophore model developed for the 5,6-fused bicyclic chemical series (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). The structural overlay demonstrated rough alignment of the core heterocycle and flanking arene substructure. Bearing in mind these design considerations, <b>23</b> was characterized as a potent biochemical inhibitor (IC<sub>50</sub> = 0.027 Î¼M). Cellular characterization further demonstrated the potency of <b>23</b> in the <i>p</i>-ERK assay (IC<sub>50</sub> = 0.096 Î¼M) and the KYSE antiproliferation assay (IC<sub>50</sub> = 0.72 Î¼M). As previously observed, the 2-amino, 3-chlopropyridine motif correlated with low hERG affinity (IC<sub>50</sub> > 30 Î¼M).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of <b>24</b> and <b>19</b> supports binding hypothesis of hybrid <b>23</b>. PDB code of SHP2-<b>24</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDD">6MDD</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Considering the substantial structural changes made to the flanking substituents of the root design <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), we were motivated to better understand the nature of the evolving proteinâligand interactions. To this end, a cocrystal structure of <b>1</b> was obtained (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The major polar interactions included those anticipated by the pharmacophore model (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a): a polar interaction between the pyrazolopyrimidinone carbonyl and R111; a polar interaction between pyrazolopyrimidinone NâH and E250; a Piâcation interaction between the 2-amino, 3-chloropyridine heterocycle and R111; and an H-bond donor interaction between the spirocyclic amine and F113. Previously unobserved interactions included water-mediated interactions between the pyrazolopyrimidinone carbonyl, T219, and N217, as well as polar interactions between the spirocyclic amine and the F113, E110, and T108 triad. Conspicuously absent were polar interactions with the 2-aminocyclopyropyl, 3-chloropyridine substructure present in <b>1</b>. This observation helped rationalize the equivalent potency of structurally diverse regioisomeric aminopyridine <b>22</b>. Lacking donorâacceptor interactions in this region of the SHP2 allosteric binding pocket, regioisomeric aminopyridines produced comparable biochemical inhibition. A key observation from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> is that the aminopyridine-based analogs delivered hERG selective SHP2 inhibitors.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cocrystal structure of <b>1</b> in the SHP2 allosteric pocket (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDC">6MDC</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of their overall in vitro profile, <b>1</b> and <b>14</b> were prioritized for additional profiling, and were selective versus a panel of 30 G-protein-coupled receptors (GPCRs), ion channels, nuclear receptors, transporters, enzymes, and kinases (IC<sub>50</sub> > 30 Î¼M). Whereas preliminary evaluation of hERG binding by a dofetilide binding assay indicated <b>1</b> weakly inhibited hERG (IC<sub>50</sub> = 17 Î¼M), a more detailed evaluation by Q-Patch demonstrated that the compound did not engage a functional hERG interaction (IC<sub>50</sub> > 30 Î¼M). The in vitro metabolic clearance profile (mouse ER = 27%, rat ER = 46%) and clean CYP450 profile (CYP 3A4, 2D6, and 2C9 IC<sub>50</sub> >50 Î¼M) of <b>1</b> encouraged further in vivo evaluation. Compound <b>1</b> was dosed IV/PO at 1/5 mg/kg, respectively, to male Sprague Dawley rats in a crossover study design. Compound <b>1</b> demonstrated a moderate-high clearance (â¼83% hepatic extraction) which was under predicted in vitro by rat liver microsomes (Cl = 26.1 Î¼L/min/mg, <i>T</i><sub>1/2</sub> = 53.2 min) assuming a hepatic blood flow of 55 mL/min/kg. The volume of distribution was moderate-high (3.9 L/kg) with a terminal half-life of 2.7 h. Following oral administration, the compound had low oral bioavailability (â¼2% F), which is consistent with poor in vitro permeability (PAMPA). This limited exposure therefore prevented further pharmacologic evaluation of <b>1</b> in a mouse tumor xenograft model.</div><div class="NLM_p">We thus turned to <b>14</b>, a potent compound (KYSE520 <i>p</i>-ERK IC<sub>50</sub> = 0.093 Î¼M; antiproliferative IC<sub>50</sub> = 0.170 Î¼M) with a less selective profile (hERG IC<sub>50</sub> = 0.29 Î¼M) to characterize in vivo pharmacodynamic markers. In addition to its robust antiproliferative effects, <b>14</b> had acceptable stability in mouse liver microsomes (Cl = 36.8, Î¼L/min/mg, <i>T</i><sub>1/2</sub> = 60.2 min) and was sufficiently soluble (pH = 6.8 equilibrium solubility = 0.42 mM) to enable PK pharmacokinetic evaluation. Compound <b>14</b> was dosed IV/PO at 1 and 5 mg/kg, respectively, to male Sprague Dawley rats in a crossover study design. Compound <b>14</b> demonstrated high clearance (>hepatic blood flow), a high volume of distribution (10.5 L/kg), a moderate half-life (<i>T</i><sub>1/2</sub> = 4.6 h), and moderate oral bioavailability (F = 51%). Additionally, the PK and in vivo activity of <b>14</b> was assessed in mice subcutaneously implanted with the KYSE520 carcinoma cell line. Tumor-bearing mice were given a single oral dose of <b>14</b> at 10, 30, and 100 mg/kg. Free concentrations of <b>14</b> (89% mouse plasma protein bound) correlated well with the MAPK pharmacodynamic markers, <i>p</i>-ERK and DUSP6 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The maximal PD effect, as determined by <i>p</i>-ERK and DUSP6 concentrations in blood, was observed at 100 mg/kg for at least 8 h, with PD rebound correlating with clearance of <b>14</b>.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PKâPD of <b>14</b> at 10, 30, and 100 mg/kg in mice bearing KYSE520 xenografts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">As part of a program directed at identifying allosteric SHP2 inhibitors, we successfully merged the salient structural features of established SHP2 ligands (e.g., <b>2</b>) with new HTS hits (e.g., <b>3</b>, <b>4</b>, <b>25</b>). This pharmacophore blending exercise produced pyrazolopyrimidinone <b>5</b>, which contains a 5,6-fused heterocycle that was confirmed by X-ray crystallography to bind to the same allosteric tunnel site as <b>2</b>. Extension and conformational restriction of the amine substituent led to the identification of <b>14</b>, which elicited a robust PKâPD correlation in a mouse tumor xenograft model. This result further motivated us to improve the poor hERG selectivity associated with the 5,6-fused bicyclic series. Substitution of the pyrazolopyrimidinone core with other 5,6-fused heterocycles provided new potent allosteric scaffolds with similar binding modalities but failed to address the hERG selectivity. A more successful approach was found through modification of the pendant chloroarene presented by <b>14</b>. Decoration of the chloroarene with nitrogen heteroatoms, as in aminopyridine <b>19</b>, provided a firm handle for improving hERG selectivity and a new vector for synthetic manipulation. Continued experimentation demonstrated that cyclopropane <b>1</b> successfully balanced high biochemical and cellular potency with impressive hERG selectivity (Q-Patch IC<sub>50</sub> > 30 Î¼M). While our in vitro objectives were met in this study, compound <b>1</b> ultimately fell short of demonstrating sufficiently robust oral bioavailability to support PKâPD and tumor efficacy studies. Taken together, these investigations demonstrated the structural determinants governing efficient, cellularly potent, allosteric SHP2 binders from various 5,6-fused bicyclic frameworks, a clear strategy for effectively improving hERG selectivity, and ultimately served as a basis for further optimization.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound Synthesis and Characterization</h3><div class="NLM_p">Compound purity was assessed by high-pressure liquid chromatography (HPLC) to confirm >95% purity. All solvents employed were commercially available anhydrous grade, and reagents were used as received unless otherwise noted. A Biotage Initiator Sixty system was used for microwave heating. Flash column chromatography was performed on either an Analogix Intelliflash 280 using Si 50 columns (32â63 Î¼m, 230â400 mesh, 60 Ã) or on a Biotage SP1 system (32â63 Î¼m particle size, KP-Sil, 60 Ã pore size). Preparative high-pressure liquid chromatography (HPLC) was performed using a Waters 2525 pump with a 2487 dual wavelength detector and 2767 sample manager. Columns were Waters C18 OBD 5 Î¼m, either 50 Ã 100 mm<sup>2</sup> Xbridge or 30 Ã 100 mm<sup>2</sup> Sunfire. NMR spectra were recorded on Bruker AV400 (Avance 400 MHz) or AV600 (Avance 600 MHz) instruments. Analytical liquid chromatographyâmass spectrometry (LCMS) was conducted using an Agilent 1100 series with UV detection at 214 and 254 nm and an electrospray mode (ESI) coupled with a Waters ZQ single quad mass detector. One of the three methods was used: (method A) 5â95% acetonitrile/H<sub>2</sub>O with 5 mM ammonium formate with a 2 min run, 3 Î¼L injection through an inertisil C8 3 cm Ã 5 mm Ã 3 Î¼m; (method B) 20â95% acetonitrile/H<sub>2</sub>O with 10 mM ammonium hydroxide with a 2 min run, 3 Î¼L injection through an inertisil C8 3 cm Ã 5 mm Ã Î¼m; (method C) 5â95% acetonitrile/H<sub>2</sub>O with 0.05% trifluoroacetic acid with a 2 min run, 3 Î¼L injection through a Sunfire C18 3.5 Î¼m 3.0 Ã 30 mm<sup>2</sup>. Purity of all tested compounds was determined by LC/ESI-MS Data recorded using an Agilent 6220 mass spectrometer with electrospray ionization source and Agilent 1200 liquid chromatography. The mass accuracy of the system has been found to be <5 ppm. HPLC separation was performed at 75 mL/min flow rate with the indicated gradient within 3.5 min with an initial hold of 10 s. Ammonia hydroxide (10 mM) or TFA (0.1 M) was used as the modifier additive in the aqueous phase.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Synthesis of SHP389: 6-((3<i>S</i>,4<i>S</i>)-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(3-chloro-2-(cyclopropylamino)pyridin-4-yl)-5-methyl-2,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>1</b>)</h4><div class="NLM_p">Hydrazine hydrate (9.17 mL, 187 mmol) was added to a solution of 6-chloro-3-methyluracil (10 g, 62.3 mmol) in ethanol (200 mL). The resulting mixture was stirred at 80 Â°C. The slurry became increasingly thick over the course of 10 min. The heating was continued for 1 h; then, the heat bath was removed and the reaction mixture was allowed to cool to room temperature for 1 h. The resulting suspension was filtered, and the filter cake was dried under vacuum. The intermediate 6-hydrazinyl-3-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione was obtained as a white powder (9.7 g, 100% yield) and was used directly in the next transformation.</div><div class="NLM_p">To a suspension of 6-hydrazinyl-3-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (5.26 g, 33.7 mmol) in MeOH (25 mL) was added 2,3-dichlorobenzaldehyde (5.50 g, 40.4 mmol). The result mixture was stirred at room temperature for 30 min. The slurry became very thick and was diluted with methanol (25 mL) to facilitate stirring. The reaction was maintained for an additional 30 min, at which point the reaction was complete by LCMS. The slurry was filtered and the filter cake was dried under vacuum for 16 h to provide 6-((4-methoxybenzyl)diazenyl)-3-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione as a white solid (8.0 g, 87% yield). LCMS: <i>m</i>/<i>z</i> 280 (M + 1)<sup>+</sup>, <i>R</i><sub>t</sub> = 0.43 min.</div><div class="NLM_p">To a suspension of 6-((4-methoxybenzyl)diazenyl)-3-methylpyrimidine-2,4(1<i>H</i>,3H)-dione (0.68 g, 2.479 mmol) in DMF (8 mL) and <i>i</i>-PrOH (4 mL) was added 2,3-dichloroisonicotinaldehyde (0.436 g, 2.479 mmol) and piperidine (0.241 mL, 2.430 mmol). The result mixture was stirred at 85 Â°C for 1 h. At completion, the reaction mixture was partitioned between water (50 mL) and ethyl acetate (50 mL). The layers were separated, and the aqueous layer was washed with ethyl acetate (50 mL). The combined organics were washed with brine (40 mL), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude was purified by flash chromatography over silica gel (0â10% methanol/DCM eluent) to afford 3-(2,3-dichloropyridin-4-yl)-2-(4-methoxybenzyl)-5-methyl-2<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine-4,6(5<i>H</i>,7<i>H</i>)-dione as a yellow solid (420 mg, 39% yield, 90% purity). LCMS: <i>m</i>/<i>z</i> 432 (M + 1)<sup>+</sup>, <i>R</i><sub>t</sub> = 1.29 min.</div><div class="NLM_p">To a suspension of 3-(2,3-dichloropyridin-4-yl)-2-(4-methoxybenzyl)-5-methyl-2<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine-4,6(5<i>H</i>,7<i>H</i>)-dione (500 mg, 1.16 mmol) in DMSO (3 mL) was added cyclopropanamine (330 mg, 5.78 mmol). The resulting mixture was microwave-heated to 140 Â°C for 20 min. At completion, the reaction was partitioned between water (15 mL) and ethyl acetate (15 mL). The organics were separated, and the aqueous layer was washed with ethyl acetate (2 Ã 10 mL). The combined organics were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude was purified by flash chromatography over silica gel (0â70% ethyl acetate/heptane eluent) to provide 3-(3-chloro-2-(cyclopropylamino)pyridin-4-yl)-2-(4-methoxybenzyl)-5-methyl-2,7-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine-4,6(5<i>H</i>)-dione (280 mgs, 53% yield). LCMS: <i>m</i>/<i>z</i> 453.2 (M + 1)<sup>+</sup>, <i>R</i><sub>t</sub> = 0.65 min.</div><div class="NLM_p">To a solution of 3-(3-chloro-2-(cyclopropylamino)pyridin-4-yl)-2-(4-methoxybenzyl)-5-methyl-2,7-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine-4,6(5<i>H</i>)-dione (280 mg, 0.618 mmol) in DMF (2 mL) was added (benzotriazol-1-yl-oxy)tris(dimethylamino)phosphonium hexafluorophosphate (820 mgs, 1.855 mmol). After 15 min, the mixture was treated with (3<i>S</i>,4<i>S</i>)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine (195 mgs, 0.804 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (753 mgs, 4.95 mmol). At completion, the reaction was partitioned between water (15 mL) and ethyl acetate (15 mL). The organics were separated, and the aqueous phase was washed with ethyl acetate (2 Ã 10 mL). The combined organics were washed with brine (10 mL), dried over MgSO<sub>4</sub>, and concentrated. The crude was purified by flash chromatography over silica gel (0â5% MeOH/DCM eluent) to provide 6-((3<i>S</i>,4<i>S</i>)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(3-chloro-2-(cyclopropylamino)pyridin-4-yl)-2-(4-methoxybenzyl)-5-methyl-2,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (170 mg, 45% yield). LCMS: <i>m</i>/<i>z</i> 606.0 (M + 1)<sup>+</sup>, <i>R</i><sub>t</sub> = 0.72 min.</div><div class="NLM_p last">A solution of 6-((3<i>S</i>,4<i>S</i>)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(3-chloro-2-(cyclopropylamino)pyridin-4-yl)-2-(4-methoxybenzyl)-5-methyl-2,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (170 mg, 0.281 mmol) in TFA (3 mL) and DCE (3 mL) was heated to 70 Â°C. After 2 h, the reaction was concentrated, then dissolved in DCM, treated with heptane, and concentrated. The crude was purified by prep HPLC to provide 6-((3<i>S</i>,4<i>S</i>)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(3-chloro-2-(cyclopropylamino)pyridin-4-yl)-5-methyl-2,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (53 mg, 38% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 8.04 (d, <i>J</i> = 5.05 Hz, 1 H), 6.76 (d, <i>J</i> = 5.31 Hz, 1 H), 4.20â4.26 (m, 1 H), 3.85 (d, <i>J</i> = 8.59 Hz, 1 H), 3.70 (d, <i>J</i> = 8.84 Hz, 1 H), 3.43â3.53 (m, 7 H), 2.99â3.17 (m, 5 H), 2.74 (tt, <i>J</i> = 7.01, 3.47 Hz, 1 H), 1.86â2.06 (m, 3 H), 1.67â1.82 (m, 3 H), 1.22 (d, <i>J</i> = 6.57 Hz, 4 H), 0.79â0.87 (m, 2 H), 0.55â0.63 (m, 2 H). LCMS: <i>m</i>/<i>z</i> 485.3 (M + 1)<sup>+</sup>, <i>R</i><sub>t</sub> = 0.88 min.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Protein Expression and Purification</h3><div class="NLM_p last">The gene encoding human SHP2 from residues Met1âLeu525 was inserted into a pET30 vector. A coding sequence for a 6Ã histidine tag followed by a tobacco etch virus (TEV) protease consensus sequence was added 5â² to the SHP2 gene sequence. The construct was transformed into BL21 Star (DE3) cells and grown at 37 Â°C in Terrific Broth containing 100 Î¼g/mL kanamycin. At an OD600 of 4.0, SHP2 expression was induced using 1 mM IPTG. Cells were harvested following overnight growth at 18 Â°C. Cell pellets were resuspended in lysis buffer containing 50 mM TrisâHCl, pH 8.5, 25 mM imidazole, 500 mM NaCl, 2.5 mM MgCl2, 1 mM tris(2-carboxyethyl)phosphine (TCEP), 1 Î¼g/mL DNase1, and complete ethylenediaminetetraacetic acid (EDTA)-free protease inhibitor and lysed using a microfluidizer, followed by ultracentrifugation. The supernatant was loaded onto a HisTrap HP chelating column in 50 mM TrisâHCl, 25 mM imidazole, 500 mM NaCl, and 1 mM TCEP, and protein was eluted with the addition of 250 mM imidazole. The N-terminal histidine tag was removed with an overnight incubation using TEV protease at 4 Â°C. The protein was subsequently diluted to 50 mM NaCl with 20 mM TrisâHCl, pH 8.5, 1 mM TCEP, then applied to a HiTrap Q FastFlow column equilibrated with 20 mM Tris, pH 8.5, 50 mM NaCl, 1 mM TCEP. The protein was eluted with a 10-column volume gradient from 50 to 500 mM NaCl. Fractions containing SHP2 were pooled and concentrated, then loaded onto a HiLoad Superdex200 PG 16/100 column, exchanging the protein into the crystallization buffer, 20 mM TrisâHCl, pH 8.5, 150 mM NaCl, and 3 mM TCEP. The protein was concentrated to 15 mg/mL for use in crystallization. Crystallization, differential scanning fluorimetry (DSF), and high-throughput screening assays used the 1-525 construct of SHP2, whereas biochemical assays used the 2-593 construct.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biochemical Assay</h3><div class="NLM_p">SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation step leads to the release of the autoinhibitory interface of SHP2, which in turn renders the SHP2 PTP active and available for substrate recognition and reaction catalysis. The catalytic activity of SHP2 was monitored using the surrogate substrate DiFMUP in a prompt fluorescence assay format. More specifically, the phosphatase reactions were performed at room temperature in a 384-well black polystyrene plate, with a flat bottom, low-flange, nonbinding surface (Corning, cat. no. 3575) using a final reaction volume of 25 Î¼L and the following assay buffer conditions: 60 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.2, 75 mM NaCl, 75 mM KCl, 1 mM EDTA, 0.05% P-20, 5 mM dithiothreitol (DTT).</div><div class="NLM_p last">The inhibition of SHP2 from the tested compounds (concentrations varying from 0.003 to 100 Î¼M) was monitored using an assay in which 0.5 nM of SHP2 was incubated with of 0.5 Î¼M of peptide IRS1_pY1172(dPEG8)pY1222(sequence H2N-LN(pY)IDLDLV- (dPEG8)LST(pY)ASINFQK-amide). After 30â60 min incubation at 25 Â°C, the surrogate substrate DiFMUP (Invitrogen, cat. no. D6567, 200 Î¼M) was added to the reaction and incubated at 25 Â°C for 30 min (200 Î¼M for residue 2-593, 100 Î¼M for residue 1-525 construct). The reaction was then quenched by the addition of 5 Î¼L of a 160 Î¼M solution of bpV(Phen) (Enzo Life Sciences cat. no. ALX-270-204). The fluorescence signal was monitored using a microplate reader (Envision, PerkinElmer) using excitation and emission wavelengths of 340 and 450 nm, respectively. The inhibitor doseâresponse curves were analyzed using normalized IC<sub>50</sub> regression curve fitting with control-based normalization.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cellular Assay</h3><div class="NLM_p last"><i>p</i>-ERK cellular assay using the AlphaScreen SureFire Phospho-ERK1/2 Kit (PerkinElmer) was performed as follows: KYSE520 cells (30â000 cells/well) were grown in a 96-well plate culture overnight and treated with SHP2 inhibitors at concentrations of 20, 6.6, 2.2, 0.74, 0.24, 0.08, and 0.027 Î¼M for 2 h at 37 Â°C. Incubations were terminated by addition of 30 Î¼L of lysis buffer (PerkinElmer) supplied with the SureFire phospho-extracellular signal-regulated kinase (<i>p</i>-ERK) assay kit (PerkinElmer). Samples were processed according to the manufacturerâs directions. The fluorescence signal from <i>p</i>-ERK was measured in duplicate using a 2101 multilabel reader (PerkinElmer Envision). The percentage of inhibition was normalized by the total ERK signal and compared with the DMSO vehicle control.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cell Proliferation Assay</h3><div class="NLM_p last">Cells (1500 cells/well) were plated onto 96-well plates in 100 Î¼L of medium (RPMI-1640 containing 10% fetal bovine serum, Lonza). Compounds with various concentrations (1.25, 2.5, 5, 10, and 20 Î¼M) were added 24 h after cell plating. At day 5, 50 Î¼L of Celltiter-Glo reagent (Promega) was added and the luminescent signal was determined according to the supplierâs instruction (Promega).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Selectivity Assays</h3><div class="NLM_p last">Activity of <b>1</b> vs a panel composed of select GPCR, ion channel, nuclear receptor, transporter, enzyme, and kinase targets is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_001.csv" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Differential Scanning Fluorimetry</h3><div class="NLM_p last">DSF was used as a method to identify compounds that stabilize SHP2 from thermal denaturation. The following assay conditions were used: 100 Î¼g/mL SHP2, 5Ã SYPRO Orange dye (5000Ã concentrate in DMSO; Life Technologies), 100 mM Bis-Tris (pH 6.5), 100 mM NaCl, 0.25 mM TCEP, and 5% DMSO. The final compound concentration evaluated was 100 Î¼M. To carry out the experiment, 9.5 Î¼L of DSF assay solution was dispensed into an assay plate (LightCycler; 480 multiwell plate 384 white) containing 500 nL of compound dissolved in DMSO and then mixed. The final assay volume was 10 Î¼L per well in a 384-well format. Plates were then sealed after reagent addition, centrifuged at 1000 rpm for 1 min, and read on a Bio-Rad C1000 thermal cycler with a CFX384 real-time system using an excitation of 465 nm and an emission at 580 nm. The temperature was ramped from 25 to 75 Â°C, and measurements were taken at 0.5 Â°C increments. The melting temperature (<i>T</i><sub>m</sub>) of the raw fluorescence data was identified as the midpoint of the transitions via a semiparametric fit. The Î<i>T</i><sub>m</sub> was determined by comparing the individual Tm values for each compound with the mean <i>T</i><sub>m</sub> of the apo SHP2 protein controls (32 per plate) containing DMSO only.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Crystallization and Structure Determination</h3><div class="NLM_p">Sitting drop vapor diffusion method was used for crystallization, with the crystallization well containing 17% poly(ethylene glycol) 3350 and 200 mM ammonium phosphate and a drop with a 1:1 volume of SHP2 protein and crystallization solution. Crystals were formed within 5 days and subsequently soaked in the crystallization solution with 2.5 mM X. This was followed by cryoprotection using the crystallization solution with the addition of 20% glycerol and 1 mM concentration of compounds <b>1</b>, <b>3</b>, <b>4</b>, <b>5</b>, or <b>24</b>, followed by flash-freezing directly into liquid nitrogen.</div><div class="NLM_p last">Diffraction data for the SHP2/compound <b>2</b> complex is reported elsewhere,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and those for SHP2/compound <b>1</b>, <b>3</b>, <b>4</b>, <b>5</b>, and <b>24</b> complexes were collected on a Dectris Pilatus 6 M detector at beamline 17-ID (IMCA-CAT) at the Advanced Photon Source at Argonne National Laboratories. The data were measured from a single crystal maintained at 100 K at a wavelength of 1 Ã, and the reflections were indexed, integrated, and scaled using XDS.24. The spacegroup of the complex was P21, with two molecules in the asymmetric unit. The structure was determined with Fourier methods, using the SHP2 apo structure1 (PDB accession <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>) with all waters removed. Structure determination was achieved through iterative rounds of positional and simulated annealing refinement using BUSTER 25 with model building using COOT.26. Individual B factors were refined using an overall anisotropic B-factor refinement along with bulk solvent correction. The solvent, phosphate ions, and inhibitor were built into the density in later rounds of the refinement. Data collection and refinement statistics are shown in Tables 1 and 2 of the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_005.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Pharmacophore Model</h3><div class="NLM_p last">A consensus pharmacophore tool with ICM v.3.7-2d was used for visualization of ligand structures from SHP2 crystal structures with <b>1</b>, <b>2</b>, and <b>3</b>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Docking Models</h3><div class="NLM_p last">An initial structure of <b>15</b> was modeled from the crystal structure of <b>1</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDC">6MDC</a>), and R111 conformation was modeled on the basis of a previous observation from SHP099 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>) for a hydrogen bond. Protein force-field parameters were assigned with the protein preparation tool with Maestro v.2014-2 (Schrodinger). Then, the structure was energy-minimized with MacroModel BatchMin v.10.4. <b>18</b> was modeled from the <b>20</b> crystal structure, then minimized with MacroModel. A low-energy conformation around the thioether group of <b>23</b> was obtained with B3LYP/6-31G(d,p) with IEF-PCM water model using Gaussian 03. An initial complex model of <b>23</b> was built on the basis of the rigid molecule overlay to the SHP2-<b>20</b> structure using the low-energy conformation of <b>23</b>. Then, the complex was relaxed using MacroModel using 10 kJ/mol/Ã<sup>2</sup> restraint energy on the low-energy conformation of thioether derived from Gaussian 03.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Pharmacokinetics</h3><div class="NLM_p last">All animal-related procedures were conducted under a Novartis IACUC-approved protocol in compliance with Animal Welfare Act regulations and the Guide for the Care and Use of Laboratory Animals. Male C57BL/6 mice were obtained from Harlan Laboratories. Following iv administration (via tail vein) at 1 mg/kg, approximately 50 Î¼L of whole blood was collected via tail transection, at 0.083, 0.5, 1, 2, 4, and 7 h postdose and transferred to an Eppendorf microcentrifuge tube containing EDTA. Oral administration (at 5 mg/kg) and collection procedures were similar to IV, except with whole blood collection at 0.25, 0.5, 1, 2, 4, and 7 h. The blood was centrifuged at 5000 rpm, and plasma was transferred to a Matrix 96-well plate, capped, and stored frozen (â20 Â°C) for parent compound analysis. Samples were precipitated and diluted with acetonitrile-containing internal standard and prepared for LC/MS/MS. An aliquot (20 Î¼L) of each sample was injected into an API4000 LC/MS/MS system for analysis, and transitions of 352.05 amu (Q1) and 267.10 amu (Q3) were monitored. All pharmacokinetic (PK) parameters were derived from concentrationâtime data by noncompartmental analyses. All PK parameters were calculated with the computer program WinNonlin (version 6.4) purchased from Certara Company (St. Louis, MO). For the intravenous dose, the concentration of unchanged compound at time 0 was calculated on the basis of a logâlinear regression of first two data points to back-extrapolate <i>C</i>(0). The area under the concentrationâtime curve (AUC<sub>last</sub>) was calculated using the linear trapezoidal rule. The bioavailability was estimated from the following equation<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_m001.gif" alt="" id="_i22" /></img></span>Results are expressed as mean. No further statistical analysis was performed.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Tumor Xenograft Experiments</h3><div class="NLM_p last">All animal studies were carried out according to the Novartis Guide for the Care and Use of Laboratory Animals. Six-week old female athymic NU/NU mice (Charles River Labs, MA), were inoculated subcutaneously with KYSE520 esophageal carcinoma cells (ATCC) at a concentration of 2 Ã 10<sup>6</sup> in a suspension containing 50% phenol red-free matrigel (BD Biosciences) in Hankâs balanced salt solution. For PKâPD studies, mice were administered a single dose of vehicle control (0.5% methylcellulose, 0.1% Tween 80) or <b>14</b> by oral gavage once tumors reached roughly 300 mm<sup>3</sup>. Mice were subsequently euthanized at predetermined time points following a single dose of compound at which point plasma and xenograft fragments were harvested for determination of <b>14</b> concentrations and PD modulation. Phospho-ERK PD assessment was carried on lysed frozen tumor tissue fragments following the protocol provided by the Mesoscale Discovery assay whole cell lysis kits (Catalog#: Total ERK1/2: K151DXD, phospho-ERK1/2: K151DWD). Protein concentration was assessed by BCA (Pierce, Catalog # 23225) and 2.5 mg for total ERK or 20 mg for phospho-ERK was loaded onto mesoscale plates. Samples were analyzed by a mesoscale plate reader. Data was analyzed and fold change in phospho-ERK1/2 levels were calculated by normalizing to total ERK concentrations and the ratio of phospho-ERK/total ERK in the vehicle-treated group. DUSP6 PD assessment was carried out by quantitative real-time polymerase chain reaction (PCR). Frozen tumor fragments were processed to extract mRNA (Qiagen #74106). RNA quantification was performed using Nanodrop 8000. One-step qPCR (Qiagen, #204645) was performed on the 7900 HT Fast Real-Time PCR system (Themo Fisher Scientific) using a human DUSP6 primer set (Hs00737962, Life Technologies) multiplexed with a housekeeping gene control primer, HPO (#4326314E, Life Technologies). Data was analyzed and normalized to the expression of a housekeeping gene, human ribosomal protein lateral stalk subunit P0, HPO, to calculate the fold change in mRNA expression with and without <b>14</b>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01725" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64016" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64016" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01725" class="ext-link">10.1021/acs.jmedchem.8b01725</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings with SHP2 IC<sub>50</sub>, % inhibition @40mM, <i>p</i>-ERK IC<sub>50</sub>, antiproliferation IC<sub>50</sub>, hERG (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a, pharmacophore model from <b>2</b>, <b>3</b>, and <b>4</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, docking model of <b>15</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Related to <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, X-ray structure of <b>24</b> and docking model of <b>19</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">X-ray data tables, selectivity panel data for 1; PK profiles for 1, 5, 14; synthetic procedures; molecular formula strings, docking models (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>â<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_005.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_001.csv">jm8b01725_si_001.csv (2.01 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_002.pdb">jm8b01725_si_002.pdb (6.11 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_003.pdb">jm8b01725_si_003.pdb (305.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_004.pdb">jm8b01725_si_004.pdb (301.91 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_005.pdf">jm8b01725_si_005.pdf (290.82 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD9">6MD9</a> for SHP2 in complex with compound <b>3</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDA">6MDA</a> for SHP2 in complex with compound <b>4</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a> for SHP2 in complex with compound <b>5</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDD">6MDD</a> for SHP2 in complex with compound <b>24</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDC">6MDC</a> for SHP2 in complex with compound <b>1</b>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01725" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14371" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14371" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew J. LaMarche</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6588-2302" title="Orcid link">http://orcid.org/0000-0002-6588-2302</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0865697c7c606d7f26646965697a6b606d4866677e697a7c617b266b6765"><span class="__cf_email__" data-cfemail="b8d5d9ccccd0ddcf96d4d9d5d9cadbd0ddf8d6d7ced9caccd1cb96dbd7d5">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey
T. Bagdanoff</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhouliang Chen</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Acker</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying-Nan Chen</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Homan Chan</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Dore</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brant Firestone</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Fodor</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology & Therapeutics, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jorge Fortanet</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murphy Hentemann</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mitsunori Kato</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Koenig</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura R. LaBonte</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetic
Sciences, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shumei Liu</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Movarid Mohseni</span> - <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rukundo Ntaganda</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Sarver</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Troy Smith</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Sendzik</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis Stams</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology & Therapeutics, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stan Spence</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Towler</span> - <span class="hlFld-Affiliation affiliation">Chemical
and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongyun Wang</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ping Wang</span> - <span class="hlFld-Affiliation affiliation">Oncology Disease Area, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah L. Williams</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , and , Novartis Institutes for Biomedical
Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e1944-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61165" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61165" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Instituted. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The authors thank Yue Pan, Dan Palacios, Joe Wzorek, and Jonathan Hempel for editing suggestions and the entire SHP2 team.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase</p></td></tr><tr><td class="NLM_term">RAS</td><td class="NLM_def"><p class="first last">rat sarcoma protein</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription proteins</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl Î²-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemeyer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HÃ¤hlen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Somatic Mutations in PTPN11 in Juvenile Myelomonocytic Leukemia, Myelodysplactic Syndromes and Acute Myeloid Leukemia</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">148</span>â <span class="NLM_lpage">150</span>, <span class="refDoi">Â DOI: 10.1038/ng1156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+H%C3%A4hlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+Mutations+in+PTPN11+in+Juvenile+Myelomonocytic+Leukemia%2C+Myelodysplactic+Syndromes+and+Acute+Myeloid+Leukemia&doi=10.1038%2Fng1156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0liRiDbhECgvbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DH%25C3%25A4hlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520Mutations%2520in%2520PTPN11%2520in%2520Juvenile%2520Myelomonocytic%2520Leukemia%252C%2520Myelodysplactic%2520Syndromes%2520and%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150%26doi%3D10.1038%2Fng1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaitzidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">The Tyrosine Phosphoatase Shp2 (PTPN11) in Cancer</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">179</span>â <span class="NLM_lpage">192</span>, <span class="refDoi">Â DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+Tyrosine+Phosphoatase+Shp2+%28PTPN11%29+in+Cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0liRiDbhECgvbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520Tyrosine%2520Phosphoatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yomogita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatakeyama, M.</span></span> <span> </span><span class="NLM_article-title">Isolation of a Distinct Class of Gain-of-Function SHP-2 Mutants with Oncogenic RAS-like Transforming Activity From Solid Tumors</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3508</span>â <span class="NLM_lpage">3515</span>, <span class="refDoi">Â DOI: 10.1038/sj.onc.1211019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Hagashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+Distinct+Class+of+Gain-of-Function+SHP-2+Mutants+with+Oncogenic+RAS-like+Transforming+Activity+From+Solid+Tumors&doi=10.1038%2Fsj.onc.1211019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0ljxxuE6c_snwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHagashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520Distinct%2520Class%2520of%2520Gain-of-Function%2520SHP-2%2520Mutants%2520with%2520Oncogenic%2520RAS-like%2520Transforming%2520Activity%2520From%2520Solid%2520Tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515%26doi%3D10.1038%2Fsj.onc.1211019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandless, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Potent Stimulation of SH-PTP2 Phosphatase Activity by Simultaneous Occupancy of Both SH2 Domains</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">2897</span>â <span class="NLM_lpage">2900</span>, <span class="refDoi">Â DOI: 10.1074/jbc.270.7.2897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1074%2Fjbc.270.7.2897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=7531695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADyaK28XltVyltrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=2897-2900&author=S.+Pluskeyauthor=T.+J.+Wandlessauthor=C.+T.+Walshauthor=S.+E.+Shoelson&title=Potent+Stimulation+of+SH-PTP2+Phosphatase+Activity+by+Simultaneous+Occupancy+of+Both+SH2+Domains&doi=10.1074%2Fjbc.270.7.2897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains</span></div><div class="casAuthors">Pluskey, Scott; Wandless, Thomas J.; Walsh, Christopher, T.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2897-2900</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Src homol. 2 (SH2) domains are phosphotyrosine binding modules found within many cytoplasmic proteins.  A major function of SH2 domains is to bring about the phys. assembly of signaling complexes.  Here, it is shown that, that in addn., simultaneous occupancy of both SH2 domains of phosphoprotein tyrosine phosphatase SH-PTP2 (Syp, PTP 1D, PTP-2C) by a tethered peptide with 2 IRS-1-derived phosphorylation sites potently stimulates phosphatase activity.  The concn. required for activation by the tethered peptide was 80-160-fold lower than either corresponding monophosphorylated peptide.  Moreover, the diphosphorylated peptide stimulated catalytic activity 37-fold, compared with 9-16-fold for the monophosphorylated peptides.  Mutational analyses of the SH2 domains of SH-PTP2 confirmed that both SH2 domains participate in this effect.  Binding studies with a tandem construct comprising the N-plus C-terminal SH2 domains showed that the diphosphorylated peptide binds with 60-90-fold higher affinity than either monophosphorylated sequence.  These results demonstrated that SH-PTP2 activity can be potently regulated by interacting via both of its SH2 domains with phosphoproteins having 2 cognate phosphorylation sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTlCRxkwiHh7Vg90H21EOLACvtfcHk0ljxxuE6c_snwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltVyltrs%253D&md5=c17c9344fc6b9978f7021263855b776d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.7.2897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.7.2897%26sid%3Dliteratum%253Aachs%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DWandless%26aufirst%3DT.%2BJ.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DPotent%2520Stimulation%2520of%2520SH-PTP2%2520Phosphatase%2520Activity%2520by%2520Simultaneous%2520Occupancy%2520of%2520Both%2520SH2%2520Domains%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D2897%26epage%3D2900%26doi%3D10.1074%2Fjbc.270.7.2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, L.</span></span> <span> </span><span class="NLM_article-title">The âShpâing News: SH2 Domain-Containing Tyrosine Phosphatases in Cell Signaling</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">284</span>â <span class="NLM_lpage">293</span>, <span class="refDoi">Â DOI: 10.1016/S0968-0004(03)00091-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2FS0968-0004%2803%2900091-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=12826400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%98Shp%E2%80%99ing+News%3A+SH2+Domain-Containing+Tyrosine+Phosphatases+in+Cell+Signaling&doi=10.1016%2FS0968-0004%2803%2900091-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span></div><div class="casAuthors">Neel, Benjamin G.; Gu, Haihua; Pao, Lily</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Src homol.-2 (SH2) domain-contg. phosphatases (Shps) are a small, highly conserved subfamily of protein tyrosine phosphatases, members of which are present in both vertebrates and invertebrates.  The mechanism of regulation of Shps by ligand binding is now well understood.  Much is also known about the normal signaling pathways regulated by each Shp and the consequences of Shp deficiency.  Recent studies have identified mutations in human Shp2 as the cause of the inherited disorder, Noonan syndrome.  Shp2 mutations might also contribute to the pathogenesis of some leukemias.  In addn., Shp2 might be a key virulence determinant for the important human pathogen, Helicobacter pylori.  Despite these efforts, however, the key targets of each Shp have remained elusive.  Identifying these substrates remains a major challenge for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zIEChntK0rVg90H21EOLACvtfcHk0ljxxuE6c_snwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D&md5=bce9fc3db0a41b29ba605251dc46c64f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2803%2900091-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252803%252900091-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2598Shp%25E2%2580%2599ing%2520News%253A%2520SH2%2520Domain-Containing%2520Tyrosine%2520Phosphatases%2520in%2520Cell%2520Signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293%26doi%3D10.1016%2FS0968-0004%2803%2900091-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, G. S.</span></span> <span> </span><span class="NLM_article-title">PTPN11 is the First Identified Proto-Oncogene That Encodes a Tyrosine Phosphatase</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">862</span>â <span class="NLM_lpage">867</span>, <span class="refDoi">Â DOI: 10.1182/blood-2006-07-028829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1182%2Fblood-2006-07-028829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=17053061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+First+Identified+Proto-Oncogene+That+Encodes+a+Tyrosine+Phosphatase&doi=10.1182%2Fblood-2006-07-028829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span></div><div class="casAuthors">Chan, Rebecca J.; Feng, Gen-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-867</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Elucidation of the mol. mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes.  One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homol. 2 (SH2) domains (Shp2).  This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis.  More recently, somatic missense PTPN11 gain-of-function mutations were detected in leukemias and rarely in solid tumors, and were found to induce aberrant hyperactivation of the Ras-Erk pathway.  This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the mol. mechanisms underlying cell transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqsuOora-d37Vg90H21EOLACvtfcHk0ljD92JKbXv0wA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D&md5=8c5760a6ac385635f9794acbf5b64a03</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-028829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-028829%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520First%2520Identified%2520Proto-Oncogene%2520That%2520Encodes%2520a%2520Tyrosine%2520Phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867%26doi%3D10.1182%2Fblood-2006-07-028829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tiganis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, A. M.</span></span> <span> </span><span class="NLM_article-title">Protein Tyrosine Phosphatase Function: the Substrated Perspective</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">15</span>, <span class="refDoi">Â DOI: 10.1042/BJ20061548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1042%2FBJ20061548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=17238862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFOisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2007&pages=1-15&author=T.+Tiganisauthor=A.+M.+Bennett&title=Protein+Tyrosine+Phosphatase+Function%3A+the+Substrated+Perspective&doi=10.1042%2FBJ20061548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatase function: the substrate perspective</span></div><div class="casAuthors">Tiganis, Tony; Bennett, Anton M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now well established that the members of the protein tyrosine phosphatase (PTP) superfamily play crit. roles in fundamental biol. processes.  Although there has been much progress in defining the function of PTPs, the task of identifying substrates for these enzymes still presents a challenge.  Many PTPs have yet to have their physiol. substrates identified.  The focus of this review is on the current state of knowledge of PTP substrates and the approaches used to identify them.  The authors propose exptl. criteria that should be satisfied in order to rigorously assign PTP substrates as bona fide.  Finally, the progress that has been made in defining the biol. roles of PTPs through the identification of their substrates is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod89zW3LtOs7Vg90H21EOLACvtfcHk0ljD92JKbXv0wA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFOisQ%253D%253D&md5=e0b404da50fc57e25efe140026d6cd53</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1042%2FBJ20061548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061548%26sid%3Dliteratum%253Aachs%26aulast%3DTiganis%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DA.%2BM.%26atitle%3DProtein%2520Tyrosine%2520Phosphatase%2520Function%253A%2520the%2520Substrated%2520Perspective%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D402%26spage%3D1%26epage%3D15%26doi%3D10.1042%2FBJ20061548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vazhappilly, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Azawi, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdu-Allah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Shorbagi, A.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Awady, R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SHP2 by New Compounds Induces Differential Effects on RAS/RAF/ERK and PI3K/AKT Pathways in Different Cancer Cell Types</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">10</span>, <span class="refDoi">Â DOI: 10.1007/s10637-018-0626-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1007%2Fs10637-018-0626-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=1-10&author=C.+G.+Vazhappillyauthor=E.+Salehauthor=W.+Ramadanauthor=V.+Menonauthor=A.+M.+Al-Azawiauthor=H.+Taraziauthor=H.+Abdu-Allahauthor=A.-N.+El-Shorbagiauthor=R.+El-Awady&title=Inhibition+of+SHP2+by+New+Compounds+Induces+Differential+Effects+on+RAS%2FRAF%2FERK+and+PI3K%2FAKT+Pathways+in+Different+Cancer+Cell+Types&doi=10.1007%2Fs10637-018-0626-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1007%2Fs10637-018-0626-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-018-0626-5%26sid%3Dliteratum%253Aachs%26aulast%3DVazhappilly%26aufirst%3DC.%2BG.%26aulast%3DSaleh%26aufirst%3DE.%26aulast%3DRamadan%26aufirst%3DW.%26aulast%3DMenon%26aufirst%3DV.%26aulast%3DAl-Azawi%26aufirst%3DA.%2BM.%26aulast%3DTarazi%26aufirst%3DH.%26aulast%3DAbdu-Allah%26aufirst%3DH.%26aulast%3DEl-Shorbagi%26aufirst%3DA.-N.%26aulast%3DEl-Awady%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520SHP2%2520by%2520New%2520Compounds%2520Induces%2520Differential%2520Effects%2520on%2520RAS%252FRAF%252FERK%2520and%2520PI3K%252FAKT%2520Pathways%2520in%2520Different%2520Cancer%2520Cell%2520Types%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2018%26spage%3D1%26epage%3D10%26doi%3D10.1007%2Fs10637-018-0626-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschhof, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDay, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hembrough, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustgi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fereshetian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catenacci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bass, A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Wild-type KRAS-Amplified Gastroesophageal Cancer Through Combined MEK and SHP2 Inhibition</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">968</span>â <span class="NLM_lpage">977</span>, <span class="refDoi">Â DOI: 10.1038/s41591-018-0022-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41591-018-0022-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29808010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=968-977&author=G.+S.+Wongauthor=J.+Zhouauthor=J.+B.+Liuauthor=Z.+Wuauthor=X.+Xuauthor=T.+Liauthor=D.+Xuauthor=S.+E.+Schumacherauthor=J.+Puschhofauthor=J.+McFarlandauthor=C.+Zouauthor=A.+Dulakauthor=L.+Hendersonauthor=P.+Xuauthor=E.+O%E2%80%99Dayauthor=R.+Rendakauthor=W.-L.+Liaoauthor=F.+Cecchiauthor=T.+Hembroughauthor=S.+Schwartzauthor=C.+Szetoauthor=A.+K.+Rustgiauthor=K.-K.+Wongauthor=J.+A.+Diehlauthor=K.+Jensenauthor=F.+Grazianoauthor=A.+Ruzzoauthor=S.+Fereshetianauthor=P.+Mertinsauthor=S.+A.+Carrauthor=R.+Beroukhimauthor=K.+Nakamuraauthor=E.+Okiauthor=M.+Watanabeauthor=H.+Babaauthor=Y.+Imamuraauthor=D.+Catenacciauthor=A.+J.+Bass&title=Targeting+Wild-type+KRAS-Amplified+Gastroesophageal+Cancer+Through+Combined+MEK+and+SHP2+Inhibition&doi=10.1038%2Fs41591-018-0022-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition</span></div><div class="casAuthors">Wong, Gabrielle S.; Zhou, Jin; Liu, Jie Bin; Wu, Zhong; Xu, Xinsen; Li, Tianxia; Xu, David; Schumacher, Steven E.; Puschhof, Jens; McFarland, James; Zou, Charles; Dulak, Austin; Henderson, Les; Xu, Peng; O'Day, Emily; Rendak, Rachel; Liao, Wei-li; Cecchi, Fabiola; Hembrough, Todd; Schwartz, Sarit; Szeto, Christopher; Rustgi, Anil K.; Wong, Kwok-Kin; Diehl, J. Alan; Jensen, Karin; Graziano, Francesco; Ruzzo, Annamaria; Fereshetian, Shaunt; Mertins, Philipp; Carr, Steven A.; Beroukhim, Rameen; Nakamura, Kenichi; Oki, Eiji; Watanabe, Masayuki; Baba, Hideo; Imamura, Yu; Catenacci, Daniel; Bass, Adam J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">968-977</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The role of KRAS, when activated through canonical mutations, has been well established in cancer1.  Here it explore a secondary means of KRAS activation in cancer: focal high-level amplification of the KRAS gene in the absence of coding mutations.  These amplifications occur most commonly in esophageal, gastric and ovarian adenocarcinomas2-4.  KRAS-amplified gastric cancer models show marked overexpression of the KRAS protein and are insensitive to MAPK blockade owing to their capacity to adaptively respond by rapidly increasing KRAS-GTP levels.  Here it demonstrate that inhibition of the guanine-exchange factors SOS1 and SOS2 or the protein tyrosine phosphatase SHP2 can attenuate this adaptive process and that targeting these factors, both genetically and pharmacol., can enhance the sensitivity of KRAS-amplified models to MEK inhibition in both in vitro and in vivo settings.  These data demonstrate the relevance of copy-no. amplification as a mechanism of KRAS activation, and uncover the therapeutic potential for targeting of these tumors through combined SHP2 and MEK inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTIe1Ygfy-ibVg90H21EOLACvtfcHk0lgqngDjsQGZBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvE&md5=9b0e728428d655cebea911300b5ed91a</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0022-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0022-x%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DG.%2BS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%2BB.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DSchumacher%26aufirst%3DS.%2BE.%26aulast%3DPuschhof%26aufirst%3DJ.%26aulast%3DMcFarland%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DDulak%26aufirst%3DA.%26aulast%3DHenderson%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DE.%26aulast%3DRendak%26aufirst%3DR.%26aulast%3DLiao%26aufirst%3DW.-L.%26aulast%3DCecchi%26aufirst%3DF.%26aulast%3DHembrough%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DSzeto%26aufirst%3DC.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DDiehl%26aufirst%3DJ.%2BA.%26aulast%3DJensen%26aufirst%3DK.%26aulast%3DGraziano%26aufirst%3DF.%26aulast%3DRuzzo%26aufirst%3DA.%26aulast%3DFereshetian%26aufirst%3DS.%26aulast%3DMertins%26aufirst%3DP.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DOki%26aufirst%3DE.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DCatenacci%26aufirst%3DD.%26aulast%3DBass%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Wild-type%2520KRAS-Amplified%2520Gastroesophageal%2520Cancer%2520Through%2520Combined%2520MEK%2520and%2520SHP2%2520Inhibition%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D968%26epage%3D977%26doi%3D10.1038%2Fs41591-018-0022-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mainardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulero-SÃ¡nchez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prahallad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimpenfort, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieftink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonÃ§alves-Ribeiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernards, R.</span></span> <span> </span><span class="NLM_article-title">SHP2 is Required for Growth of KRAS-Mutant Non-Small-Cell Lung Cancer In Vivo</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">961</span>â <span class="NLM_lpage">967</span>, <span class="refDoi">Â DOI: 10.1038/s41591-018-0023-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41591-018-0023-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29808006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=961-967&author=S.+Mainardiauthor=A.+Mulero-S%C3%A1nchezauthor=A.+Prahalladauthor=G.+Germanoauthor=A.+Bosmaauthor=P.+Krimpenfortauthor=C.+Lieftinkauthor=J.+D.+Steinbergauthor=N.+de+Witauthor=S.+Gon%C3%A7alves-Ribeiroauthor=E.+Nadalauthor=A.+Bardelliauthor=A.+Villanuevaauthor=R.+Bernards&title=SHP2+is+Required+for+Growth+of+KRAS-Mutant+Non-Small-Cell+Lung+Cancer+In+Vivo&doi=10.1038%2Fs41591-018-0023-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4fR"><div class="casContent"><span class="casTitleNuber">4f</span><div class="casTitle"><span class="NLM_cas:atitle">SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo</span></div><div class="casAuthors">Mainardi, Sara; Mulero-Sanchez, Antonio; Prahallad, Anirudh; Germano, Giovanni; Bosma, Astrid; Krimpenfort, Paul; Lieftink, Cor; Steinberg, Jeffrey D.; de Wit, Niels; Goncalves-Ribeiro, Samuel; Nadal, Ernest; Bardelli, Alberto; Villanueva, Alberto; Bernards, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">961-967</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">RAS mutations are frequent in human cancer, esp. in pancreatic, colorectal and non-small-cell lung cancers (NSCLCs).  Inhibition of the RAS oncoproteins has proven difficult, and attempts to target downstream effectors have been hampered by the activation of compensatory resistance mechanisms.  It is also well established that KRAS-mutant tumors are insensitive to inhibition of upstream growth factor receptor signaling.  Thus, epidermal growth factor receptor antibody therapy is only effective in KRAS wild-type colon cancers.  Consistently, inhibition of SHP2 (also known as PTPN11), which links receptor tyrosine kinase signaling to the RAS-RAF-MEK-ERK pathway11,12, was shown to be ineffective in KRAS-mutant or BRAF-mutant cancer cell lines.  Tha data also indicate that SHP2 inhibition in KRAS-mutant NSCLC cells under normal cell culture conditions has little effect.  By contrast, SHP2 inhibition under growth factor-limiting conditions in vitro results in a senescence response.  In vivo, inhibition of SHP2 in KRAS-mutant NSCLC also provokes a senescence response, which is exacerbated by MEK inhibition.  Tha data identify SHP2 inhibition as an unexpected vulnerability of KRAS-mutant NSCLC cells that remains undetected in cell culture and can be exploited therapeutically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLHUMCtBqtZrVg90H21EOLACvtfcHk0lgqngDjsQGZBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvL&md5=8e1ce1eb5d30d3985aafdec9d07f205d</span></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3DMainardi%26aufirst%3DS.%26aulast%3DMulero-S%25C3%25A1nchez%26aufirst%3DA.%26aulast%3DPrahallad%26aufirst%3DA.%26aulast%3DGermano%26aufirst%3DG.%26aulast%3DBosma%26aufirst%3DA.%26aulast%3DKrimpenfort%26aufirst%3DP.%26aulast%3DLieftink%26aufirst%3DC.%26aulast%3DSteinberg%26aufirst%3DJ.%2BD.%26aulast%3Dde%2BWit%26aufirst%3DN.%26aulast%3DGon%25C3%25A7alves-Ribeiro%26aufirst%3DS.%26aulast%3DNadal%26aufirst%3DE.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DVillanueva%26aufirst%3DA.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DSHP2%2520is%2520Required%2520for%2520Growth%2520of%2520KRAS-Mutant%2520Non-Small-Cell%2520Lung%2520Cancer%2520In%2520Vivo%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D961%26epage%3D967%26doi%3D10.1038%2Fs41591-018-0023-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bunda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heir, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alamsahebpour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raught, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zadeh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohh, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SHP2âMediated Dephosphorylation of Ras Suppresses Oncogenesis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">8859</span> <span class="refDoi">Â DOI: 10.1038/ncomms9859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fncomms9859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=26617336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=S.+Bundaauthor=K.+Burrellauthor=P.+Heirauthor=L.+Zengauthor=A.+Alamsahebpourauthor=Y.+Kanoauthor=B.+Raughtauthor=Z.-Y.+Zhangauthor=G.+Zadehauthor=M.+Ohh&title=Inhibition+of+SHP2%E2%80%93Mediated+Dephosphorylation+of+Ras+Suppresses+Oncogenesis&doi=10.1038%2Fncomms9859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis</span></div><div class="casAuthors">Bunda, Severa; Burrell, Kelly; Heir, Pardeep; Zeng, Lifan; Alamsahebpour, Amir; Kano, Yoshihito; Raught, Brian; Zhang, Zhong-Yin; Zadeh, Gelareh; Ohh, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8859</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ras is phosphorylated on a conserved tyrosine at position 32 within the switch I region via Src kinase.  This phosphorylation inhibits the binding of effector Raf while promoting the engagement of GTPase-activating protein (GAP) and GTP hydrolysis.  Here we identify SHP2 as the ubiquitously expressed tyrosine phosphatase that preferentially binds to and dephosphorylates Ras to increase its assocn. with Raf and activate downstream proliferative Ras/ERK/MAPK signalling.  In comparison to normal astrocytes, SHP2 activity is elevated in astrocytes isolated from glioblastoma multiforme (GBM)-prone H-Ras(12V) knock-in mice as well as in glioma cell lines and patient-derived GBM specimens exhibiting hyperactive Ras.  Pharmacol. inhibition of SHP2 activity attenuates cell proliferation, soft-agar colony formation and orthotopic GBM growth in NOD/SCID mice and decelerates the progression of low-grade astrocytoma to GBM in a spontaneous transgenic glioma mouse model.  These results identify SHP2 as a direct activator of Ras and a potential therapeutic target for cancers driven by a previously 'undruggable' oncogenic or hyperactive Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhWi25AJiphrVg90H21EOLACvtfcHk0lgqngDjsQGZBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP&md5=8524ad9cc6f2e85abaff6b07c698f464</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fncomms9859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9859%26sid%3Dliteratum%253Aachs%26aulast%3DBunda%26aufirst%3DS.%26aulast%3DBurrell%26aufirst%3DK.%26aulast%3DHeir%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAlamsahebpour%26aufirst%3DA.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26aulast%3DZadeh%26aufirst%3DG.%26aulast%3DOhh%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520SHP2%25E2%2580%2593Mediated%2520Dephosphorylation%2520of%2520Ras%2520Suppresses%2520Oncogenesis%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fncomms9859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jie, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildener-Leapman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">508</span>â <span class="NLM_lpage">518</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-14-1215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1158%2F0008-5472.CAN-14-1215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=25480946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVenurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=508-518&author=J.+Liauthor=H.-B.+Jieauthor=Y.+Leiauthor=N.+Gildener-Leapmanauthor=S.+Trivedi&title=PD-1%2FSHP-2+Inhibits+Tc1%2FTh1+Phenotypic+Responses+and+the+Activation+of+T+Cells+in+the+Tumor+Microenvironment&doi=10.1158%2F0008-5472.CAN-14-1215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span></div><div class="casAuthors">Li, Jing; Jie, Hyun-Bae; Lei, Yu; Gildener-Leapman, Neil; Trivedi, Sumita; Green, Tony; Kane, Lawrence P.; Ferris, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">508-518</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study addresses the mechanisms through which PD-1 antibody therapy restores the ability of the immune system to recognize and attack tumors by skewing intratumoral T cells toward a more potent activation phenotype that is assocd. with enhanced signaling and a reversal of their immunosuppressed phenotype.  Immune rejection of tumors is mediated by IFNÎ³ prodn. and T-cell cytolytic activity.  These processes are impeded by PD-1, a coinhibitory mol. expressed on T cells that is elevated in tumor-infiltrating lymphocytes (TIL).  PD-1 elevation may reflect T-cell exhaustion marked by decreased proliferation, prodn. of type I cytokines, and poor cytolytic activity.  Although anti-PD-1 antibodies enhance IFNÎ³ secretion after stimulation of the T-cell receptor (TCR), the mechanistic link between PD-1 and its effects on T-cell help (Tc1/Th1 skewing) remains unclear.  In prospectively collected cancer tissues, we found that TIL exhibited dampened Tc1/Th1 skewing and activation compared with peripheral blood lymphocytes (PBL).  When PD-1 bound its ligand PD-L1, we obsd. a marked suppression of crit. TCR target genes and Th1 cytokines.  Conversely, PD-1 blockade reversed these suppressive effects of PD-1:PD-L1 ligation.  We also found that the TCR-regulated phosphatase SHP-2 was expressed higher in TIL than in PBL, tightly correlating with PD-1 expression and neg. regulation of TCR target genes.  Overall, these results defined a PD-1/SHP-2/STAT1/T-bet signaling axis mediating the suppressive effects of PD-1 on Th1 immunity at tumor sites.  Our findings argue that PD-1 or SHP-2 blockade will be sufficient to restore robust Th1 immunity and T-cell activation and thereby reverse immunosuppression in the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe6jAWHNatvLVg90H21EOLACvtfcHk0lgg89v8GArDog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVenurY%253D&md5=695007f0715b5eee2b7e47deaf87ae23</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1215%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJie%26aufirst%3DH.-B.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DGildener-Leapman%26aufirst%3DN.%26aulast%3DTrivedi%26aufirst%3DS.%26atitle%3DPD-1%252FSHP-2%2520Inhibits%2520Tc1%252FTh1%2520Phenotypic%2520Responses%2520and%2520the%2520Activation%2520of%2520T%2520Cells%2520in%2520the%2520Tumor%2520Microenvironment%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D508%26epage%3D518%26doi%3D10.1158%2F0008-5472.CAN-14-1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasmal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vale, R. D.</span></span> <span> </span><span class="NLM_article-title">T Cell Costimulatory Receptor CD28 is a Primary Target for PD-1-Mediated Inhibition</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_fpage">1428</span>â <span class="NLM_lpage">1433</span>, <span class="refDoi">Â DOI: 10.1126/science.aaf1292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1126%2Fscience.aaf1292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=28280247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVWhu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=1428-1433&author=E.+Huiauthor=J.+Cheungauthor=J.+Zhuauthor=X.+Suauthor=M.+J.+Taylorauthor=H.+A.+Wallweberauthor=D.+K.+Sasmalauthor=J.+Huangauthor=J.+M.+Kimauthor=I.+Mellmanauthor=R.+D.+Vale&title=T+Cell+Costimulatory+Receptor+CD28+is+a+Primary+Target+for+PD-1-Mediated+Inhibition&doi=10.1126%2Fscience.aaf1292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition</span></div><div class="casAuthors">Hui, Enfu; Cheung, Jeanne; Zhu, Jing; Su, Xiaolei; Taylor, Marcus J.; Wallweber, Heidi A.; Sasmal, Dibyendu K.; Huang, Jun; Kim, Jeong M.; Mellman, Ira; Vale, Ronald D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6332</span>),
    <span class="NLM_cas:pages">1428-1433</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">PD-1-targeted therapies have been a breakthrough for treating certain tumors and can rejuvenate T cells to unleash the anticancer immune response (see the Perspective by Clouthier and Ohashi).  It is widely believed that PD-1 suppresses signaling through the T cell receptor (TCR).  However, Hui et al. find instead that the TCR costimulatory receptor, CD28, is the primary target of PD-1 signaling.  Independently, Kamphorst et al. show that CD28 is required for PD-1 therapies to kill cancer cells efficiently and eliminate chronic viral infections in mice.  Lung cancer patients that responded to PD-1 therapy had more CD28+ T cells, which suggests that CD28 may predict treatment response.  Science, ibid p. 1428, p. 1423; see also p. 1373.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM_s4cf1lkxrVg90H21EOLACvtfcHk0lgg89v8GArDog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVWhu7g%253D&md5=69750b99b68316ee035a0b7eeddfb9fa</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf1292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf1292%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DE.%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DSasmal%26aufirst%3DD.%2BK.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DVale%26aufirst%3DR.%2BD.%26atitle%3DT%2520Cell%2520Costimulatory%2520Receptor%2520CD28%2520is%2520a%2520Primary%2520Target%2520for%2520PD-1-Mediated%2520Inhibition%26jtitle%3DScience%26date%3D2017%26spage%3D1428%26epage%3D1433%26doi%3D10.1126%2Fscience.aaf1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Topalian, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodi, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brahmer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettinger, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powderly, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leming, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spigel, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonia, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardoll, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharfman, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taube, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMiller, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jure-Kunkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollia, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigginton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sznol, M.</span></span> <span> </span><span class="NLM_article-title">Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">2443</span>â <span class="NLM_lpage">2454</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1200690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1056%2FNEJMoa1200690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=22658127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2rs7fN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=2443-2454&author=S.+L.+Topalianauthor=F.+S.+Hodiauthor=J.+R.+Brahmerauthor=S.+N.+Gettingerauthor=D.+C.+Smithauthor=D.+F.+McDermottauthor=J.+D.+Powderlyauthor=R.+D.+Carvajalauthor=J.+A.+Sosmanauthor=M.+B.+Atkinsauthor=P.+D.+Lemingauthor=D.+R.+Spigelauthor=S.+J.+Antoniaauthor=L.+Hornauthor=C.+G.+Drakeauthor=D.+M.+Pardollauthor=L.+Chenauthor=W.+H.+Sharfmanauthor=R.+A.+Andersauthor=J.+M.+Taubeauthor=T.+L.+McMillerauthor=H.+Xuauthor=A.+J.+Kormanauthor=M.+Jure-Kunkelauthor=S.+Agrawalauthor=D.+McDonaldauthor=G.+D.+Kolliaauthor=A.+Guptaauthor=J.+M.+Wiggintonauthor=M.+Sznol&title=Safety%2C+Activity%2C+and+Immune+Correlates+of+Anti-PD-1+Antibody+in+Cancer&doi=10.1056%2FNEJMoa1200690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, activity, and immune correlates of anti-PD-1 antibody in cancer</span></div><div class="casAuthors">Topalian, Suzanne L.; Hodi, F. Stephen; Brahmer, Julie R.; Gettinger, Scott N.; Smith, David C.; McDermott, David F.; Powderly, John D.; Carvajal, Richard D.; Sosman, Jeffrey A.; Atkins, Michael B.; Leming, Philip D.; Spigel, David R.; Antonia, Scott J.; Horn, Leora; Drake, Charles G.; Pardoll, Drew M.; Chen, Lieping; Sharfman, William H.; Anders, Robert A.; Taube, Janis M.; McMiller, Tracee L.; Xu, Haiying; Korman, Alan J.; Jure-Kunkel, Maria; Agrawal, Shruti; McDonald, Daniel; Kollia, Georgia D.; Gupta, Ashok; Wigginton, Jon M.; Sznol, Mario</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2443-2454</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance.  We assessed the antitumor activity and safety of BMS-936558, an antibody that specifically blocks PD-1.  Methods: We enrolled patients with advanced melanoma, non-small-cell lung cancer, castration-resistant prostate cancer, or renal-cell or colorectal cancer to receive anti-PD-1 antibody at a dose of 0.1 to 10.0 mg per kg of body wt. every 2 wk.  Response was assessed after each 8-wk treatment cycle.  Patients received up to 12 cycles until disease progression or a complete response occurred.  Results: A total of 296 patients received treatment through Feb. 24, 2012.  Grade 3 or 4 drug-related adverse events occurred in 14% of patients; there were three deaths from pulmonary toxicity.  No max. tolerated dose was defined.  Adverse events consistent with immune-related causes were obsd.  Among 236 patients in whom response could be evaluated, objective responses (complete or partial responses) were obsd. in those with non-small-cell lung cancer, melanoma, or renal-cell cancer.  Cumulative response rates (all doses) were 18% among patients with non-small-cell lung cancer (14 of 76 patients), 28% among patients with melanoma (26 of 94 patients), and 27% among patients with renal-cell cancer (9 of 33 patients).  Responses were durable; 20 of 31 responses lasted 1 yr or more in patients with 1 yr or more of follow-up.  To assess the role of intratumoral PD-1 ligand (PD-L1) expression in the modulation of the PD-1-PD-L1 pathway, immunohistochem. anal. was performed on pretreatment tumor specimens obtained from 42 patients.  Of 17 patients with PD-L1-neg. tumors, none had an objective response; 9 of 25 patients (36%) with PD-L1-pos. tumors had an objective response (P = 0.006).  Conclusions: Anti-PD-1 antibody produced objective responses in approx. one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse-event profile does not appear to preclude its use.  Preliminary data suggest a relationship between PD-L1 expression on tumor cells and objective response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLOPvHybmlvbVg90H21EOLACvtfcHk0lgg89v8GArDog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2rs7fN&md5=7c13f228ef92b6089982fc878d3a394b</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1200690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1200690%26sid%3Dliteratum%253Aachs%26aulast%3DTopalian%26aufirst%3DS.%2BL.%26aulast%3DHodi%26aufirst%3DF.%2BS.%26aulast%3DBrahmer%26aufirst%3DJ.%2BR.%26aulast%3DGettinger%26aufirst%3DS.%2BN.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DMcDermott%26aufirst%3DD.%2BF.%26aulast%3DPowderly%26aufirst%3DJ.%2BD.%26aulast%3DCarvajal%26aufirst%3DR.%2BD.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DAtkins%26aufirst%3DM.%2BB.%26aulast%3DLeming%26aufirst%3DP.%2BD.%26aulast%3DSpigel%26aufirst%3DD.%2BR.%26aulast%3DAntonia%26aufirst%3DS.%2BJ.%26aulast%3DHorn%26aufirst%3DL.%26aulast%3DDrake%26aufirst%3DC.%2BG.%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSharfman%26aufirst%3DW.%2BH.%26aulast%3DAnders%26aufirst%3DR.%2BA.%26aulast%3DTaube%26aufirst%3DJ.%2BM.%26aulast%3DMcMiller%26aufirst%3DT.%2BL.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DKorman%26aufirst%3DA.%2BJ.%26aulast%3DJure-Kunkel%26aufirst%3DM.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DMcDonald%26aufirst%3DD.%26aulast%3DKollia%26aufirst%3DG.%2BD.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DWigginton%26aufirst%3DJ.%2BM.%26aulast%3DSznol%26aufirst%3DM.%26atitle%3DSafety%252C%2520Activity%252C%2520and%2520Immune%2520Correlates%2520of%2520Anti-PD-1%2520Antibody%2520in%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D2443%26epage%3D2454%26doi%3D10.1056%2FNEJMoa1200690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ohigashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsurui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoriki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashizuka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsushima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span> <span> </span><span class="NLM_article-title">Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2947</span>â <span class="NLM_lpage">2953</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-04-1469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1158%2F1078-0432.CCR-04-1469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=15837746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlejt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2947-2953&author=Y.+Ohigashiauthor=M.+Shoauthor=Y.+Yamadaauthor=Y.+Tsuruiauthor=K.+Hamadaauthor=N.+Ikedaauthor=T.+Mizunoauthor=R.+Yorikiauthor=H.+Kashizukaauthor=K.+Yaneauthor=F.+Tsushimaauthor=N.+Otsukiauthor=H.+Yagitaauthor=M.+Azumaauthor=Y.+Nakajima&title=Clinical+Significance+of+Programmed+Death-1+Ligand-1+and+Programmed+Death-1+Ligand-2+Expression+in+Human+Esophageal+Cancer&doi=10.1158%2F1078-0432.CCR-04-1469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer</span></div><div class="casAuthors">Ohigashi, Yuichiro; Sho, Masayuki; Yamada, Yukishige; Tsurui, Yoshikazu; Hamada, Kaoru; Ikeda, Naoya; Mizuno, Takashi; Yoriki, Ryo; Kashizuka, Hisanori; Yane, Katsunari; Tsushima, Fumihiko; Otsuki, Noriko; Yagita, Hideo; Azuma, Miyuki; Nakajima, Yoshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2947-2953</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The neg. regulatory programmed death-1/programmed death-1 ligand (PD-1/PD-L) pathway in T-cell activation has been suggested to play an important role in tumor evasion from host immunity.  In this study, we investigated the expression of PD-L1 and PD-L2 in human esophageal cancer to define their clin. significance in patients' prognosis after surgery.  Exptl. Design: PD-L1 and PD-L2 gene expression was evaluated in 41 esophagectomy patients by real-time quant. PCR.  The protein expression was also evaluated with newly generated monoclonal antibodies that recognize human PD-L1 (MIH1) and PD-L2 (MIH18).  Results: The protein and the mRNA levels of detn. by immunohistochem. and real-time quant. PCR were closely correlated.  PD-L-pos. patients had a significantly poorer prognosis than the neg. patients.  This was more pronounced in the advanced stage of tumor than in the early stage.  Furthermore, multivariate anal. indicated that PD-L status was an independent prognostic factor.  Although there was no significant correlation between PD-L1 expression and tumor-infiltrating T lymphocytes, PD-L2 expression was inversely correlated with tumor-infiltrating CD8+ T cells.  Conclusions: These data suggest that PD-L1 and PD-L2 status may be a new predictor of prognosis for patients with esophageal cancer and provide the rationale for developing novel immunotherapy of targeting PD-1/PD-L pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIMQiC4R0LD7Vg90H21EOLACvtfcHk0lhijDHbPS1xVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlejt7k%253D&md5=1dd37b483171a10070310ccd559c9e35</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1469%26sid%3Dliteratum%253Aachs%26aulast%3DOhigashi%26aufirst%3DY.%26aulast%3DSho%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DTsurui%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DN.%26aulast%3DMizuno%26aufirst%3DT.%26aulast%3DYoriki%26aufirst%3DR.%26aulast%3DKashizuka%26aufirst%3DH.%26aulast%3DYane%26aufirst%3DK.%26aulast%3DTsushima%26aufirst%3DF.%26aulast%3DOtsuki%26aufirst%3DN.%26aulast%3DYagita%26aufirst%3DH.%26aulast%3DAzuma%26aufirst%3DM.%26aulast%3DNakajima%26aufirst%3DY.%26atitle%3DClinical%2520Significance%2520of%2520Programmed%2520Death-1%2520Ligand-1%2520and%2520Programmed%2520Death-1%2520Ligand-2%2520Expression%2520in%2520Human%2520Esophageal%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2947%26epage%3D2953%26doi%3D10.1158%2F1078-0432.CCR-04-1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overduin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1423</span>â <span class="NLM_lpage">1437</span>, <span class="refDoi">Â DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+Protein+Tyrosine+Phosphatase+SHP2+for+Therapeutic+Intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0lhijDHbPS1xVg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520for%2520Therapeutic%2520Intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GarciaâFortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labonte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slisz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of an Allosteric SHP2 Inhibitor for Cancer Therapy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">148</span>â <span class="NLM_lpage">152</span>, <span class="refDoi">Â DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-152&author=Y.+P.+Chenauthor=M.+J.+LaMarcheauthor=P.+Fekkesauthor=J.+Garcia%E2%80%93Fortanetauthor=M.+Ackerauthor=H.+Chanauthor=Z.+Chenauthor=Z.+Dengauthor=F.+Feiauthor=B.+Firestoneauthor=M.+Fodorauthor=H.+Gaoauthor=S.+Hoauthor=K.+Hsiaoauthor=Z.+Kangauthor=N.+Keenauthor=L.+Labonteauthor=S.+Liuauthor=M.+Meyerauthor=M.+Puauthor=E.+Priceauthor=T.+Ramseyauthor=J.+Sliszauthor=P.+Wangauthor=G.+Yangauthor=J.+Zhangauthor=P.+Zhuauthor=W.+R.+Sellersauthor=T.+Stamsauthor=P.+D.+Fortin&title=Discovery+of+an+Allosteric+SHP2+Inhibitor+for+Cancer+Therapy&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 Î¼M), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lgzXwPcCs98Fg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BP.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarcia%25E2%2580%2593Fortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DF.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLabonte%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26atitle%3DDiscovery%2520of%2520an%2520Allosteric%2520SHP2%2520Inhibitor%2520for%2520Cancer%2520Therapy%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D152%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argintaru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">647</span>â <span class="NLM_lpage">656</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.7b00980</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00980" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=647-656&author=M.+Fodorauthor=E.+Priceauthor=P.+Wangauthor=H.+Luauthor=A.+Argintaruauthor=Z.+Chenauthor=M.+Glickauthor=H.+Haoauthor=M.+Katoauthor=R.+Koenigauthor=J.+R.+LaRochelleauthor=G.+Liuauthor=E.+McNeillauthor=D.+Majumdarauthor=G.+A.+Nishiguchiauthor=L.+B.+Perezauthor=G.+Parisauthor=C.+M.+Quinnauthor=T.+Ramseyauthor=M.+Sendzikauthor=M.+D.+Shultzauthor=S.+L.+Williamsauthor=T.+Stamsauthor=S.+C.+Blacklowauthor=M.+G.+Ackerauthor=M.+J.+LaMarche&title=Dual+Allosteric+Inhibition+of+SHP2+Phosphatase&doi=10.1021%2Facschembio.7b00980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dual allosteric inhibition of SHP2 phosphatase</span></div><div class="casAuthors">Fodor, Michelle; Price, Edmund; Wang, Ping; Lu, Hengyu; Argintaru, Andreea; Chen, Zhouliang; Glick, Meir; Hao, Huai-Xiang; Kato, Mitsunori; Koenig, Robert; La Rochelle, Jonathan R.; Liu, Gang; McNeill, Eric; Majumdar, Dyuti; Nishiguchi, Gisele A.; Perez, Lawrence B.; Paris, Gregory; Quinn, Christopher M.; Ramsey, Timothy; Sendzik, Martin; Shultz, Michael David; Williams, Sarah L.; Stams, Travis; Blacklow, Stephen C.; Acker, Michael G.; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">647-656</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a cytoplasmic protein tyrosine phosphatase encoded by the PTPN11 gene and is involved in cell proliferation, differentiation, and survival.  Recently, we reported an allosteric mechanism of inhibition that stabilizes the auto-inhibited conformation of SHP2.  SHP099 (1) was identified and characterized as a moderately potent, orally bioavailable, allosteric small mol. inhibitor, which binds to a tunnel-like pocket formed by the confluence of three domains of SHP2.  In this report, we describe further screening strategies that enabled the identification of a second, distinct small mol. allosteric site.  SHP244 (2) was identified as a weak inhibitor of SHP2 with modest thermal stabilization of the enzyme.  X-ray crystallog. revealed that 2 binds and stabilizes the inactive, closed conformation of SHP2, at a distinct, previously unexplored binding site-a cleft formed at the interface of the N-terminal SH2 and PTP domains.  Derivatization of 2 using structure-based design resulted in an increase in SHP2 thermal stabilization, biochem. inhibition, and subsequent MAPK pathway modulation.  Downregulation of DUSP6 mRNA, a downstream MAPK pathway marker, was obsd. in KYSE-520 cancer cells.  Remarkably, simultaneous occupation of both allosteric sites by 1 and 2 was possible, as characterized by cooperative biochem. inhibition expts. and X-ray crystallog.  Combining an allosteric site 1 inhibitor with an allosteric site 2 inhibitor led to enhanced pharmacol. pathway inhibition in cells.  This work illustrates a rare example of dual allosteric targeted protein inhibition, demonstrates screening methodol. and tactics to identify allosteric inhibitors, and enables further interrogation of SHP2 in cancer and related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdw7pTS6sOLVg90H21EOLACvtfcHk0lgzXwPcCs98Fg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D&md5=8e4de4c353b9fc196c81e1cb51e367df</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DArgintaru%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGlick%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DR.%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMcNeill%26aufirst%3DE.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26aulast%3DParis%26aufirst%3DG.%26aulast%3DQuinn%26aufirst%3DC.%2BM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DDual%2520Allosteric%2520Inhibition%2520of%2520SHP2%2520Phosphatase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D647%26epage%3D656%26doi%3D10.1021%2Facschembio.7b00980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia
Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7773</span>â <span class="NLM_lpage">7782</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b00680</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00680" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7773-7782&author=J.+Garcia%0AFortanetauthor=C.+H.-T.+Chenauthor=Y.-N.+P.+Chenauthor=Z.+Chenauthor=Z.+Dengauthor=B.+Firestoneauthor=P.+Fekkesauthor=M.+Fodorauthor=P.+D.+Fortinauthor=C.+Fridrichauthor=D.+Grunenfelderauthor=S.+Hoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=N.+Keenauthor=L.+R.+LaBonteauthor=J.+Larrowauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=F.+Lombardoauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=T.+Ramseyauthor=W.+R.+Sellersauthor=M.+D.+Shultzauthor=T.+Stamsauthor=C.+Towlerauthor=P.+Wangauthor=S.+L.+Williamsauthor=J.-H.+Zhangauthor=M.+J.+LaMarche&title=Allosteric+Inhibition+of+SHP2%3A+Identification+of+a+Potent%2C+Selective%2C+and+Orally+Efficacious+Phosphatase+Inhibitor&doi=10.1021%2Facs.jmedchem.6b00680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span></div><div class="casAuthors">Garcia Fortanet, Jorge; Chen, Christine Hiu-Tung; Chen, Ying-Nan P.; Chen, Zhouliang; Deng, Zhan; Firestone, Brant; Fekkes, Peter; Fodor, Michelle; Fortin, Pascal D.; Fridrich, Cary; Grunenfelder, Denise; Ho, Samuel; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Keen, Nick; LaBonte, Laura R.; Larrow, Jay; Lenoir, Francois; Liu, Gang; Liu, Shumei; Lombardo, Franco; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Ramsey, Timothy; Sellers, William R.; Shultz, Michael D.; Stams, Travis; Towler, Christopher; Wang, Ping; Williams, Sarah L.; Zhang, Ji-Hu; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7773-7782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway.  SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1).  Because it is an oncoprotein assocd. with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest.  Recently in our labs., a small mol. inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2.  A high throughput screen was performed to identify progressable chem. matter, and X-ray crystallog. revealed the location of binding in a previously undisclosed allosteric binding pocket.  Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein-ligand interactions were characterized.  These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (SHP099, 1), a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6RT7zfZnvfLVg90H21EOLACvtfcHk0lgHNxtXU161ZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP&md5=dfe43b5253e172576386f86797087f7b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%2BFortanet%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26aulast%3DChen%26aufirst%3DY.-N.%2BP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLaBonte%26aufirst%3DL.%2BR.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DAllosteric%2520Inhibition%2520of%2520SHP2%253A%2520Identification%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520Phosphatase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7773%26epage%3D7782%26doi%3D10.1021%2Facs.jmedchem.6b00680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Tyrosine Phosphatase SHP-2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">441</span>â <span class="NLM_lpage">450</span>, <span class="refDoi">Â DOI: 10.1016/S0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+Structure+of+the+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2FS0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Ã resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0lgHNxtXU161ZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450%26doi%3D10.1016%2FS0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Revealing Mechanisms for SH2 Domain Mediated Regulation of the Protein Tyrosine Phosphatase SHP-2</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">249</span>â <span class="NLM_lpage">254</span>, <span class="refDoi">Â DOI: 10.1016/S0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+Mechanisms+for+SH2+Domain+Mediated+Regulation+of+the+Protein+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2FS0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0lgHNxtXU161ZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520Mechanisms%2520for%2520SH2%2520Domain%2520Mediated%2520Regulation%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254%26doi%3D10.1016%2FS0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">Novartis SHP2 patent applications:</p></div><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Grunenfelder, D.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Stams, T. M.</span>; <span class="NLM_string-name">Williams, S.</span></span> <span> </span><span class="NLM_article-title">1 -Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine Derivatives and Compositions Thereof for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO15107493</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Chen&author=J.+G.+Fortanet&author=D.+Grunenfelder&author=R.+Karki&author=M.+Kato&author=M.+J.+LaMarche&author=L.+B.+Perez&author=T.+M.+Stams&author=S.+Williams&title=1+-Pyridazin-%2Ftriazin-3-yl-piper%28-azine%29%2Fidine%2Fpyrolidine+Derivatives+and+Compositions+Thereof+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3D1%2520-Pyridazin-%252Ftriazin-3-yl-piper%2528-azine%2529%252Fidine%252Fpyrolidine%2520Derivatives%2520and%2520Compositions%2520Thereof%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Williams, S.</span>; <span class="NLM_string-name">Sendzik, M.</span></span> <span> </span><span class="NLM_article-title">1-(Triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine Derivatives and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO15107494</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=R.+Karki&author=M.+Kato&author=M.+J.+LaMarche&author=L.+B.+Perez&author=S.+Williams&author=M.+Sendzik&title=1-%28Triazin-3-yl%2Fpyridazin-3-yl%29-piper%28-azine%29idine+Derivatives+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3D1-%2528Triazin-3-yl%252Fpyridazin-3-yl%2529-piper%2528-azine%2529idine%2520Derivatives%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Smith, T.</span>; <span class="NLM_string-name">Williams, S.</span>; <span class="NLM_string-name">Toure, B.
B.</span>; <span class="NLM_string-name">Sendzik, M.</span></span> <span> </span><span class="NLM_article-title">N-azaspirocycloalkane Substituted N-Heteroaryl Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO15107495</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+H.+Chen&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=R.+Karki&author=M.+Kato&author=M.+J.+LaMarche&author=L.+B.+Perez&author=T.+Smith&author=S.+Williams&author=B.%0AB.+Toure&author=M.+Sendzik&title=N-azaspirocycloalkane+Substituted+N-Heteroaryl+Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DN-azaspirocycloalkane%2520Substituted%2520N-Heteroaryl%2520Compounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Sarver, P. J.</span>; <span class="NLM_string-name">Shultz, M.</span>; <span class="NLM_string-name">Smith, T.
D.</span>; <span class="NLM_string-name">Williams, S.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO16203404</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+T.+Bagdanoff&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=M.+Kato&author=M.+J.+LaMarche&author=P.+J.+Sarver&author=M.+Shultz&author=T.%0AD.+Smith&author=S.+Williams&title=Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Tamez, V.</span>; <span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO16203405</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Z.+Chen&author=J.+G.+Fortanet&author=M.+J.+LaMarche&author=M.+Sendzik&author=V.+Tamez&author=B.+Yu&title=Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Jouk, A.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Liu, G.</span>; <span class="NLM_string-name">Palermo, M.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Sarver, P. J.</span>; <span class="NLM_string-name">Shultz, M. D.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Toure, B.
B.</span>; <span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO16203406</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Z.+Chen&author=J.+G.+Fortanet&author=A.+Jouk&author=R.+Karki&author=M.+J.+LaMarche&author=G.+Liu&author=M.+Palermo&author=L.+B.+Perez&author=P.+J.+Sarver&author=M.+D.+Shultz&author=M.+Sendzik&author=B.%0AB.+Toure&author=B.+Yu&title=Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Majumdar, D.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Smith, T.
D.</span>; <span class="NLM_string-name">Yang, F.</span>; <span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO17216706</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Z.+Chen&author=J.+G.+Fortanet&author=R.+Karki&author=M.+J.+LaMarche&author=D.+Majumdar&author=L.+B.+Perez&author=M.+Sendzik&author=T.%0AD.+Smith&author=F.+Yang&author=B.+Yu&title=Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Flemming, A.</span></span> <span> </span><span class="NLM_article-title">Allosteric Phosphatase Inhibitor Puts Brake on Cancer Cells</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">530</span>â <span class="NLM_lpage">531</span>, <span class="refDoi">Â DOI: 10.1038/nrd.2016.157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fnrd.2016.157" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=530-531&author=A.+Flemming&title=Allosteric+Phosphatase+Inhibitor+Puts+Brake+on+Cancer+Cells&doi=10.1038%2Fnrd.2016.157"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.157%26sid%3Dliteratum%253Aachs%26aulast%3DFlemming%26aufirst%3DA.%26atitle%3DAllosteric%2520Phosphatase%2520Inhibitor%2520Puts%2520Brake%2520on%2520Cancer%2520Cells%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D530%26epage%3D531%26doi%3D10.1038%2Fnrd.2016.157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Batth, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tollenaere, M. A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francavilla, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span> <span> </span><span class="NLM_article-title">Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2784</span>â <span class="NLM_lpage">2796</span>, <span class="refDoi">Â DOI: 10.1016/j.celrep.2018.02.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2Fj.celrep.2018.02.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29514104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktVKmsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=2784-2796&author=T.+S.+Batthauthor=M.+Papettiauthor=A.+Pfeifferauthor=M.+A.+X.+Tollenaereauthor=C.+Francavillaauthor=J.+V.+Olsen&title=Large-Scale+Phosphoproteomics+Reveals+Shp-2+Phosphatase-Dependent+Regulators+of+Pdgf+Receptor+Signaling&doi=10.1016%2Fj.celrep.2018.02.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling</span></div><div class="casAuthors">Batth, Tanveer S.; Papetti, Moreno; Pfeiffer, Anamarija; Tollenaere, Maxim A. X.; Francavilla, Chiara; Olsen, Jesper V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2784-2796</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Despite its low cellular abundance, phosphotyrosine (pTyr) regulates numerous cell signaling pathways in health and disease.  We applied comprehensive phosphoproteomics to unravel differential regulators of receptor tyrosine kinase (RTK)-initiated signaling networks upon activation by Pdgf-Î²Î², Fgf-2, or Igf-1 and identified more than 40,000 phosphorylation sites, including many phosphotyrosine sites without addnl. enrichment.  The anal. revealed RTK-specific regulation of hundreds of pTyr sites on key signaling mols.  We found the tyrosine phosphatase Shp-2 to be the master regulator of Pdgfr pTyr signaling.  Application of a recently introduced allosteric Shp-2 inhibitor revealed global regulation of the Pdgf-dependent tyrosine phosphoproteome, which significantly impaired cell migration.  In addn., we present a list of hundreds of Shp-2-dependent targets and putative substrates, including Rasa1 and Cortactin with increased pTyr and Gab1 and Erk1/2 with decreased pTyr.  Our study demonstrates that large-scale quant. phosphoproteomics can precisely dissect tightly regulated kinase-phosphatase signaling networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDY-Vxay_pvLVg90H21EOLACvtfcHk0liJOaaWUYYwLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktVKmsbc%253D&md5=fbdaeb4de24e15a5a0e4d8db5e072a9e</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.02.038%26sid%3Dliteratum%253Aachs%26aulast%3DBatth%26aufirst%3DT.%2BS.%26aulast%3DPapetti%26aufirst%3DM.%26aulast%3DPfeiffer%26aufirst%3DA.%26aulast%3DTollenaere%26aufirst%3DM.%2BA.%2BX.%26aulast%3DFrancavilla%26aufirst%3DC.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26atitle%3DLarge-Scale%2520Phosphoproteomics%2520Reveals%2520Shp-2%2520Phosphatase-Dependent%2520Regulators%2520of%2520Pdgf%2520Receptor%2520Signaling%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D22%26spage%3D2784%26epage%3D2796%26doi%3D10.1016%2Fj.celrep.2018.02.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. L.</span></span> <span> </span><span class="NLM_article-title">Scaffold-Based Novel SHP2 Allosteric Inhibitors Design Using Receptor-Ligand Pharmacophore Model, Virtual Screening and Molecular Dynamics</span>. <i>Comput. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">179</span>â <span class="NLM_lpage">188</span>, <span class="refDoi">Â DOI: 10.1016/j.compbiolchem.2018.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2Fj.compbiolchem.2018.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29494926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsF2kurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2018&pages=179-188&author=W.+Y.+Jinauthor=Y.+Maauthor=W.+Liauthor=H.+L.+Liauthor=R.+L.+Wang&title=Scaffold-Based+Novel+SHP2+Allosteric+Inhibitors+Design+Using+Receptor-Ligand+Pharmacophore+Model%2C+Virtual+Screening+and+Molecular+Dynamics&doi=10.1016%2Fj.compbiolchem.2018.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamics</span></div><div class="casAuthors">Jin, Wen-Yan; Ma, Ying; Li, Wei-Ya; Li, Hong-Lian; Wang, Run-Ling</div><div class="citationInfo"><span class="NLM_cas:title">Computational Biology and Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-188</span>CODEN:
                <span class="NLM_cas:coden">CBCOCH</span>;
        ISSN:<span class="NLM_cas:issn">1476-9271</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SHP2 is a potential target for the development of novel therapies for SHP2-dependent cancers.  In our research, with the aid of the 'Receptor-Ligand Pharmacophore' technique, a 3D-QSAR method was carried out to explore structure activity relationship of SHP2 allosteric inhibitors.  Structure-based drug design was employed to optimize SHP099, an efficacious, potent, and selective SHP2 allosteric inhibitor.  A novel class of selective SHP2 allosteric inhibitors was discovered by using the powerful 'SBP', 'ADMET' and 'CDOCKER' techniques.  By means of mol. dynamics simulations, it was obsd. that these novel inhibitors not only had the same function as SHP099 did in inhibiting SHP2, but also had more favorable conformation for binding to the receptor.  Thus, this report may provide a new method in discovering novel and selective SHP2 allosteric inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzg1OlgVdJ5bVg90H21EOLACvtfcHk0lgON18upvU8AA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsF2kurc%253D&md5=327433bbc88dbce0bdbda3369648e797</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1016%2Fj.compbiolchem.2018.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.compbiolchem.2018.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DW.%2BY.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DR.%2BL.%26atitle%3DScaffold-Based%2520Novel%2520SHP2%2520Allosteric%2520Inhibitors%2520Design%2520Using%2520Receptor-Ligand%2520Pharmacophore%2520Model%252C%2520Virtual%2520Screening%2520and%2520Molecular%2520Dynamics%26jtitle%3DComput.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D73%26spage%3D179%26epage%3D188%26doi%3D10.1016%2Fj.compbiolchem.2018.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dardaei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fordjour, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langenbucher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainor, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friboulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagogo-Jack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruddy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cecca, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmaster, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caponigro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span> <span> </span><span class="NLM_article-title">SHP2 Inhibition Restores Sensitivity in ALK-Rearranged Non-Small-Cell Lung Cancer Resistant to ALK Inhibitors</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">512</span>â <span class="NLM_lpage">517</span>, <span class="refDoi">Â DOI: 10.1038/nm.4497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fnm.4497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29505033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVOlu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=512-517&author=L.+Dardaeiauthor=H.+Q.+Wangauthor=M.+Singhauthor=P.+Fordjourauthor=K.+X.+Shawauthor=S.+Yodaauthor=G.+Kerrauthor=K.+Yuauthor=J.+Liangauthor=Y.+Caoauthor=Y.+Chenauthor=M.+S.+Lawrenceauthor=A.+Langenbucherauthor=J.+F.+Gainorauthor=L.+Fribouletauthor=I.+Dagogo-Jackauthor=D.+T.+Myersauthor=E.+Labrotauthor=D.+Ruddyauthor=M.+Parksauthor=D.+Leeauthor=R.+H.+Di+Ceccaauthor=S.+Moodyauthor=H.+Haoauthor=M.+Mohseniauthor=M.+LaMarcheauthor=J.+Williamsauthor=K.+Hoffmasterauthor=G.+Caponigroauthor=A.+T.+Shawauthor=A.+N.+Hataauthor=C.+H.+Benesauthor=F.+Liauthor=J.+A.+Engelman&title=SHP2+Inhibition+Restores+Sensitivity+in+ALK-Rearranged+Non-Small-Cell+Lung+Cancer+Resistant+to+ALK+Inhibitors&doi=10.1038%2Fnm.4497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15dR"><div class="casContent"><span class="casTitleNuber">15d</span><div class="casTitle"><span class="NLM_cas:atitle">SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors</span></div><div class="casAuthors">Dardaei, Leila; Wang, Hui Qin; Singh, Manrose; Fordjour, Paul; Shaw, Katherine X.; Yoda, Satoshi; Kerr, Grainne; Yu, Kristine; Liang, Jinsheng; Cao, Yichen; Chen, Yan; Lawrence, Michael S.; Langenbucher, Adam; Gainor, Justin F.; Friboulet, Luc; Dagogo-Jack, Ibiayi; Myers, David T.; Labrot, Emma; Ruddy, David; Parks, Melissa; Lee, Dana; Di Cecca, Richard H.; Moody, Susan; Hao, Huaixiang; Mohseni, Morvarid; LaMarche, Matthew; Williams, Juliet; Hoffmaster, Keith; Caponigro, Giordano; Shaw, Alice T.; Hata, Aaron N.; Benes, Cyril H.; Li, Fang; Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">512-517</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Most anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung tumors initially respond to small-mol. ALK inhibitors, but drug resistance often develops.  Of tumors that develop resistance to highly potent second-generation ALK inhibitors, approx. half harbor resistance mutations in ALK, while the other half have other mechanisms underlying resistance.  Members of the latter group often have activation of at least one of several different tyrosine kinases driving resistance.  Such tumors are not expected to respond to lorlatinib-a third-generation inhibitor targeting ALK that is able to overcome all clin. identified resistant mutations in ALK-and further therapeutic options are limited.  Herein, we deployed a shRNA screen of 1,000 genes in multiple ALK-inhibitor-resistant patient-derived cells (PDCs) to discover those that confer sensitivity to ALK inhibition.  This approach identified SHP2, a nonreceptor protein tyrosine phosphatase, as a common targetable resistance node in multiple PDCs.  SHP2 provides a parallel survival input downstream of multiple tyrosine kinases that promote resistance to ALK inhibitors.  Treatment with SHP099, the recently discovered small-mol. inhibitor of SHP2, in combination with the ALK tyrosine kinase inhibitor (TKI) ceritinib halted the growth of resistant PDCs through preventing compensatory RAS and ERK1 and ERK2 (ERK1/2) reactivation.  These findings suggest that combined ALK and SHP2 inhibition may be a promising therapeutic strategy for resistant cancers driven by several different ALK-independent mechanisms underlying resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBbW-AAzZ-grVg90H21EOLACvtfcHk0lgON18upvU8AA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVOlu78%253D&md5=e40334532f10444b2df350345add9d0e</span></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1038%2Fnm.4497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4497%26sid%3Dliteratum%253Aachs%26aulast%3DDardaei%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%2BQ.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DFordjour%26aufirst%3DP.%26aulast%3DShaw%26aufirst%3DK.%2BX.%26aulast%3DYoda%26aufirst%3DS.%26aulast%3DKerr%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DLangenbucher%26aufirst%3DA.%26aulast%3DGainor%26aufirst%3DJ.%2BF.%26aulast%3DFriboulet%26aufirst%3DL.%26aulast%3DDagogo-Jack%26aufirst%3DI.%26aulast%3DMyers%26aufirst%3DD.%2BT.%26aulast%3DLabrot%26aufirst%3DE.%26aulast%3DRuddy%26aufirst%3DD.%26aulast%3DParks%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DDi%2BCecca%26aufirst%3DR.%2BH.%26aulast%3DMoody%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DLaMarche%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DHoffmaster%26aufirst%3DK.%26aulast%3DCaponigro%26aufirst%3DG.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DHata%26aufirst%3DA.%2BN.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DSHP2%2520Inhibition%2520Restores%2520Sensitivity%2520in%2520ALK-Rearranged%2520Non-Small-Cell%2520Lung%2520Cancer%2520Resistant%2520to%2520ALK%2520Inhibitors%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D512%26epage%3D517%26doi%3D10.1038%2Fnm.4497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Leukemia-Associated SHP2E69K Mutant by the Allosteric SHP2 Inhibitor SHP099</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1246</span>â <span class="NLM_lpage">1249</span>, <span class="refDoi">Â DOI: 10.1038/s41375-018-0020-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41375-018-0020-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29568093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOmsrrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=1246-1249&author=X.+Sunauthor=Y.+Renauthor=S.+Gunawanauthor=P.+Tengauthor=Z.+Chenauthor=H.+R.+Lawrenceauthor=J.+Caiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Selective+Inhibition+of+Leukemia-Associated+SHP2E69K+Mutant+by+the+Allosteric+SHP2+Inhibitor+SHP099&doi=10.1038%2Fs41375-018-0020-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15eR"><div class="casContent"><span class="casTitleNuber">15e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099</span></div><div class="casAuthors">Sun, X.; Ren, Y.; Gunawan, S.; Teng, P.; Chen, Z.; Lawrence, H. R.; Cai, J.; Lawrence, N. J.; Wu, J.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1246-1249</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The article studies selective inhibition of leukemia-assocd. SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099.  Our findings here identify SHP2E69K as a SHP099-sensitive mutation, wherein three of four most common oncogenic SHP2 mutants studied here are resistant to SHP099.  Moreover, whether Noonan syndrome-assocd. SHP2 mutants are sensitive to SHP099 remained to be tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQzBW1E1YhLVg90H21EOLACvtfcHk0lj5BXeRDcFx1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOmsrrK&md5=2cb9342a2e06eac4b9d9043163e4095c</span></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=10.1038%2Fs41375-018-0020-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41375-018-0020-5%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGunawan%26aufirst%3DS.%26aulast%3DTeng%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DSelective%2520Inhibition%2520of%2520Leukemia-Associated%2520SHP2E69K%2520Mutant%2520by%2520the%2520Allosteric%2520SHP2%2520Inhibitor%2520SHP099%26jtitle%3DLeukemia%26date%3D2018%26volume%3D32%26spage%3D1246%26epage%3D1249%26doi%3D10.1038%2Fs41375-018-0020-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kostallari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasnicka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaqoob, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongjarupong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, V. H.</span></span> <span> </span><span class="NLM_article-title">Hepatic Stellate Cell-Derived Platelet-Derived Growth Factor Receptor-Alpha-Enriched Extracellular Vesicles Promote Liver Fibrosis in Mice Through SHP2</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">333</span>â <span class="NLM_lpage">348</span>, <span class="refDoi">Â DOI: 10.1002/hep.29803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1002%2Fhep.29803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29360139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Klu7zF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=333-348&author=E.+Kostallariauthor=P.+Hirsovaauthor=A.+Prasnickaauthor=V.+K.+Vermaauthor=U.+Yaqoobauthor=N.+Wongjarupongauthor=L.+R.+Robertsauthor=V.+H.+Shah&title=Hepatic+Stellate+Cell-Derived+Platelet-Derived+Growth+Factor+Receptor-Alpha-Enriched+Extracellular+Vesicles+Promote+Liver+Fibrosis+in+Mice+Through+SHP2&doi=10.1002%2Fhep.29803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15fR"><div class="casContent"><span class="casTitleNuber">15f</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2</span></div><div class="casAuthors">Kostallari, Enis; Hirsova, Petra; Prasnicka, Alena; Verma, Vikas K.; Yaqoob, Usman; Wongjarupong, Nicha; Roberts, Lewis R.; Shah, Vijay H.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">333-348</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Liver fibrosis is characterized by the activation and migration of hepatic stellate cells (HSCs), followed by matrix deposition.  Recently, several studies have shown the importance of extracellular vesicles (EVs) derived from liver cells, such as hepatocytes and endothelial cells, in liver pathobiol.  While most of the studies describe how liver cells modulate HSC behavior, an important gap exists in the understanding of HSC-derived signals and more specifically HSC-derived EVs in liver fibrosis.  Here, we investigated the mols. released through HSC-derived EVs, the mechanism of their release, and the role of these EVs in fibrosis.  Mass spectrometric anal. showed that platelet-derived growth factor (PDGF) receptor-alpha (PDGFRÎ±) was enriched in EVs derived from PDGF-BB-treated HSCs.  Moreover, patients with liver fibrosis had increased PDGFRÎ± levels in serum EVs compared to healthy individuals.  Mechanistically, in vitro tyrosine720-to-phenylalanine mutation on the PDGFRÎ± sequence abolished enrichment of PDGFRÎ± in EVs and redirected the receptor toward degrdn.  Congruently, the inhibition of Src homol. 2 domain tyrosine phosphatase 2, the regulatory binding partner of phosphorylated tyrosine720, also inhibited PDGFRÎ± enrichment in EVs.  EVs derived from PDGFRÎ±-overexpressing cells promoted in vitro HSC migration and in vivo liver fibrosis.  Finally, administration of Src homol. 2 domain tyrosine phosphatase 2inhibitor, SHP099, to carbon tetrachloride-administered mice inhibited PDGFRÎ± enrichment in serum EVs and reduced liver fibrosis.  Conclusion: PDGFRÎ± is enriched in EVs derived from PDGF-BB-treated HSCs in an Src homol. 2 domain tyrosine phosphatase 2-dependent manner and these PDGFRÎ±-enriched EVs participate in development of liver fibrosis. (Hepatol. 2018;68:333-348).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofC4FQDJF6aLVg90H21EOLACvtfcHk0lj5BXeRDcFx1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Klu7zF&md5=f2a5e625ad4715f9b5be28370632d054</span></div><a href="/servlet/linkout?suffix=cit15f&amp;dbid=16384&amp;doi=10.1002%2Fhep.29803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.29803%26sid%3Dliteratum%253Aachs%26aulast%3DKostallari%26aufirst%3DE.%26aulast%3DHirsova%26aufirst%3DP.%26aulast%3DPrasnicka%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DV.%2BK.%26aulast%3DYaqoob%26aufirst%3DU.%26aulast%3DWongjarupong%26aufirst%3DN.%26aulast%3DRoberts%26aufirst%3DL.%2BR.%26aulast%3DShah%26aufirst%3DV.%2BH.%26atitle%3DHepatic%2520Stellate%2520Cell-Derived%2520Platelet-Derived%2520Growth%2520Factor%2520Receptor-Alpha-Enriched%2520Extracellular%2520Vesicles%2520Promote%2520Liver%2520Fibrosis%2520in%2520Mice%2520Through%2520SHP2%26jtitle%3DHepatology%26date%3D2018%26volume%3D68%26spage%3D333%26epage%3D348%26doi%3D10.1002%2Fhep.29803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemulapalli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span> <span> </span><span class="NLM_article-title">Structural Reorganization of SHP2 by Oncogenic Mutations and Implications for Oncoprotein Resistance to Allosteric Inhibition</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="NLM_elocation-id">4508</span> <span class="refDoi">Â DOI: 10.1038/s41467-018-06823-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41467-018-06823-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=30375388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A280%3ADC%252BB3cvkslelsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+R.+LaRochelleauthor=M.+Fodorauthor=V.+Vemulapalliauthor=M.+Mohseniauthor=P.+Wangauthor=T.+Stamsauthor=M.+J.+LaMarcheauthor=R.+Chopraauthor=M.+G.+Ackerauthor=S.+C.+Blacklow&title=Structural+Reorganization+of+SHP2+by+Oncogenic+Mutations+and+Implications+for+Oncoprotein+Resistance+to+Allosteric+Inhibition&doi=10.1038%2Fs41467-018-06823-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15gR"><div class="casContent"><span class="casTitleNuber">15g</span><div class="casTitle"><span class="NLM_cas:atitle">Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition</span></div><div class="casAuthors">LaRochelle Jonathan R; Vemulapalli Vidyasiri; Blacklow Stephen C; LaRochelle Jonathan R; Vemulapalli Vidyasiri; Blacklow Stephen C; Fodor Michelle; Mohseni Morvarid; Wang Ping; Stams Travis; LaMarche Matthew J; Chopra Rajiv; Acker Michael G</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4508</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Activating mutations in PTPN11, encoding the cytosolic protein tyrosine phosphatase SHP2, result in developmental disorders and act as oncogenic drivers in patients with hematologic cancers.  The allosteric inhibitor SHP099 stabilizes the wild-type SHP2 enzyme in an autoinhibited conformation that is itself destabilized by oncogenic mutations.  Here, we report the impact of the highly activated and most frequently observed mutation, E76K, on the structure of SHP2, and investigate the effect of E76K and other oncogenic mutations on allosteric inhibition by SHP099.  SHP2(E76K) adopts an open conformation but can be restored to the closed, autoinhibited conformation, near-identical to the unoccupied wild-type enzyme, when complexed with SHP099.  SHP099 inhibitory activity against oncogenic SHP2 variants in vitro and in cells scales inversely with the activating strength of the mutation, indicating that either oncoselective or vastly more potent inhibitors will be necessary to suppress oncogenic signaling by the most strongly activating SHP2 mutations in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRglXfZMl481dts4TFFB11gfW6udTcc2eZ2W6t7k2xtXLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvkslelsA%253D%253D&md5=ceac9384173a0439b945b51f7bc65ea1</span></div><a href="/servlet/linkout?suffix=cit15g&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06823-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06823-9%26sid%3Dliteratum%253Aachs%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DVemulapalli%26aufirst%3DV.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26atitle%3DStructural%2520Reorganization%2520of%2520SHP2%2520by%2520Oncogenic%2520Mutations%2520and%2520Implications%2520for%2520Oncoprotein%2520Resistance%2520to%2520Allosteric%2520Inhibition%26jtitle%3DNat.%2520Commun.%26date%3D2018%26doi%3D10.1038%2Fs41467-018-06823-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">PÃ¡dua, R. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitsawong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiller, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otten, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, D.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Activating Mutations and Allosteric Drug Inhibition of the Phosphatase SHP2</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="NLM_elocation-id">4507</span> <span class="refDoi">Â DOI: 10.1038/s41467-018-06814-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41467-018-06814-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=30375376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A280%3ADC%252BB3cvkslemsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+A.+P.+P%C3%A1duaauthor=Y.+Sunauthor=I.+Markoauthor=W.+Pitsawongauthor=J.+B.+Stillerauthor=R.+Ottenauthor=D.+Kern&title=Mechanism+of+Activating+Mutations+and+Allosteric+Drug+Inhibition+of+the+Phosphatase+SHP2&doi=10.1038%2Fs41467-018-06814-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15hR"><div class="casContent"><span class="casTitleNuber">15h</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2</span></div><div class="casAuthors">Padua Ricardo A P; Sun Yizhi; Marko Ingrid; Pitsawong Warintra; Stiller John B; Otten Renee; Kern Dorothee; Sun Yizhi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4507</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Protein tyrosine phosphatase SHP2 functions as a key regulator of cell cycle control, and activating mutations cause several cancers.  Here, we dissect the energy landscape of wild-type SHP2 and the oncogenic mutation E76K.  NMR spectroscopy and X-ray crystallography reveal that wild-type SHP2 exchanges between closed, inactive and open, active conformations.  E76K mutation shifts this equilibrium toward the open state.  The previously unknown open conformation is characterized, including the active-site WPD loop in the inward and outward conformations.  Binding of the allosteric inhibitor SHP099 to E76K mutant, despite much weaker, results in an identical structure as the wild-type complex.  A conformational selection to the closed state reduces drug affinity which, combined with E76K's much higher activity, demands significantly greater SHP099 concentrations to restore wild-type  activity levels.  The differences in structural ensembles and drug-binding kinetics of cancer-associated SHP2 forms may stimulate innovative ideas for developing more potent inhibitors for activated SHP2 mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRglXfZMl481eR_TJajKxJDfW6udTcc2eYcEiauyZEV_bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvkslemsg%253D%253D&md5=676e8c7d4c85cbb7ce2fa9f756106535</span></div><a href="/servlet/linkout?suffix=cit15h&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06814-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06814-w%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A1dua%26aufirst%3DR.%2BA.%2BP.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMarko%26aufirst%3DI.%26aulast%3DPitsawong%26aufirst%3DW.%26aulast%3DStiller%26aufirst%3DJ.%2BB.%26aulast%3DOtten%26aufirst%3DR.%26aulast%3DKern%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520Activating%2520Mutations%2520and%2520Allosteric%2520Drug%2520Inhibition%2520of%2520the%2520Phosphatase%2520SHP2%26jtitle%3DNat.%2520Commun.%26date%3D2018%26doi%3D10.1038%2Fs41467-018-06814-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Czako, B.</span>; <span class="NLM_string-name">Jones, P.</span>; <span class="NLM_string-name">Cross, P.</span>; <span class="NLM_string-name">Leonard, P.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Inhibitors of PTPN11</span>. WO Patent <span class="NLM_patent">WO2017156397</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=B.+Czako&author=P.+Jones&author=P.+Cross&author=P.+Leonard&title=Heterocyclic+Inhibitors+of+PTPN11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCzako%26aufirst%3DB.%26atitle%3DHeterocyclic%2520Inhibitors%2520of%2520PTPN11%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Gu, S.</span>; <span class="NLM_string-name">Si, X.</span>; <span class="NLM_string-name">Xie, J.</span>; <span class="NLM_string-name">Shen, J.</span></span> <span> </span><span class="NLM_article-title">N-Heterocyclic Ring Compound, and Intermediate, Preparation Method, Medicine Composition and Application Thereof</span>. Chinese Patent <span class="NLM_patent">CN107286150</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+Zhu&author=S.+Gu&author=X.+Si&author=J.+Xie&author=J.+Shen&title=N-Heterocyclic+Ring+Compound%2C+and+Intermediate%2C+Preparation+Method%2C+Medicine+Composition+and+Application+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DN-Heterocyclic%2520Ring%2520Compound%252C%2520and%2520Intermediate%252C%2520Preparation%2520Method%252C%2520Medicine%2520Composition%2520and%2520Application%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span>; <span class="NLM_string-name">Gao, P.</span>; <span class="NLM_string-name">Chu, J.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Wen, C.</span>; <span class="NLM_string-name">Kang, D.</span>; <span class="NLM_string-name">Bai, J.</span>; <span class="NLM_string-name">Pei, X.</span></span> <span> </span><span class="NLM_article-title">Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors</span>. WO Patent <span class="NLM_patent">WO2017211303</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Ma&author=P.+Gao&author=J.+Chu&author=X.+Wu&author=C.+Wen&author=D.+Kang&author=J.+Bai&author=X.+Pei&title=Novel+Heterocyclic+Derivatives+Useful+as+SHP2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%26atitle%3DNovel%2520Heterocyclic%2520Derivatives%2520Useful%2520as%2520SHP2%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Jogalekar, A.</span>; <span class="NLM_string-name">Won, W.</span>; <span class="NLM_string-name">Koltun, E. S.</span>; <span class="NLM_string-name">Gill, A.</span>; <span class="NLM_string-name">Mellem, K.</span>; <span class="NLM_string-name">Aay, N.</span>; <span class="NLM_string-name">Buckl, A.</span>; <span class="NLM_string-name">Semko, C.</span>; <span class="NLM_string-name">Kiss, G.</span></span> <span> </span><span class="NLM_article-title">2,5-Disubstituted 3-Methyl Pyrazines and 2,5,6-Trisubstituted 3-Methyl Pyrazines As Allosteric SHP2 Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018013597</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+Jogalekar&author=W.+Won&author=E.+S.+Koltun&author=A.+Gill&author=K.+Mellem&author=N.+Aay&author=A.+Buckl&author=C.+Semko&author=G.+Kiss&title=2%2C5-Disubstituted+3-Methyl+Pyrazines+and+2%2C5%2C6-Trisubstituted+3-Methyl+Pyrazines+As+Allosteric+SHP2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJogalekar%26aufirst%3DA.%26atitle%3D2%252C5-Disubstituted%25203-Methyl%2520Pyrazines%2520and%25202%252C5%252C6-Trisubstituted%25203-Methyl%2520Pyrazines%2520As%2520Allosteric%2520SHP2%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span>; <span class="NLM_string-name">Aay, N.</span>; <span class="NLM_string-name">Mellem, K.</span>; <span class="NLM_string-name">Buckyl, A.</span>; <span class="NLM_string-name">Koltun, E. S.</span>; <span class="NLM_string-name">Semko, C.</span>; <span class="NLM_string-name">Kiss, G.</span></span> <span> </span><span class="NLM_article-title">Pyridine Compounds as Allosteric SHP2 Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018136264</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+Gill&author=N.+Aay&author=K.+Mellem&author=A.+Buckyl&author=E.+S.+Koltun&author=C.+Semko&author=G.+Kiss&title=Pyridine+Compounds+as+Allosteric+SHP2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DA.%26atitle%3DPyridine%2520Compounds%2520as%2520Allosteric%2520SHP2%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Blank, B. R.</span>; <span class="NLM_string-name">Pitzen, J.</span>; <span class="NLM_string-name">Wang, G.</span>; <span class="NLM_string-name">Won, W. S.</span>; <span class="NLM_string-name">Tzitzilonis, C.</span>; <span class="NLM_string-name">Li, J. J.</span>; <span class="NLM_string-name">Koltun, E. S.</span>; <span class="NLM_string-name">Aay, N.</span>; <span class="NLM_string-name">Buckyl, A.</span>; <span class="NLM_string-name">Mellem, K.</span>; <span class="NLM_string-name">Semko, C.</span>; <span class="NLM_string-name">Jogalekar, A.</span>; <span class="NLM_string-name">Kiss, G.</span>; <span class="NLM_string-name">Gill, A.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Compounds as Allosteric SHP2 Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018136265</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=B.+R.+Blank&author=J.+Pitzen&author=G.+Wang&author=W.+S.+Won&author=C.+Tzitzilonis&author=J.+J.+Li&author=E.+S.+Koltun&author=N.+Aay&author=A.+Buckyl&author=K.+Mellem&author=C.+Semko&author=A.+Jogalekar&author=G.+Kiss&author=A.+Gill&title=Bicyclic+Compounds+as+Allosteric+SHP2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlank%26aufirst%3DB.%2BR.%26atitle%3DBicyclic%2520Compounds%2520as%2520Allosteric%2520SHP2%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span>; <span class="NLM_string-name">Giordanetto, F.</span>; <span class="NLM_string-name">Greisman, J. B.</span>; <span class="NLM_string-name">Maragakis, P.</span>; <span class="NLM_string-name">Taylor, A. M.</span>; <span class="NLM_string-name">Walters, W. P.</span></span> <span> </span><span class="NLM_article-title">SHP2 Phosphatase Inhibitors and Methods of Use Thereof</span>. WO Patent <span class="NLM_patent">WO2018057884</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=B.+K.+Albrecht&author=F.+Giordanetto&author=J.+B.+Greisman&author=P.+Maragakis&author=A.+M.+Taylor&author=W.+P.+Walters&title=SHP2+Phosphatase+Inhibitors+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DSHP2%2520Phosphatase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span>; <span class="NLM_string-name">Greisman, J. B.</span>; <span class="NLM_string-name">Maragakis, P.</span>; <span class="NLM_string-name">Taylor, A. M.</span>; <span class="NLM_string-name">Dipietro, L. V.</span>; <span class="NLM_string-name">Kelley, E. H.</span>; <span class="NLM_string-name">Lescarbeau, A.</span>; <span class="NLM_string-name">Murcko, M. A.</span>; <span class="NLM_string-name">Pierce, L. C. T.</span>; <span class="NLM_string-name">Shortsleeves, K. C.</span>; <span class="NLM_string-name">Walters, W. P.</span>; <span class="NLM_string-name">Bhat, S.</span>; <span class="NLM_string-name">Therrien, E.</span>; <span class="NLM_string-name">Dahlgren, M. K.</span></span> <span> </span><span class="NLM_article-title">Pyrazolo[3,4-B]Pyrazine Derivatives as SHP2 Phosphatase Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018081091</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=F.+Giordanetto&author=J.+B.+Greisman&author=P.+Maragakis&author=A.+M.+Taylor&author=L.+V.+Dipietro&author=E.+H.+Kelley&author=A.+Lescarbeau&author=M.+A.+Murcko&author=L.+C.+T.+Pierce&author=K.+C.+Shortsleeves&author=W.+P.+Walters&author=S.+Bhat&author=E.+Therrien&author=M.+K.+Dahlgren&title=Pyrazolo%5B3%2C4-B%5DPyrazine+Derivatives+as+SHP2+Phosphatase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26atitle%3DPyrazolo%255B3%252C4-B%255DPyrazine%2520Derivatives%2520as%2520SHP2%2520Phosphatase%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. M.</span>; <span class="NLM_string-name">Lescarbeau, A.</span>; <span class="NLM_string-name">Kelley, E. H.</span>; <span class="NLM_string-name">Shortsleeves, K. C.</span>; <span class="NLM_string-name">Dipietro, L. V.</span>; <span class="NLM_string-name">Walters, W. P.</span>; <span class="NLM_string-name">Murcko, M. A.</span>; <span class="NLM_string-name">Pierce, L. C.</span>; <span class="NLM_string-name">Tang, Y.</span>; <span class="NLM_string-name">Giordanetto, F.</span>; <span class="NLM_string-name">Greisman, J. B.</span>; <span class="NLM_string-name">Maragakis, P.</span>; <span class="NLM_string-name">Bhat, S.</span>; <span class="NLM_string-name">Dahlgeren, M. K.</span>; <span class="NLM_string-name">Therrien, E.</span></span> <span> </span><span class="NLM_article-title">Pyrazolo[3,4-B]Pyrazine Derivatives as SHP2 Phosphatase Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018218133</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+M.+Taylor&author=A.+Lescarbeau&author=E.+H.+Kelley&author=K.+C.+Shortsleeves&author=L.+V.+Dipietro&author=W.+P.+Walters&author=M.+A.+Murcko&author=L.+C.+Pierce&author=Y.+Tang&author=F.+Giordanetto&author=J.+B.+Greisman&author=P.+Maragakis&author=S.+Bhat&author=M.+K.+Dahlgeren&author=E.+Therrien&title=Pyrazolo%5B3%2C4-B%5DPyrazine+Derivatives+as+SHP2+Phosphatase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26atitle%3DPyrazolo%255B3%252C4-B%255DPyrazine%2520Derivatives%2520as%2520SHP2%2520Phosphatase%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haderk, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzitzilonis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordec, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakely, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bivona, T. G.</span></span> <span> </span><span class="NLM_article-title">RAS Nucleotide Cycling Underlies the SHP2 Phosphatase Dependence of Mutant BRAF-, NF1- and RAS-Driven Cancers</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">1064</span>â <span class="NLM_lpage">1073</span>, <span class="refDoi">Â DOI: 10.1038/s41556-018-0169-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41556-018-0169-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=30104724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2isLnP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=1064-1073&author=R.+J.+Nicholsauthor=F.+Haderkauthor=C.+Stahlhutauthor=C.+J.+Schulzeauthor=G.+Hemmatiauthor=D.+Wildesauthor=C.+Tzitzilonisauthor=K.+Mordecauthor=A.+Marquezauthor=J.+Romeroauthor=T.+Hsiehauthor=A.+Zamanauthor=V.+Olivasauthor=C.+McCoachauthor=C.+M.+Blakelyauthor=Z.+Wangauthor=G.+Kissauthor=E.+S.+Koltunauthor=A.+L.+Gillauthor=M.+Singhauthor=M.+A.+Goldsmithauthor=J.+A.+M.+Smithauthor=T.+G.+Bivona&title=RAS+Nucleotide+Cycling+Underlies+the+SHP2+Phosphatase+Dependence+of+Mutant+BRAF-%2C+NF1-+and+RAS-Driven+Cancers&doi=10.1038%2Fs41556-018-0169-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17hR"><div class="casContent"><span class="casTitleNuber">17h</span><div class="casTitle"><span class="NLM_cas:atitle">RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers</span></div><div class="casAuthors">Nichols, Robert J.; Haderk, Franziska; Stahlhut, Carlos; Schulze, Christopher J.; Hemmati, Golzar; Wildes, David; Tzitzilonis, Christos; Mordec, Kasia; Marquez, Abby; Romero, Jason; Hsieh, Tientien; Zaman, Aubhishek; Olivas, Victor; McCoach, Caroline; Blakely, Collin M.; Wang, Zhengping; Kiss, Gert; Koltun, Elena S.; Gill, Adrian L.; Singh, Mallika; Goldsmith, Mark A.; Smith, Jacqueline A. M.; Bivona, Trever G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1064-1073</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Oncogenic alterations in the RAS/RAF/MEK/ERK pathway drive the growth of a wide spectrum of cancers.  While BRAF and MEK inhibitors are efficacious against BRAFV600E-driven cancers, effective targeted therapies are lacking for most cancers driven by other pathway alterations, including non-V600E oncogenic BRAF, RAS GTPase-activating protein (GAP) NF1 (neurofibromin 1) loss and oncogenic KRAS.  Here, we show that targeting the SHP2 phosphatase (encoded by PTPN11) with RMC-4550, a small-mol. allosteric inhibitor, is effective in human cancer models bearing RAS-GTP-dependent oncogenic BRAF (for example, class 3 BRAF mutants), NF1 loss or nucleotide-cycling oncogenic RAS (for example, KRASG12C).  SHP2 inhibitor treatment decreases oncogenic RAS/RAF/MEK/ERK signalling and cancer growth by disrupting SOS1-mediated RAS-GTP loading.  Our findings illuminate a crit. function for SHP2 in promoting oncogenic RAS/MAPK pathway activation in cancers with RAS-GTP-dependent oncogenic BRAF, NF1 loss and nucleotide-cycling oncogenic KRAS.  SHP2 inhibition is a promising mol. therapeutic strategy for patients with cancers bearing these oncogenic drivers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2gVKE5Juu_LVg90H21EOLACvtfcHk0liJoqx7f2hEWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2isLnP&md5=05e84e5c0d51d501c229e118f44aa6cd</span></div><a href="/servlet/linkout?suffix=cit17h&amp;dbid=16384&amp;doi=10.1038%2Fs41556-018-0169-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41556-018-0169-1%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DHaderk%26aufirst%3DF.%26aulast%3DStahlhut%26aufirst%3DC.%26aulast%3DSchulze%26aufirst%3DC.%2BJ.%26aulast%3DHemmati%26aufirst%3DG.%26aulast%3DWildes%26aufirst%3DD.%26aulast%3DTzitzilonis%26aufirst%3DC.%26aulast%3DMordec%26aufirst%3DK.%26aulast%3DMarquez%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DHsieh%26aufirst%3DT.%26aulast%3DZaman%26aufirst%3DA.%26aulast%3DOlivas%26aufirst%3DV.%26aulast%3DMcCoach%26aufirst%3DC.%26aulast%3DBlakely%26aufirst%3DC.%2BM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DKiss%26aufirst%3DG.%26aulast%3DKoltun%26aufirst%3DE.%2BS.%26aulast%3DGill%26aufirst%3DA.%2BL.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DGoldsmith%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DBivona%26aufirst%3DT.%2BG.%26atitle%3DRAS%2520Nucleotide%2520Cycling%2520Underlies%2520the%2520SHP2%2520Phosphatase%2520Dependence%2520of%2520Mutant%2520BRAF-%252C%2520NF1-%2520and%2520RAS-Driven%2520Cancers%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2018%26spage%3D1064%26epage%3D1073%26doi%3D10.1038%2Fs41556-018-0169-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarver, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichkule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">6-Amino-3-Methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01726</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01726" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=P.+Sarverauthor=M.+Ackerauthor=J.+T.+Bagdanoffauthor=Z.+Chenauthor=Y.+N.+Chenauthor=H.+Chanauthor=B.+Firestoneauthor=M.+Fodorauthor=J.+Garcia-Fortanetauthor=H.+Haoauthor=M.+Hentemannauthor=M.+Katoauthor=R.+Koenigauthor=L.+R.+LaBonteauthor=G.+Liuauthor=S.+Liuauthor=C.+Liuauthor=E.+McNeilauthor=M.+Mohseniauthor=M.+Sendzikauthor=T.+Stamsauthor=S.+Spenceauthor=V.+Tamezauthor=R.+Tichkuleauthor=C.+Towlerauthor=H.+Wangauthor=P.+Wangauthor=S.+L.+Williamsauthor=B.+Yuauthor=M.+J.+LaMarche&title=6-Amino-3-Methylpyrimidinones+as+Potent%2C+Selective%2C+and+Orally+Efficacious+SHP2+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01726"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01726%26sid%3Dliteratum%253Aachs%26aulast%3DSarver%26aufirst%3DP.%26aulast%3DAcker%26aufirst%3DM.%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%2BN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DGarcia-Fortanet%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DHentemann%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DR.%26aulast%3DLaBonte%26aufirst%3DL.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMcNeil%26aufirst%3DE.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DSpence%26aufirst%3DS.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DTichkule%26aufirst%3DR.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3D6-Amino-3-Methylpyrimidinones%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520SHP2%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.8b01726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitch, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platzer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Moreno, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, L. P.</span></span> <span> </span><span class="NLM_article-title">Arginine: Its pKa Value Revisited</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">752</span>â <span class="NLM_lpage">761</span>, <span class="refDoi">Â DOI: 10.1002/pro.2647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1002%2Fpro.2647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=25808204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVaht7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=752-761&author=C.+A.+Fitchauthor=G.+Platzerauthor=M.+Okonauthor=E.+B.+Garcia-Morenoauthor=L.+P.+McIntosh&title=Arginine%3A+Its+pKa+Value+Revisited&doi=10.1002%2Fpro.2647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Arginine: Its pKa value revisited</span></div><div class="casAuthors">Fitch, Carolyn A.; Platzer, Gerald; Okon, Mark; Garcia-Moreno E., Bertrand; McIntosh, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">752-761</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Using complementary approaches of potentiometry and NMR spectroscopy, we have detd. that the equil. acid dissocn. const. (pKa value) of the arginine guanidinium group is 13.8 Â± 0.1.  This is substantially higher than that of â¼12 often used in structure-based electrostatics calcns. and cited in biochem. textbooks.  The revised intrinsic pKa value helps explains why arginine side chains in proteins are always predominantly charged, even at pH values as great as 10.  The high pKa value also reinforces the observation that arginine side chains are invariably protonated under physiol. conditions of near neutral pH.  This occurs even when the guanidinium moiety is buried in a hydrophobic micro-environment, such as that inside a protein or a lipid membrane, thought to be incompatible with the presence of a charged group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOgRAuc6HbkLVg90H21EOLACvtfcHk0liJoqx7f2hEWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVaht7k%253D&md5=e2144529f99b55edbb43306f17bbf152</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fpro.2647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2647%26sid%3Dliteratum%253Aachs%26aulast%3DFitch%26aufirst%3DC.%2BA.%26aulast%3DPlatzer%26aufirst%3DG.%26aulast%3DOkon%26aufirst%3DM.%26aulast%3DGarcia-Moreno%26aufirst%3DE.%2BB.%26aulast%3DMcIntosh%26aufirst%3DL.%2BP.%26atitle%3DArginine%253A%2520Its%2520pKa%2520Value%2520Revisited%26jtitle%3DProtein%2520Sci.%26date%3D2015%26volume%3D24%26spage%3D752%26epage%3D761%26doi%3D10.1002%2Fpro.2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">The synthesis of spirocyclic amines is included in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_001.csv" class="ext-link">SI</a> for this manuscript. They may also be found at:</p></div><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuoliang, C.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Tamez, V.</span>; <span class="NLM_string-name">Bing, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted Pyrimidinones for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO2016203405</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=C.+Zhuoliang&author=J.+G.+Fortanet&author=M.+J.+LaMarche&author=M.+Sendzik&author=V.+Tamez&author=Y.+Bing&title=Preparation+of+Substituted+Pyrimidinones+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhuoliang%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520Substituted%2520Pyrimidinones%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Sarver, P. J.</span>; <span class="NLM_string-name">Shultz, M.</span>; <span class="NLM_string-name">Smith, T. D. S.</span>; <span class="NLM_string-name">Williams, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted Pyrazolopyrimidinones and Pyrrolopyrimidinones for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO2016203404</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+T.+Bagdanoff&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=M.+Kato&author=M.+J.+LaMarche&author=P.+J.+Sarver&author=M.+Shultz&author=T.+D.+S.+Smith&author=S.+Williams&title=Preparation+of+Substituted+Pyrazolopyrimidinones+and+Pyrrolopyrimidinones+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26atitle%3DPreparation%2520of%2520Substituted%2520Pyrazolopyrimidinones%2520and%2520Pyrrolopyrimidinones%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e','cit4f'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e','cit14f','cit14g'],'ref15':['cit15a','cit15b','cit15c','cit15d','cit15e','cit15f','cit15g','cit15h'],'ref16':['cit16a','cit16b'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e','cit17f','cit17g','cit17h'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 27 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kerstin Hiesinger, Dmitry Darâin, Ewgenij Proschak, <span class="NLM_string-name hlFld-ContribAuthor">Mikhail Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 150-183. <a href="https://doi.org/10.1021/acs.jmedchem.0c01473" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BMedicinal%252BChemistry%26aulast%3DHiesinger%26aufirst%3DKerstin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D150%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yelena Mostinski, Guus J. J. E. Heynen, Maria Pascual LÃ³pez-Alberca, Jerome Paul, Sandra Miksche, Silke Radetzki, David Schaller, Elena Shanina, Carola Seyffarth, Yuliya Kolomeets, Nandor Ziebart, Judith de Schryver, Sylvia Oestreich, Martin Neuenschwander, Yvette Roske, Udo Heinemann, Christoph Rademacher, Andrea Volkamer, Jens Peter von Kries, Walter Birchmeier, <span class="NLM_string-name hlFld-ContribAuthor">Marc NazarÃ©</span>. </span><span class="cited-content_cbyCitation_article-title">From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14780-14804. <a href="https://doi.org/10.1021/acs.jmedchem.0c01265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BPyrazolones%252Bto%252BAzaindoles%25253A%252BEvolution%252Bof%252BActive-Site%252BSHP2%252BInhibitors%252BBased%252Bon%252BScaffold%252BHopping%252Band%252BBioisosteric%252BReplacement%26aulast%3DMostinski%26aufirst%3DYelena%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D19112020%26volume%3D63%26issue%3D23%26spage%3D14780%26epage%3D14804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew J. LaMarche, Michael Acker, Andreea Argintaru, Daniel Bauer, Julie Boisclair, Homan Chan, Christine Hiu-Tung Chen, Ying-Nan Chen, Zhouliang Chen, Zhan Deng, Michael Dore, David Dunstan, Jianmei Fan, Peter Fekkes, Brant Firestone, Michelle Fodor, Jorge Garcia-Fortanet, Pascal D. Fortin, Cary Fridrich, John Giraldes, Meir Glick, Denise Grunenfelder, Huia-Xiang Hao, Martin Hentemann, Samuel Ho, Andriana Jouk, Zhao B. Kang, Rajesh Karki, Mitsunori Kato, Nick Keen, Robert Koenig, Laura R. LaBonte, Jay Larrow, Gang Liu, Shumei Liu, Dyuti Majumdar, Simon Mathieu, Matthew J. Meyer, Morvarid Mohseni, Rukundo Ntaganda, Mark Palermo, Lawrence Perez, Minying Pu, Timothy Ramsey, John Reilly, Patrick Sarver, William R. Sellers, Martin Sendzik, Michael D. Shultz, Joanna Slisz, Kelly Slocum, Troy Smith, Stanley Spence, Travis Stams, Christopher Straub, Victoriano Tamez, Jr., Bakary-Barry Toure, Christopher Towler, Ping Wang, Hongyun Wang, Sarah L. Williams, Fan Yang, Bing Yu, Ji-Hu Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Suzanne Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13578-13594. <a href="https://doi.org/10.1021/acs.jmedchem.0c01170" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01170%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BTNO155%25252C%252Ban%252BAllosteric%252BSHP2%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLaMarche%26aufirst%3DMatthew%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D24092020%26date%3D10092020%26volume%3D63%26issue%3D22%26spage%3D13578%26epage%3D13594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinrui Yuan, Hong Bu, Jinpei Zhou, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Huibin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11368-11396. <a href="https://doi.org/10.1021/acs.jmedchem.0c00249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bof%252BSHP2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BCurrent%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D10062020%26date%3D27052020%26volume%3D63%26issue%3D20%26spage%3D11368%26epage%3D11396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bingsong Han, Francesco G. Salituro, <span class="NLM_string-name hlFld-ContribAuthor">Maria-Jesus Blanco</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1810-1819. <a href="https://doi.org/10.1021/acsmedchemlett.9b00655" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00655%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImpact%252Bof%252BAllosteric%252BModulation%252Bin%252BDrug%252BDiscovery%25253A%252BInnovation%252Bin%252BEmerging%252BChemical%252BModalities%26aulast%3DHan%26aufirst%3DBingsong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26122019%26date%3D10032020%26date%3D20032020%26date%3D10032020%26volume%3D11%26issue%3D10%26spage%3D1810%26epage%3D1819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingliang Wang, Jianfeng Lu, Mi Wang, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7510-7528. <a href="https://doi.org/10.1021/acs.jmedchem.0c00471" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00471%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSHP2-D26%252Bas%252Ba%252BFirst%25252C%252BPotent%25252C%252Band%252BEffective%252BPROTAC%252BDegrader%252Bof%252BSHP2%252BProtein%26aulast%3DWang%26aufirst%3DMingliang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20032020%26date%3D21052020%26volume%3D63%26issue%3D14%26spage%3D7510%26epage%3D7528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Maja KÃ¶hn</span>. </span><span class="cited-content_cbyCitation_article-title">Turn and Face the Strange: A New View on Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2020,</strong> <em>6 </em>
                                    (4)
                                     , 467-477. <a href="https://doi.org/10.1021/acscentsci.9b00909" title="DOI URL">https://doi.org/10.1021/acscentsci.9b00909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.9b00909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.9b00909%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DTurn%252Band%252BFace%252Bthe%252BStrange%25253A%252BA%252BNew%252BView%252Bon%252BPhosphatases%26aulast%3DK%25C3%25B6hn%26aufirst%3DMaja%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D09092019%26date%3D13032020%26volume%3D6%26issue%3D4%26spage%3D467%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patrick Sarver, Michael Acker, Jeffrey T. Bagdanoff, Zhouliang Chen, Ying-Nan Chen, Homan Chan, Brant Firestone, Michelle Fodor, Jorge Fortanet, Huaixiang Hao, Murphy Hentemann, Mitsunori Kato, Robert Koenig, Laura R. LaBonte, Gang Liu, Shumei Liu, Chen Liu, Eric McNeill, Morvarid Mohseni, Martin Sendzik, Travis Stams, Stan Spence, Victoriano Tamez, Ritesh Tichkule, Christopher Towler, Hongyun Wang, Ping Wang, Sarah L. Williams, Bing Yu, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. LaMarche</span>. </span><span class="cited-content_cbyCitation_article-title">6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1793-1802. <a href="https://doi.org/10.1021/acs.jmedchem.8b01726" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01726%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Amino-3-methylpyrimidinones%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BEfficacious%252BSHP2%252BInhibitors%26aulast%3DSarver%26aufirst%3DPatrick%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D05112018%26date%3D16022019%26date%3D28012019%26volume%3D62%26issue%3D4%26spage%3D1793%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios  Chatzigoulas</span>, <span class="hlFld-ContribAuthor ">Zoe  Cournia</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of allosteric modulators: Challenges and successes. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2021,</strong> <em>17 </em><a href="https://doi.org/10.1002/wcms.1529" title="DOI URL">https://doi.org/10.1002/wcms.1529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1529%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DRational%252Bdesign%252Bof%252Ballosteric%252Bmodulators%25253A%252BChallenges%252Band%252Bsuccesses%26aulast%3DChatzigoulas%26aufirst%3DAlexios%26date%3D2021%26date%3D2021%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Guo</span>, <span class="hlFld-ContribAuthor ">Yaping  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (22)
                                     , 5504-5523. <a href="https://doi.org/10.1002/slct.202100186" title="DOI URL">https://doi.org/10.1002/slct.202100186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100186%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCross%252Bthe%252BUndruggable%252BBarrier%25252C%252Bthe%252BDevelopment%252Bof%252BSHP2%252BInhibitors%25253A%252BFrom%252BCatalytic%252BSite%252BInhibitors%252Bto%252BAllosteric%252BInhibitors%26aulast%3DGuo%26aufirst%3DYu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D22%26spage%3D5504%26epage%3D5523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. Lucas  Kerr</span>, <span class="hlFld-ContribAuthor ">Franziska  Haderk</span>, <span class="hlFld-ContribAuthor ">Trever G.  Bivona</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>62 </em>, 1-12. <a href="https://doi.org/10.1016/j.cbpa.2020.11.007" title="DOI URL">https://doi.org/10.1016/j.cbpa.2020.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2020.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2020.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DAllosteric%252BSHP2%252Binhibitors%252Bin%252Bcancer%25253A%252BTargeting%252Bthe%252Bintersection%252Bof%252BRAS%25252C%252Bresistance%25252C%252Band%252Bthe%252Bimmune%252Bmicroenvironment%26aulast%3DKerr%26aufirst%3DD.%2BLucas%26date%3D2021%26volume%3D62%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangbo  Yang</span>, <span class="hlFld-ContribAuthor ">Zhijia  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan  Pei</span>, <span class="hlFld-ContribAuthor ">Ning  Song</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Hanlin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaobei  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Qiu</span>, <span class="hlFld-ContribAuthor ">Huijin  Feng</span>, <span class="hlFld-ContribAuthor ">Yaxi  Yang</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113341. <a href="https://doi.org/10.1016/j.ejmech.2021.113341" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113341%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthalidomide-based%252BPROTAC%252Bsmall%252Bmolecules%252Bas%252Bthe%252Bhighly%252Befficient%252BSHP2%252Bdegraders%26aulast%3DYang%26aufirst%3DXiangbo%26date%3D2021%26volume%3D218%26spage%3D113341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Bingxue  Qu</span>, <span class="hlFld-ContribAuthor ">Haiyan  Yang</span>, <span class="hlFld-ContribAuthor ">Shengquan  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">If small molecules immunotherapy comes, can the prime be far behind?. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113356. <a href="https://doi.org/10.1016/j.ejmech.2021.113356" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113356%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIf%252Bsmall%252Bmolecules%252Bimmunotherapy%252Bcomes%25252C%252Bcan%252Bthe%252Bprime%252Bbe%252Bfar%252Bbehind%25253F%26aulast%3DZhang%26aufirst%3DJingyu%26date%3D2021%26volume%3D218%26spage%3D113356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Dong</span>, <span class="hlFld-ContribAuthor ">Da  Han</span>, <span class="hlFld-ContribAuthor ">Xinyi  Meng</span>, <span class="hlFld-ContribAuthor ">Mengchuan  Xu</span>, <span class="hlFld-ContribAuthor ">Chuwen  Zheng</span>, <span class="hlFld-ContribAuthor ">Qin  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Activating Mutation of SHP2 Establishes a Tumorigenic Phonotype Through Cell-Autonomous and Non-Cell-Autonomous Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.630712" title="DOI URL">https://doi.org/10.3389/fcell.2021.630712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.630712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.630712%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DActivating%252BMutation%252Bof%252BSHP2%252BEstablishes%252Ba%252BTumorigenic%252BPhonotype%252BThrough%252BCell-Autonomous%252Band%252BNon-Cell-Autonomous%252BMechanisms%26aulast%3DDong%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangan  Mitra</span>, <span class="hlFld-ContribAuthor ">Senthil R.  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">SmallâMolecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 777-787. <a href="https://doi.org/10.1002/cmdc.202000706" title="DOI URL">https://doi.org/10.1002/cmdc.202000706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000706%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSmall%2525E2%252580%252590Molecule%252BInhibitors%252Bof%252BShp2%252BPhosphatase%252Bas%252BPotential%252BChemotherapeutic%252BAgents%252Bfor%252BGlioblastoma%25253A%252BA%252BMinireview%26aulast%3DMitra%26aufirst%3DRangan%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D777%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yihui  Song</span>, <span class="hlFld-ContribAuthor ">Min  Zhao</span>, <span class="hlFld-ContribAuthor ">Yahong  Wu</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A multifunctional cross-validation high-throughput screening protocol enabling the discovery of new SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 750-762. <a href="https://doi.org/10.1016/j.apsb.2020.10.021" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.10.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.10.021%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DA%252Bmultifunctional%252Bcross-validation%252Bhigh-throughput%252Bscreening%252Bprotocol%252Benabling%252Bthe%252Bdiscovery%252Bof%252Bnew%252BSHP2%252Binhibitors%26aulast%3DSong%26aufirst%3DYihui%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D750%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities â A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 721-773. <a href="https://doi.org/10.1111/cbdd.13807" title="DOI URL">https://doi.org/10.1111/cbdd.13807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DEmerging%252Bchemical%252Bscaffolds%252Bwith%252Bpotential%252BSHP2%252Bphosphatase%252Binhibitory%252Bcapabilities%252B%2525E2%252580%252593%252BA%252Bcomprehensive%252Breview%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D721%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohe  Yang</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Yueying  Yang</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a therapeutic strategy for inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113264. <a href="https://doi.org/10.1016/j.ejmech.2021.113264" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113264%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252Binflammatory%252Bdiseases%26aulast%3DLiu%26aufirst%3DYang%26date%3D2021%26volume%3D214%26spage%3D113264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhendong  Song</span>, <span class="hlFld-ContribAuthor ">Meijing  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Xue-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ziyang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 13-29. <a href="https://doi.org/10.1016/j.apsb.2020.07.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Bin%252Btumor-targeted%252Btherapies%26aulast%3DSong%26aufirst%3DZhendong%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D13%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Yao-Nan  Jia</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112657. <a href="https://doi.org/10.1016/j.ejmech.2020.112657" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112657%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Band%252BPROTAC%252Bdegraders%26aulast%3DTang%26aufirst%3DKai%26date%3D2020%26volume%3D204%26spage%3D112657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Bing  Yang</span>, <span class="hlFld-ContribAuthor ">Rui-Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>100 </em>, 103875. <a href="https://doi.org/10.1016/j.bioorg.2020.103875" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103875%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyridine%252Bderivatives%252Bas%252Bselective%252BSHP2%252Binhibitors%26aulast%3DLiu%26aufirst%3DWen-Shan%26date%3D2020%26volume%3D100%26spage%3D103875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kwang-Eun  Choi</span>, <span class="hlFld-ContribAuthor ">Anand  Balupuri</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">The Study on the hERG Blocker Prediction Using Chemical Fingerprint Analysis. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (11)
                                     , 2615. <a href="https://doi.org/10.3390/molecules25112615" title="DOI URL">https://doi.org/10.3390/molecules25112615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25112615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25112615%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BStudy%252Bon%252Bthe%252BhERG%252BBlocker%252BPrediction%252BUsing%252BChemical%252BFingerprint%252BAnalysis%26aulast%3DChoi%26aufirst%3DKwang-Eun%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D11%26spage%3D2615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soobin  Wang</span>, <span class="hlFld-ContribAuthor ">Alessia  Battigelli</span>, <span class="hlFld-ContribAuthor ">Dahlia  Alkekhia</span>, <span class="hlFld-ContribAuthor ">Alexis  Fairman</span>, <span class="hlFld-ContribAuthor ">Valentin  Antoci</span>, <span class="hlFld-ContribAuthor ">Wentian  Yang</span>, <span class="hlFld-ContribAuthor ">Douglas  Moore</span>, <span class="hlFld-ContribAuthor ">Anita  Shukla</span>. </span><span class="cited-content_cbyCitation_article-title">Controlled delivery of a protein tyrosine phosphatase inhibitor, SHP099, using cyclodextrin-mediated hostâguest interactions in polyelectrolyte multilayer films for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (34)
                                     , 20073-20082. <a href="https://doi.org/10.1039/D0RA03864D" title="DOI URL">https://doi.org/10.1039/D0RA03864D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA03864D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA03864D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DControlled%252Bdelivery%252Bof%252Ba%252Bprotein%252Btyrosine%252Bphosphatase%252Binhibitor%25252C%252BSHP099%25252C%252Busing%252Bcyclodextrin-mediated%252Bhost%2525E2%252580%252593guest%252Binteractions%252Bin%252Bpolyelectrolyte%252Bmultilayer%252Bfilms%252Bfor%252Bcancer%252Btherapy%26aulast%3DWang%26aufirst%3DSoobin%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D34%26spage%3D20073%26epage%3D20082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dadong  Shen</span>, <span class="hlFld-ContribAuthor ">Wenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guofeng  Wu</span>, <span class="hlFld-ContribAuthor ">Runpu  Shen</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112117. <a href="https://doi.org/10.1016/j.ejmech.2020.112117" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112117%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bpotential%252Bof%252Btargeting%252BSHP2%252Bin%252Bhuman%252Bdevelopmental%252Bdisorders%252Band%252Bcancers%26aulast%3DShen%26aufirst%3DDadong%26date%3D2020%26volume%3D190%26spage%3D112117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bohee  Kim</span>, <span class="hlFld-ContribAuthor ">Seungjin  Jo</span>, <span class="hlFld-ContribAuthor ">Sung Bum  Park</span>, <span class="hlFld-ContribAuthor ">Chong Hak  Chae</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Byumseok  Koh</span>, <span class="hlFld-ContribAuthor ">Inji  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and structure-activity relationship study of SHP2 inhibitor containing 3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (1)
                                     , 126756. <a href="https://doi.org/10.1016/j.bmcl.2019.126756" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126756%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Band%252Bstructure-activity%252Brelationship%252Bstudy%252Bof%252BSHP2%252Binhibitor%252Bcontaining%252B3%25252C4%25252C6-trihydroxy-5-oxo-5H-benzo%25255B7%25255Dannulene%26aulast%3DKim%26aufirst%3DBohee%26date%3D2020%26volume%3D30%26issue%3D1%26spage%3D126756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panagiotis  Parsonidis</span>, <span class="hlFld-ContribAuthor ">Mahammad  Shaik</span>, <span class="hlFld-ContribAuthor ">Athanasia Panagiota  Serafeim</span>, <span class="hlFld-ContribAuthor ">Ioanna  Vlachou</span>, <span class="hlFld-ContribAuthor ">Vasiliki  Daikopoulou</span>, <span class="hlFld-ContribAuthor ">Ioannis  Papasotiriou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Activity of Pyrazine Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4389. <a href="https://doi.org/10.3390/molecules24234389" title="DOI URL">https://doi.org/10.3390/molecules24234389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234389%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BActivity%252Bof%252BPyrazine%252BCompounds%26aulast%3DParsonidis%26aufirst%3DPanagiotis%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SHP2 binding interactions with (a) <b>2</b>, (b) <b>3</b>, and (c) <b>4</b>. PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD9">6MD9</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDA">6MDA</a>, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Pharmacophore model derived from <b>2</b>, <b>3</b>, and <b>4</b>. Blue is H-bond donor. Red is H-bond acceptor. Green is lipophilic. (b) In vitro profile of designed ligand <b>5</b>. (c) Cocrystal of <b>5</b> in SHP2 allosteric pocket (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyrazolopyrimidinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>NNH<sub>2</sub>âH<sub>2</sub>O, EtOH, 80 Â°C; (b) 4-methoxybenzaldehyde, MeOH; (c) R<sup>1</sup>COH, piperidine, dimethylformamide (DMF), <i>i</i>-PrOH, 90 Â°C; (d) R<sup>2</sup>R<sup>3</sup>NH<sub>2</sub>, (benzotriazol-1-yl-oxy)tris(dimethylamino)phosphonium hexafluorophosphate, DMF (e) trifluoroacetic acid (TFA), 1,2-dichloroethene (DCE), 70 Â°C; (f) benzaldehyde, MeOH; (g) <i>t</i>-BuONa, dimethyl sulfoxide (DMSO), O<sub>2</sub>; (h) POCl<sub>3</sub>, Me<sub>4</sub>N<sup>+</sup>I<sup>â</sup>, 100 Â°C; and (i) R<sup>2</sup>R<sup>3</sup>NH<sub>2</sub>, <i>N</i>,<i>N</i>-diisopropylethylamine, <i>N</i>-methyl-2-pyrrolidone, Î¼-wave, 120 Â°C.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>15</b> modeled into the SHP2 allosteric binding pocket preserves R111 interaction. (Docking model built from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of <b>24</b> and <b>19</b> supports binding hypothesis of hybrid <b>23</b>. PDB code of SHP2-<b>24</b><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDD">6MDD</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cocrystal structure of <b>1</b> in the SHP2 allosteric pocket (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDC">6MDC</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/medium/jm-2018-01725j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PKâPD of <b>14</b> at 10, 30, and 100 mg/kg in mice bearing KYSE520 xenografts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-4/acs.jmedchem.8b01725/20190221/images/large/jm-2018-01725j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01725&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71712" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71712" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemeyer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HÃ¤hlen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Somatic Mutations in PTPN11 in Juvenile Myelomonocytic Leukemia, Myelodysplactic Syndromes and Acute Myeloid Leukemia</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">148</span>â <span class="NLM_lpage">150</span>, <span class="refDoi">Â DOI: 10.1038/ng1156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+H%C3%A4hlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+Mutations+in+PTPN11+in+Juvenile+Myelomonocytic+Leukemia%2C+Myelodysplactic+Syndromes+and+Acute+Myeloid+Leukemia&doi=10.1038%2Fng1156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0ljCAdCsVMBxyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DH%25C3%25A4hlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520Mutations%2520in%2520PTPN11%2520in%2520Juvenile%2520Myelomonocytic%2520Leukemia%252C%2520Myelodysplactic%2520Syndromes%2520and%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150%26doi%3D10.1038%2Fng1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaitzidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">The Tyrosine Phosphoatase Shp2 (PTPN11) in Cancer</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">179</span>â <span class="NLM_lpage">192</span>, <span class="refDoi">Â DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+Tyrosine+Phosphoatase+Shp2+%28PTPN11%29+in+Cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0ljCAdCsVMBxyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520Tyrosine%2520Phosphoatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yomogita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatakeyama, M.</span></span> <span> </span><span class="NLM_article-title">Isolation of a Distinct Class of Gain-of-Function SHP-2 Mutants with Oncogenic RAS-like Transforming Activity From Solid Tumors</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3508</span>â <span class="NLM_lpage">3515</span>, <span class="refDoi">Â DOI: 10.1038/sj.onc.1211019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Hagashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+Distinct+Class+of+Gain-of-Function+SHP-2+Mutants+with+Oncogenic+RAS-like+Transforming+Activity+From+Solid+Tumors&doi=10.1038%2Fsj.onc.1211019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0ljCAdCsVMBxyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHagashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520Distinct%2520Class%2520of%2520Gain-of-Function%2520SHP-2%2520Mutants%2520with%2520Oncogenic%2520RAS-like%2520Transforming%2520Activity%2520From%2520Solid%2520Tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515%26doi%3D10.1038%2Fsj.onc.1211019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandless, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Potent Stimulation of SH-PTP2 Phosphatase Activity by Simultaneous Occupancy of Both SH2 Domains</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">2897</span>â <span class="NLM_lpage">2900</span>, <span class="refDoi">Â DOI: 10.1074/jbc.270.7.2897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1074%2Fjbc.270.7.2897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=7531695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADyaK28XltVyltrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=2897-2900&author=S.+Pluskeyauthor=T.+J.+Wandlessauthor=C.+T.+Walshauthor=S.+E.+Shoelson&title=Potent+Stimulation+of+SH-PTP2+Phosphatase+Activity+by+Simultaneous+Occupancy+of+Both+SH2+Domains&doi=10.1074%2Fjbc.270.7.2897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains</span></div><div class="casAuthors">Pluskey, Scott; Wandless, Thomas J.; Walsh, Christopher, T.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2897-2900</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Src homol. 2 (SH2) domains are phosphotyrosine binding modules found within many cytoplasmic proteins.  A major function of SH2 domains is to bring about the phys. assembly of signaling complexes.  Here, it is shown that, that in addn., simultaneous occupancy of both SH2 domains of phosphoprotein tyrosine phosphatase SH-PTP2 (Syp, PTP 1D, PTP-2C) by a tethered peptide with 2 IRS-1-derived phosphorylation sites potently stimulates phosphatase activity.  The concn. required for activation by the tethered peptide was 80-160-fold lower than either corresponding monophosphorylated peptide.  Moreover, the diphosphorylated peptide stimulated catalytic activity 37-fold, compared with 9-16-fold for the monophosphorylated peptides.  Mutational analyses of the SH2 domains of SH-PTP2 confirmed that both SH2 domains participate in this effect.  Binding studies with a tandem construct comprising the N-plus C-terminal SH2 domains showed that the diphosphorylated peptide binds with 60-90-fold higher affinity than either monophosphorylated sequence.  These results demonstrated that SH-PTP2 activity can be potently regulated by interacting via both of its SH2 domains with phosphoproteins having 2 cognate phosphorylation sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTlCRxkwiHh7Vg90H21EOLACvtfcHk0lhLXZZu88_thw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltVyltrs%253D&md5=c17c9344fc6b9978f7021263855b776d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.7.2897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.7.2897%26sid%3Dliteratum%253Aachs%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DWandless%26aufirst%3DT.%2BJ.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DPotent%2520Stimulation%2520of%2520SH-PTP2%2520Phosphatase%2520Activity%2520by%2520Simultaneous%2520Occupancy%2520of%2520Both%2520SH2%2520Domains%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D2897%26epage%3D2900%26doi%3D10.1074%2Fjbc.270.7.2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, L.</span></span> <span> </span><span class="NLM_article-title">The âShpâing News: SH2 Domain-Containing Tyrosine Phosphatases in Cell Signaling</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">284</span>â <span class="NLM_lpage">293</span>, <span class="refDoi">Â DOI: 10.1016/S0968-0004(03)00091-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2FS0968-0004%2803%2900091-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=12826400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%98Shp%E2%80%99ing+News%3A+SH2+Domain-Containing+Tyrosine+Phosphatases+in+Cell+Signaling&doi=10.1016%2FS0968-0004%2803%2900091-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span></div><div class="casAuthors">Neel, Benjamin G.; Gu, Haihua; Pao, Lily</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Src homol.-2 (SH2) domain-contg. phosphatases (Shps) are a small, highly conserved subfamily of protein tyrosine phosphatases, members of which are present in both vertebrates and invertebrates.  The mechanism of regulation of Shps by ligand binding is now well understood.  Much is also known about the normal signaling pathways regulated by each Shp and the consequences of Shp deficiency.  Recent studies have identified mutations in human Shp2 as the cause of the inherited disorder, Noonan syndrome.  Shp2 mutations might also contribute to the pathogenesis of some leukemias.  In addn., Shp2 might be a key virulence determinant for the important human pathogen, Helicobacter pylori.  Despite these efforts, however, the key targets of each Shp have remained elusive.  Identifying these substrates remains a major challenge for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zIEChntK0rVg90H21EOLACvtfcHk0lhLXZZu88_thw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D&md5=bce9fc3db0a41b29ba605251dc46c64f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2803%2900091-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252803%252900091-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2598Shp%25E2%2580%2599ing%2520News%253A%2520SH2%2520Domain-Containing%2520Tyrosine%2520Phosphatases%2520in%2520Cell%2520Signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293%26doi%3D10.1016%2FS0968-0004%2803%2900091-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, G. S.</span></span> <span> </span><span class="NLM_article-title">PTPN11 is the First Identified Proto-Oncogene That Encodes a Tyrosine Phosphatase</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">862</span>â <span class="NLM_lpage">867</span>, <span class="refDoi">Â DOI: 10.1182/blood-2006-07-028829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1182%2Fblood-2006-07-028829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=17053061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+First+Identified+Proto-Oncogene+That+Encodes+a+Tyrosine+Phosphatase&doi=10.1182%2Fblood-2006-07-028829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span></div><div class="casAuthors">Chan, Rebecca J.; Feng, Gen-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-867</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Elucidation of the mol. mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes.  One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homol. 2 (SH2) domains (Shp2).  This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis.  More recently, somatic missense PTPN11 gain-of-function mutations were detected in leukemias and rarely in solid tumors, and were found to induce aberrant hyperactivation of the Ras-Erk pathway.  This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the mol. mechanisms underlying cell transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqsuOora-d37Vg90H21EOLACvtfcHk0lhLXZZu88_thw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D&md5=8c5760a6ac385635f9794acbf5b64a03</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-028829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-028829%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520First%2520Identified%2520Proto-Oncogene%2520That%2520Encodes%2520a%2520Tyrosine%2520Phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867%26doi%3D10.1182%2Fblood-2006-07-028829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tiganis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, A. M.</span></span> <span> </span><span class="NLM_article-title">Protein Tyrosine Phosphatase Function: the Substrated Perspective</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>402</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">15</span>, <span class="refDoi">Â DOI: 10.1042/BJ20061548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1042%2FBJ20061548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=17238862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFOisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2007&pages=1-15&author=T.+Tiganisauthor=A.+M.+Bennett&title=Protein+Tyrosine+Phosphatase+Function%3A+the+Substrated+Perspective&doi=10.1042%2FBJ20061548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatase function: the substrate perspective</span></div><div class="casAuthors">Tiganis, Tony; Bennett, Anton M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now well established that the members of the protein tyrosine phosphatase (PTP) superfamily play crit. roles in fundamental biol. processes.  Although there has been much progress in defining the function of PTPs, the task of identifying substrates for these enzymes still presents a challenge.  Many PTPs have yet to have their physiol. substrates identified.  The focus of this review is on the current state of knowledge of PTP substrates and the approaches used to identify them.  The authors propose exptl. criteria that should be satisfied in order to rigorously assign PTP substrates as bona fide.  Finally, the progress that has been made in defining the biol. roles of PTPs through the identification of their substrates is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod89zW3LtOs7Vg90H21EOLACvtfcHk0lhLXZZu88_thw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFOisQ%253D%253D&md5=e0b404da50fc57e25efe140026d6cd53</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1042%2FBJ20061548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061548%26sid%3Dliteratum%253Aachs%26aulast%3DTiganis%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DA.%2BM.%26atitle%3DProtein%2520Tyrosine%2520Phosphatase%2520Function%253A%2520the%2520Substrated%2520Perspective%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D402%26spage%3D1%26epage%3D15%26doi%3D10.1042%2FBJ20061548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vazhappilly, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Azawi, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdu-Allah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Shorbagi, A.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Awady, R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SHP2 by New Compounds Induces Differential Effects on RAS/RAF/ERK and PI3K/AKT Pathways in Different Cancer Cell Types</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">10</span>, <span class="refDoi">Â DOI: 10.1007/s10637-018-0626-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1007%2Fs10637-018-0626-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=1-10&author=C.+G.+Vazhappillyauthor=E.+Salehauthor=W.+Ramadanauthor=V.+Menonauthor=A.+M.+Al-Azawiauthor=H.+Taraziauthor=H.+Abdu-Allahauthor=A.-N.+El-Shorbagiauthor=R.+El-Awady&title=Inhibition+of+SHP2+by+New+Compounds+Induces+Differential+Effects+on+RAS%2FRAF%2FERK+and+PI3K%2FAKT+Pathways+in+Different+Cancer+Cell+Types&doi=10.1007%2Fs10637-018-0626-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1007%2Fs10637-018-0626-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-018-0626-5%26sid%3Dliteratum%253Aachs%26aulast%3DVazhappilly%26aufirst%3DC.%2BG.%26aulast%3DSaleh%26aufirst%3DE.%26aulast%3DRamadan%26aufirst%3DW.%26aulast%3DMenon%26aufirst%3DV.%26aulast%3DAl-Azawi%26aufirst%3DA.%2BM.%26aulast%3DTarazi%26aufirst%3DH.%26aulast%3DAbdu-Allah%26aufirst%3DH.%26aulast%3DEl-Shorbagi%26aufirst%3DA.-N.%26aulast%3DEl-Awady%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520SHP2%2520by%2520New%2520Compounds%2520Induces%2520Differential%2520Effects%2520on%2520RAS%252FRAF%252FERK%2520and%2520PI3K%252FAKT%2520Pathways%2520in%2520Different%2520Cancer%2520Cell%2520Types%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2018%26spage%3D1%26epage%3D10%26doi%3D10.1007%2Fs10637-018-0626-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puschhof, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâDay, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hembrough, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustgi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fereshetian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catenacci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bass, A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Wild-type KRAS-Amplified Gastroesophageal Cancer Through Combined MEK and SHP2 Inhibition</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">968</span>â <span class="NLM_lpage">977</span>, <span class="refDoi">Â DOI: 10.1038/s41591-018-0022-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41591-018-0022-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29808010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=968-977&author=G.+S.+Wongauthor=J.+Zhouauthor=J.+B.+Liuauthor=Z.+Wuauthor=X.+Xuauthor=T.+Liauthor=D.+Xuauthor=S.+E.+Schumacherauthor=J.+Puschhofauthor=J.+McFarlandauthor=C.+Zouauthor=A.+Dulakauthor=L.+Hendersonauthor=P.+Xuauthor=E.+O%E2%80%99Dayauthor=R.+Rendakauthor=W.-L.+Liaoauthor=F.+Cecchiauthor=T.+Hembroughauthor=S.+Schwartzauthor=C.+Szetoauthor=A.+K.+Rustgiauthor=K.-K.+Wongauthor=J.+A.+Diehlauthor=K.+Jensenauthor=F.+Grazianoauthor=A.+Ruzzoauthor=S.+Fereshetianauthor=P.+Mertinsauthor=S.+A.+Carrauthor=R.+Beroukhimauthor=K.+Nakamuraauthor=E.+Okiauthor=M.+Watanabeauthor=H.+Babaauthor=Y.+Imamuraauthor=D.+Catenacciauthor=A.+J.+Bass&title=Targeting+Wild-type+KRAS-Amplified+Gastroesophageal+Cancer+Through+Combined+MEK+and+SHP2+Inhibition&doi=10.1038%2Fs41591-018-0022-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition</span></div><div class="casAuthors">Wong, Gabrielle S.; Zhou, Jin; Liu, Jie Bin; Wu, Zhong; Xu, Xinsen; Li, Tianxia; Xu, David; Schumacher, Steven E.; Puschhof, Jens; McFarland, James; Zou, Charles; Dulak, Austin; Henderson, Les; Xu, Peng; O'Day, Emily; Rendak, Rachel; Liao, Wei-li; Cecchi, Fabiola; Hembrough, Todd; Schwartz, Sarit; Szeto, Christopher; Rustgi, Anil K.; Wong, Kwok-Kin; Diehl, J. Alan; Jensen, Karin; Graziano, Francesco; Ruzzo, Annamaria; Fereshetian, Shaunt; Mertins, Philipp; Carr, Steven A.; Beroukhim, Rameen; Nakamura, Kenichi; Oki, Eiji; Watanabe, Masayuki; Baba, Hideo; Imamura, Yu; Catenacci, Daniel; Bass, Adam J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">968-977</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The role of KRAS, when activated through canonical mutations, has been well established in cancer1.  Here it explore a secondary means of KRAS activation in cancer: focal high-level amplification of the KRAS gene in the absence of coding mutations.  These amplifications occur most commonly in esophageal, gastric and ovarian adenocarcinomas2-4.  KRAS-amplified gastric cancer models show marked overexpression of the KRAS protein and are insensitive to MAPK blockade owing to their capacity to adaptively respond by rapidly increasing KRAS-GTP levels.  Here it demonstrate that inhibition of the guanine-exchange factors SOS1 and SOS2 or the protein tyrosine phosphatase SHP2 can attenuate this adaptive process and that targeting these factors, both genetically and pharmacol., can enhance the sensitivity of KRAS-amplified models to MEK inhibition in both in vitro and in vivo settings.  These data demonstrate the relevance of copy-no. amplification as a mechanism of KRAS activation, and uncover the therapeutic potential for targeting of these tumors through combined SHP2 and MEK inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTIe1Ygfy-ibVg90H21EOLACvtfcHk0lg5jmzXtTg1Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvE&md5=9b0e728428d655cebea911300b5ed91a</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0022-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0022-x%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DG.%2BS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%2BB.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DSchumacher%26aufirst%3DS.%2BE.%26aulast%3DPuschhof%26aufirst%3DJ.%26aulast%3DMcFarland%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DDulak%26aufirst%3DA.%26aulast%3DHenderson%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DE.%26aulast%3DRendak%26aufirst%3DR.%26aulast%3DLiao%26aufirst%3DW.-L.%26aulast%3DCecchi%26aufirst%3DF.%26aulast%3DHembrough%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DSzeto%26aufirst%3DC.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DDiehl%26aufirst%3DJ.%2BA.%26aulast%3DJensen%26aufirst%3DK.%26aulast%3DGraziano%26aufirst%3DF.%26aulast%3DRuzzo%26aufirst%3DA.%26aulast%3DFereshetian%26aufirst%3DS.%26aulast%3DMertins%26aufirst%3DP.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DOki%26aufirst%3DE.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DCatenacci%26aufirst%3DD.%26aulast%3DBass%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Wild-type%2520KRAS-Amplified%2520Gastroesophageal%2520Cancer%2520Through%2520Combined%2520MEK%2520and%2520SHP2%2520Inhibition%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D968%26epage%3D977%26doi%3D10.1038%2Fs41591-018-0022-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mainardi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulero-SÃ¡nchez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prahallad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimpenfort, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieftink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GonÃ§alves-Ribeiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villanueva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernards, R.</span></span> <span> </span><span class="NLM_article-title">SHP2 is Required for Growth of KRAS-Mutant Non-Small-Cell Lung Cancer In Vivo</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">961</span>â <span class="NLM_lpage">967</span>, <span class="refDoi">Â DOI: 10.1038/s41591-018-0023-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41591-018-0023-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29808006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=961-967&author=S.+Mainardiauthor=A.+Mulero-S%C3%A1nchezauthor=A.+Prahalladauthor=G.+Germanoauthor=A.+Bosmaauthor=P.+Krimpenfortauthor=C.+Lieftinkauthor=J.+D.+Steinbergauthor=N.+de+Witauthor=S.+Gon%C3%A7alves-Ribeiroauthor=E.+Nadalauthor=A.+Bardelliauthor=A.+Villanuevaauthor=R.+Bernards&title=SHP2+is+Required+for+Growth+of+KRAS-Mutant+Non-Small-Cell+Lung+Cancer+In+Vivo&doi=10.1038%2Fs41591-018-0023-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4fR"><div class="casContent"><span class="casTitleNuber">4f</span><div class="casTitle"><span class="NLM_cas:atitle">SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo</span></div><div class="casAuthors">Mainardi, Sara; Mulero-Sanchez, Antonio; Prahallad, Anirudh; Germano, Giovanni; Bosma, Astrid; Krimpenfort, Paul; Lieftink, Cor; Steinberg, Jeffrey D.; de Wit, Niels; Goncalves-Ribeiro, Samuel; Nadal, Ernest; Bardelli, Alberto; Villanueva, Alberto; Bernards, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">961-967</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">RAS mutations are frequent in human cancer, esp. in pancreatic, colorectal and non-small-cell lung cancers (NSCLCs).  Inhibition of the RAS oncoproteins has proven difficult, and attempts to target downstream effectors have been hampered by the activation of compensatory resistance mechanisms.  It is also well established that KRAS-mutant tumors are insensitive to inhibition of upstream growth factor receptor signaling.  Thus, epidermal growth factor receptor antibody therapy is only effective in KRAS wild-type colon cancers.  Consistently, inhibition of SHP2 (also known as PTPN11), which links receptor tyrosine kinase signaling to the RAS-RAF-MEK-ERK pathway11,12, was shown to be ineffective in KRAS-mutant or BRAF-mutant cancer cell lines.  Tha data also indicate that SHP2 inhibition in KRAS-mutant NSCLC cells under normal cell culture conditions has little effect.  By contrast, SHP2 inhibition under growth factor-limiting conditions in vitro results in a senescence response.  In vivo, inhibition of SHP2 in KRAS-mutant NSCLC also provokes a senescence response, which is exacerbated by MEK inhibition.  Tha data identify SHP2 inhibition as an unexpected vulnerability of KRAS-mutant NSCLC cells that remains undetected in cell culture and can be exploited therapeutically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLHUMCtBqtZrVg90H21EOLACvtfcHk0lg5jmzXtTg1Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVelsbvL&md5=8e1ce1eb5d30d3985aafdec9d07f205d</span></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3DMainardi%26aufirst%3DS.%26aulast%3DMulero-S%25C3%25A1nchez%26aufirst%3DA.%26aulast%3DPrahallad%26aufirst%3DA.%26aulast%3DGermano%26aufirst%3DG.%26aulast%3DBosma%26aufirst%3DA.%26aulast%3DKrimpenfort%26aufirst%3DP.%26aulast%3DLieftink%26aufirst%3DC.%26aulast%3DSteinberg%26aufirst%3DJ.%2BD.%26aulast%3Dde%2BWit%26aufirst%3DN.%26aulast%3DGon%25C3%25A7alves-Ribeiro%26aufirst%3DS.%26aulast%3DNadal%26aufirst%3DE.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DVillanueva%26aufirst%3DA.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DSHP2%2520is%2520Required%2520for%2520Growth%2520of%2520KRAS-Mutant%2520Non-Small-Cell%2520Lung%2520Cancer%2520In%2520Vivo%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D961%26epage%3D967%26doi%3D10.1038%2Fs41591-018-0023-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bunda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heir, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alamsahebpour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raught, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zadeh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohh, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SHP2âMediated Dephosphorylation of Ras Suppresses Oncogenesis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">8859</span> <span class="refDoi">Â DOI: 10.1038/ncomms9859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fncomms9859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=26617336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=S.+Bundaauthor=K.+Burrellauthor=P.+Heirauthor=L.+Zengauthor=A.+Alamsahebpourauthor=Y.+Kanoauthor=B.+Raughtauthor=Z.-Y.+Zhangauthor=G.+Zadehauthor=M.+Ohh&title=Inhibition+of+SHP2%E2%80%93Mediated+Dephosphorylation+of+Ras+Suppresses+Oncogenesis&doi=10.1038%2Fncomms9859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis</span></div><div class="casAuthors">Bunda, Severa; Burrell, Kelly; Heir, Pardeep; Zeng, Lifan; Alamsahebpour, Amir; Kano, Yoshihito; Raught, Brian; Zhang, Zhong-Yin; Zadeh, Gelareh; Ohh, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8859</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ras is phosphorylated on a conserved tyrosine at position 32 within the switch I region via Src kinase.  This phosphorylation inhibits the binding of effector Raf while promoting the engagement of GTPase-activating protein (GAP) and GTP hydrolysis.  Here we identify SHP2 as the ubiquitously expressed tyrosine phosphatase that preferentially binds to and dephosphorylates Ras to increase its assocn. with Raf and activate downstream proliferative Ras/ERK/MAPK signalling.  In comparison to normal astrocytes, SHP2 activity is elevated in astrocytes isolated from glioblastoma multiforme (GBM)-prone H-Ras(12V) knock-in mice as well as in glioma cell lines and patient-derived GBM specimens exhibiting hyperactive Ras.  Pharmacol. inhibition of SHP2 activity attenuates cell proliferation, soft-agar colony formation and orthotopic GBM growth in NOD/SCID mice and decelerates the progression of low-grade astrocytoma to GBM in a spontaneous transgenic glioma mouse model.  These results identify SHP2 as a direct activator of Ras and a potential therapeutic target for cancers driven by a previously 'undruggable' oncogenic or hyperactive Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhWi25AJiphrVg90H21EOLACvtfcHk0lgJViBl9wJefA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP&md5=8524ad9cc6f2e85abaff6b07c698f464</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fncomms9859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9859%26sid%3Dliteratum%253Aachs%26aulast%3DBunda%26aufirst%3DS.%26aulast%3DBurrell%26aufirst%3DK.%26aulast%3DHeir%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAlamsahebpour%26aufirst%3DA.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26aulast%3DZadeh%26aufirst%3DG.%26aulast%3DOhh%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520SHP2%25E2%2580%2593Mediated%2520Dephosphorylation%2520of%2520Ras%2520Suppresses%2520Oncogenesis%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fncomms9859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jie, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildener-Leapman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, S.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">508</span>â <span class="NLM_lpage">518</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-14-1215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1158%2F0008-5472.CAN-14-1215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=25480946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVenurY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=508-518&author=J.+Liauthor=H.-B.+Jieauthor=Y.+Leiauthor=N.+Gildener-Leapmanauthor=S.+Trivedi&title=PD-1%2FSHP-2+Inhibits+Tc1%2FTh1+Phenotypic+Responses+and+the+Activation+of+T+Cells+in+the+Tumor+Microenvironment&doi=10.1158%2F0008-5472.CAN-14-1215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span></div><div class="casAuthors">Li, Jing; Jie, Hyun-Bae; Lei, Yu; Gildener-Leapman, Neil; Trivedi, Sumita; Green, Tony; Kane, Lawrence P.; Ferris, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">508-518</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study addresses the mechanisms through which PD-1 antibody therapy restores the ability of the immune system to recognize and attack tumors by skewing intratumoral T cells toward a more potent activation phenotype that is assocd. with enhanced signaling and a reversal of their immunosuppressed phenotype.  Immune rejection of tumors is mediated by IFNÎ³ prodn. and T-cell cytolytic activity.  These processes are impeded by PD-1, a coinhibitory mol. expressed on T cells that is elevated in tumor-infiltrating lymphocytes (TIL).  PD-1 elevation may reflect T-cell exhaustion marked by decreased proliferation, prodn. of type I cytokines, and poor cytolytic activity.  Although anti-PD-1 antibodies enhance IFNÎ³ secretion after stimulation of the T-cell receptor (TCR), the mechanistic link between PD-1 and its effects on T-cell help (Tc1/Th1 skewing) remains unclear.  In prospectively collected cancer tissues, we found that TIL exhibited dampened Tc1/Th1 skewing and activation compared with peripheral blood lymphocytes (PBL).  When PD-1 bound its ligand PD-L1, we obsd. a marked suppression of crit. TCR target genes and Th1 cytokines.  Conversely, PD-1 blockade reversed these suppressive effects of PD-1:PD-L1 ligation.  We also found that the TCR-regulated phosphatase SHP-2 was expressed higher in TIL than in PBL, tightly correlating with PD-1 expression and neg. regulation of TCR target genes.  Overall, these results defined a PD-1/SHP-2/STAT1/T-bet signaling axis mediating the suppressive effects of PD-1 on Th1 immunity at tumor sites.  Our findings argue that PD-1 or SHP-2 blockade will be sufficient to restore robust Th1 immunity and T-cell activation and thereby reverse immunosuppression in the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe6jAWHNatvLVg90H21EOLACvtfcHk0lgJViBl9wJefA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVenurY%253D&md5=695007f0715b5eee2b7e47deaf87ae23</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1215%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJie%26aufirst%3DH.-B.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DGildener-Leapman%26aufirst%3DN.%26aulast%3DTrivedi%26aufirst%3DS.%26atitle%3DPD-1%252FSHP-2%2520Inhibits%2520Tc1%252FTh1%2520Phenotypic%2520Responses%2520and%2520the%2520Activation%2520of%2520T%2520Cells%2520in%2520the%2520Tumor%2520Microenvironment%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D508%26epage%3D518%26doi%3D10.1158%2F0008-5472.CAN-14-1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasmal, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vale, R. D.</span></span> <span> </span><span class="NLM_article-title">T Cell Costimulatory Receptor CD28 is a Primary Target for PD-1-Mediated Inhibition</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_fpage">1428</span>â <span class="NLM_lpage">1433</span>, <span class="refDoi">Â DOI: 10.1126/science.aaf1292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1126%2Fscience.aaf1292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=28280247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVWhu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=1428-1433&author=E.+Huiauthor=J.+Cheungauthor=J.+Zhuauthor=X.+Suauthor=M.+J.+Taylorauthor=H.+A.+Wallweberauthor=D.+K.+Sasmalauthor=J.+Huangauthor=J.+M.+Kimauthor=I.+Mellmanauthor=R.+D.+Vale&title=T+Cell+Costimulatory+Receptor+CD28+is+a+Primary+Target+for+PD-1-Mediated+Inhibition&doi=10.1126%2Fscience.aaf1292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition</span></div><div class="casAuthors">Hui, Enfu; Cheung, Jeanne; Zhu, Jing; Su, Xiaolei; Taylor, Marcus J.; Wallweber, Heidi A.; Sasmal, Dibyendu K.; Huang, Jun; Kim, Jeong M.; Mellman, Ira; Vale, Ronald D.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6332</span>),
    <span class="NLM_cas:pages">1428-1433</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">PD-1-targeted therapies have been a breakthrough for treating certain tumors and can rejuvenate T cells to unleash the anticancer immune response (see the Perspective by Clouthier and Ohashi).  It is widely believed that PD-1 suppresses signaling through the T cell receptor (TCR).  However, Hui et al. find instead that the TCR costimulatory receptor, CD28, is the primary target of PD-1 signaling.  Independently, Kamphorst et al. show that CD28 is required for PD-1 therapies to kill cancer cells efficiently and eliminate chronic viral infections in mice.  Lung cancer patients that responded to PD-1 therapy had more CD28+ T cells, which suggests that CD28 may predict treatment response.  Science, ibid p. 1428, p. 1423; see also p. 1373.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM_s4cf1lkxrVg90H21EOLACvtfcHk0lgJViBl9wJefA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVWhu7g%253D&md5=69750b99b68316ee035a0b7eeddfb9fa</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf1292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf1292%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DE.%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DSasmal%26aufirst%3DD.%2BK.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DVale%26aufirst%3DR.%2BD.%26atitle%3DT%2520Cell%2520Costimulatory%2520Receptor%2520CD28%2520is%2520a%2520Primary%2520Target%2520for%2520PD-1-Mediated%2520Inhibition%26jtitle%3DScience%26date%3D2017%26spage%3D1428%26epage%3D1433%26doi%3D10.1126%2Fscience.aaf1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Topalian, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodi, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brahmer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettinger, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powderly, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leming, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spigel, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonia, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardoll, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharfman, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anders, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taube, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMiller, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korman, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jure-Kunkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollia, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigginton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sznol, M.</span></span> <span> </span><span class="NLM_article-title">Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">2443</span>â <span class="NLM_lpage">2454</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1200690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1056%2FNEJMoa1200690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=22658127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2rs7fN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=2443-2454&author=S.+L.+Topalianauthor=F.+S.+Hodiauthor=J.+R.+Brahmerauthor=S.+N.+Gettingerauthor=D.+C.+Smithauthor=D.+F.+McDermottauthor=J.+D.+Powderlyauthor=R.+D.+Carvajalauthor=J.+A.+Sosmanauthor=M.+B.+Atkinsauthor=P.+D.+Lemingauthor=D.+R.+Spigelauthor=S.+J.+Antoniaauthor=L.+Hornauthor=C.+G.+Drakeauthor=D.+M.+Pardollauthor=L.+Chenauthor=W.+H.+Sharfmanauthor=R.+A.+Andersauthor=J.+M.+Taubeauthor=T.+L.+McMillerauthor=H.+Xuauthor=A.+J.+Kormanauthor=M.+Jure-Kunkelauthor=S.+Agrawalauthor=D.+McDonaldauthor=G.+D.+Kolliaauthor=A.+Guptaauthor=J.+M.+Wiggintonauthor=M.+Sznol&title=Safety%2C+Activity%2C+and+Immune+Correlates+of+Anti-PD-1+Antibody+in+Cancer&doi=10.1056%2FNEJMoa1200690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, activity, and immune correlates of anti-PD-1 antibody in cancer</span></div><div class="casAuthors">Topalian, Suzanne L.; Hodi, F. Stephen; Brahmer, Julie R.; Gettinger, Scott N.; Smith, David C.; McDermott, David F.; Powderly, John D.; Carvajal, Richard D.; Sosman, Jeffrey A.; Atkins, Michael B.; Leming, Philip D.; Spigel, David R.; Antonia, Scott J.; Horn, Leora; Drake, Charles G.; Pardoll, Drew M.; Chen, Lieping; Sharfman, William H.; Anders, Robert A.; Taube, Janis M.; McMiller, Tracee L.; Xu, Haiying; Korman, Alan J.; Jure-Kunkel, Maria; Agrawal, Shruti; McDonald, Daniel; Kollia, Georgia D.; Gupta, Ashok; Wigginton, Jon M.; Sznol, Mario</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2443-2454</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance.  We assessed the antitumor activity and safety of BMS-936558, an antibody that specifically blocks PD-1.  Methods: We enrolled patients with advanced melanoma, non-small-cell lung cancer, castration-resistant prostate cancer, or renal-cell or colorectal cancer to receive anti-PD-1 antibody at a dose of 0.1 to 10.0 mg per kg of body wt. every 2 wk.  Response was assessed after each 8-wk treatment cycle.  Patients received up to 12 cycles until disease progression or a complete response occurred.  Results: A total of 296 patients received treatment through Feb. 24, 2012.  Grade 3 or 4 drug-related adverse events occurred in 14% of patients; there were three deaths from pulmonary toxicity.  No max. tolerated dose was defined.  Adverse events consistent with immune-related causes were obsd.  Among 236 patients in whom response could be evaluated, objective responses (complete or partial responses) were obsd. in those with non-small-cell lung cancer, melanoma, or renal-cell cancer.  Cumulative response rates (all doses) were 18% among patients with non-small-cell lung cancer (14 of 76 patients), 28% among patients with melanoma (26 of 94 patients), and 27% among patients with renal-cell cancer (9 of 33 patients).  Responses were durable; 20 of 31 responses lasted 1 yr or more in patients with 1 yr or more of follow-up.  To assess the role of intratumoral PD-1 ligand (PD-L1) expression in the modulation of the PD-1-PD-L1 pathway, immunohistochem. anal. was performed on pretreatment tumor specimens obtained from 42 patients.  Of 17 patients with PD-L1-neg. tumors, none had an objective response; 9 of 25 patients (36%) with PD-L1-pos. tumors had an objective response (P = 0.006).  Conclusions: Anti-PD-1 antibody produced objective responses in approx. one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse-event profile does not appear to preclude its use.  Preliminary data suggest a relationship between PD-L1 expression on tumor cells and objective response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLOPvHybmlvbVg90H21EOLACvtfcHk0lg6b5JII3LVQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2rs7fN&md5=7c13f228ef92b6089982fc878d3a394b</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1200690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1200690%26sid%3Dliteratum%253Aachs%26aulast%3DTopalian%26aufirst%3DS.%2BL.%26aulast%3DHodi%26aufirst%3DF.%2BS.%26aulast%3DBrahmer%26aufirst%3DJ.%2BR.%26aulast%3DGettinger%26aufirst%3DS.%2BN.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DMcDermott%26aufirst%3DD.%2BF.%26aulast%3DPowderly%26aufirst%3DJ.%2BD.%26aulast%3DCarvajal%26aufirst%3DR.%2BD.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DAtkins%26aufirst%3DM.%2BB.%26aulast%3DLeming%26aufirst%3DP.%2BD.%26aulast%3DSpigel%26aufirst%3DD.%2BR.%26aulast%3DAntonia%26aufirst%3DS.%2BJ.%26aulast%3DHorn%26aufirst%3DL.%26aulast%3DDrake%26aufirst%3DC.%2BG.%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSharfman%26aufirst%3DW.%2BH.%26aulast%3DAnders%26aufirst%3DR.%2BA.%26aulast%3DTaube%26aufirst%3DJ.%2BM.%26aulast%3DMcMiller%26aufirst%3DT.%2BL.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DKorman%26aufirst%3DA.%2BJ.%26aulast%3DJure-Kunkel%26aufirst%3DM.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DMcDonald%26aufirst%3DD.%26aulast%3DKollia%26aufirst%3DG.%2BD.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DWigginton%26aufirst%3DJ.%2BM.%26aulast%3DSznol%26aufirst%3DM.%26atitle%3DSafety%252C%2520Activity%252C%2520and%2520Immune%2520Correlates%2520of%2520Anti-PD-1%2520Antibody%2520in%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D2443%26epage%3D2454%26doi%3D10.1056%2FNEJMoa1200690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ohigashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsurui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoriki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashizuka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yane, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsushima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span> <span> </span><span class="NLM_article-title">Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2947</span>â <span class="NLM_lpage">2953</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-04-1469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1158%2F1078-0432.CCR-04-1469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=15837746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlejt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2947-2953&author=Y.+Ohigashiauthor=M.+Shoauthor=Y.+Yamadaauthor=Y.+Tsuruiauthor=K.+Hamadaauthor=N.+Ikedaauthor=T.+Mizunoauthor=R.+Yorikiauthor=H.+Kashizukaauthor=K.+Yaneauthor=F.+Tsushimaauthor=N.+Otsukiauthor=H.+Yagitaauthor=M.+Azumaauthor=Y.+Nakajima&title=Clinical+Significance+of+Programmed+Death-1+Ligand-1+and+Programmed+Death-1+Ligand-2+Expression+in+Human+Esophageal+Cancer&doi=10.1158%2F1078-0432.CCR-04-1469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer</span></div><div class="casAuthors">Ohigashi, Yuichiro; Sho, Masayuki; Yamada, Yukishige; Tsurui, Yoshikazu; Hamada, Kaoru; Ikeda, Naoya; Mizuno, Takashi; Yoriki, Ryo; Kashizuka, Hisanori; Yane, Katsunari; Tsushima, Fumihiko; Otsuki, Noriko; Yagita, Hideo; Azuma, Miyuki; Nakajima, Yoshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2947-2953</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The neg. regulatory programmed death-1/programmed death-1 ligand (PD-1/PD-L) pathway in T-cell activation has been suggested to play an important role in tumor evasion from host immunity.  In this study, we investigated the expression of PD-L1 and PD-L2 in human esophageal cancer to define their clin. significance in patients' prognosis after surgery.  Exptl. Design: PD-L1 and PD-L2 gene expression was evaluated in 41 esophagectomy patients by real-time quant. PCR.  The protein expression was also evaluated with newly generated monoclonal antibodies that recognize human PD-L1 (MIH1) and PD-L2 (MIH18).  Results: The protein and the mRNA levels of detn. by immunohistochem. and real-time quant. PCR were closely correlated.  PD-L-pos. patients had a significantly poorer prognosis than the neg. patients.  This was more pronounced in the advanced stage of tumor than in the early stage.  Furthermore, multivariate anal. indicated that PD-L status was an independent prognostic factor.  Although there was no significant correlation between PD-L1 expression and tumor-infiltrating T lymphocytes, PD-L2 expression was inversely correlated with tumor-infiltrating CD8+ T cells.  Conclusions: These data suggest that PD-L1 and PD-L2 status may be a new predictor of prognosis for patients with esophageal cancer and provide the rationale for developing novel immunotherapy of targeting PD-1/PD-L pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIMQiC4R0LD7Vg90H21EOLACvtfcHk0lg6b5JII3LVQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlejt7k%253D&md5=1dd37b483171a10070310ccd559c9e35</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1469%26sid%3Dliteratum%253Aachs%26aulast%3DOhigashi%26aufirst%3DY.%26aulast%3DSho%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DTsurui%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DN.%26aulast%3DMizuno%26aufirst%3DT.%26aulast%3DYoriki%26aufirst%3DR.%26aulast%3DKashizuka%26aufirst%3DH.%26aulast%3DYane%26aufirst%3DK.%26aulast%3DTsushima%26aufirst%3DF.%26aulast%3DOtsuki%26aufirst%3DN.%26aulast%3DYagita%26aufirst%3DH.%26aulast%3DAzuma%26aufirst%3DM.%26aulast%3DNakajima%26aufirst%3DY.%26atitle%3DClinical%2520Significance%2520of%2520Programmed%2520Death-1%2520Ligand-1%2520and%2520Programmed%2520Death-1%2520Ligand-2%2520Expression%2520in%2520Human%2520Esophageal%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2947%26epage%3D2953%26doi%3D10.1158%2F1078-0432.CCR-04-1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butterworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overduin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1423</span>â <span class="NLM_lpage">1437</span>, <span class="refDoi">Â DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+Protein+Tyrosine+Phosphatase+SHP2+for+Therapeutic+Intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0lg6b5JII3LVQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520for%2520Therapeutic%2520Intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GarciaâFortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labonte, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slisz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of an Allosteric SHP2 Inhibitor for Cancer Therapy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">148</span>â <span class="NLM_lpage">152</span>, <span class="refDoi">Â DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-152&author=Y.+P.+Chenauthor=M.+J.+LaMarcheauthor=P.+Fekkesauthor=J.+Garcia%E2%80%93Fortanetauthor=M.+Ackerauthor=H.+Chanauthor=Z.+Chenauthor=Z.+Dengauthor=F.+Feiauthor=B.+Firestoneauthor=M.+Fodorauthor=H.+Gaoauthor=S.+Hoauthor=K.+Hsiaoauthor=Z.+Kangauthor=N.+Keenauthor=L.+Labonteauthor=S.+Liuauthor=M.+Meyerauthor=M.+Puauthor=E.+Priceauthor=T.+Ramseyauthor=J.+Sliszauthor=P.+Wangauthor=G.+Yangauthor=J.+Zhangauthor=P.+Zhuauthor=W.+R.+Sellersauthor=T.+Stamsauthor=P.+D.+Fortin&title=Discovery+of+an+Allosteric+SHP2+Inhibitor+for+Cancer+Therapy&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 Î¼M), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lhhUN58cc7hhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BP.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarcia%25E2%2580%2593Fortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DF.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLabonte%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26atitle%3DDiscovery%2520of%2520an%2520Allosteric%2520SHP2%2520Inhibitor%2520for%2520Cancer%2520Therapy%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D152%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argintaru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">647</span>â <span class="NLM_lpage">656</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.7b00980</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00980" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=647-656&author=M.+Fodorauthor=E.+Priceauthor=P.+Wangauthor=H.+Luauthor=A.+Argintaruauthor=Z.+Chenauthor=M.+Glickauthor=H.+Haoauthor=M.+Katoauthor=R.+Koenigauthor=J.+R.+LaRochelleauthor=G.+Liuauthor=E.+McNeillauthor=D.+Majumdarauthor=G.+A.+Nishiguchiauthor=L.+B.+Perezauthor=G.+Parisauthor=C.+M.+Quinnauthor=T.+Ramseyauthor=M.+Sendzikauthor=M.+D.+Shultzauthor=S.+L.+Williamsauthor=T.+Stamsauthor=S.+C.+Blacklowauthor=M.+G.+Ackerauthor=M.+J.+LaMarche&title=Dual+Allosteric+Inhibition+of+SHP2+Phosphatase&doi=10.1021%2Facschembio.7b00980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dual allosteric inhibition of SHP2 phosphatase</span></div><div class="casAuthors">Fodor, Michelle; Price, Edmund; Wang, Ping; Lu, Hengyu; Argintaru, Andreea; Chen, Zhouliang; Glick, Meir; Hao, Huai-Xiang; Kato, Mitsunori; Koenig, Robert; La Rochelle, Jonathan R.; Liu, Gang; McNeill, Eric; Majumdar, Dyuti; Nishiguchi, Gisele A.; Perez, Lawrence B.; Paris, Gregory; Quinn, Christopher M.; Ramsey, Timothy; Sendzik, Martin; Shultz, Michael David; Williams, Sarah L.; Stams, Travis; Blacklow, Stephen C.; Acker, Michael G.; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">647-656</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a cytoplasmic protein tyrosine phosphatase encoded by the PTPN11 gene and is involved in cell proliferation, differentiation, and survival.  Recently, we reported an allosteric mechanism of inhibition that stabilizes the auto-inhibited conformation of SHP2.  SHP099 (1) was identified and characterized as a moderately potent, orally bioavailable, allosteric small mol. inhibitor, which binds to a tunnel-like pocket formed by the confluence of three domains of SHP2.  In this report, we describe further screening strategies that enabled the identification of a second, distinct small mol. allosteric site.  SHP244 (2) was identified as a weak inhibitor of SHP2 with modest thermal stabilization of the enzyme.  X-ray crystallog. revealed that 2 binds and stabilizes the inactive, closed conformation of SHP2, at a distinct, previously unexplored binding site-a cleft formed at the interface of the N-terminal SH2 and PTP domains.  Derivatization of 2 using structure-based design resulted in an increase in SHP2 thermal stabilization, biochem. inhibition, and subsequent MAPK pathway modulation.  Downregulation of DUSP6 mRNA, a downstream MAPK pathway marker, was obsd. in KYSE-520 cancer cells.  Remarkably, simultaneous occupation of both allosteric sites by 1 and 2 was possible, as characterized by cooperative biochem. inhibition expts. and X-ray crystallog.  Combining an allosteric site 1 inhibitor with an allosteric site 2 inhibitor led to enhanced pharmacol. pathway inhibition in cells.  This work illustrates a rare example of dual allosteric targeted protein inhibition, demonstrates screening methodol. and tactics to identify allosteric inhibitors, and enables further interrogation of SHP2 in cancer and related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdw7pTS6sOLVg90H21EOLACvtfcHk0lhhUN58cc7hhQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D&md5=8e4de4c353b9fc196c81e1cb51e367df</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DArgintaru%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGlick%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DR.%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMcNeill%26aufirst%3DE.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26aulast%3DParis%26aufirst%3DG.%26aulast%3DQuinn%26aufirst%3DC.%2BM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DDual%2520Allosteric%2520Inhibition%2520of%2520SHP2%2520Phosphatase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D647%26epage%3D656%26doi%3D10.1021%2Facschembio.7b00980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia
Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7773</span>â <span class="NLM_lpage">7782</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b00680</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00680" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7773-7782&author=J.+Garcia%0AFortanetauthor=C.+H.-T.+Chenauthor=Y.-N.+P.+Chenauthor=Z.+Chenauthor=Z.+Dengauthor=B.+Firestoneauthor=P.+Fekkesauthor=M.+Fodorauthor=P.+D.+Fortinauthor=C.+Fridrichauthor=D.+Grunenfelderauthor=S.+Hoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=N.+Keenauthor=L.+R.+LaBonteauthor=J.+Larrowauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=F.+Lombardoauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=T.+Ramseyauthor=W.+R.+Sellersauthor=M.+D.+Shultzauthor=T.+Stamsauthor=C.+Towlerauthor=P.+Wangauthor=S.+L.+Williamsauthor=J.-H.+Zhangauthor=M.+J.+LaMarche&title=Allosteric+Inhibition+of+SHP2%3A+Identification+of+a+Potent%2C+Selective%2C+and+Orally+Efficacious+Phosphatase+Inhibitor&doi=10.1021%2Facs.jmedchem.6b00680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span></div><div class="casAuthors">Garcia Fortanet, Jorge; Chen, Christine Hiu-Tung; Chen, Ying-Nan P.; Chen, Zhouliang; Deng, Zhan; Firestone, Brant; Fekkes, Peter; Fodor, Michelle; Fortin, Pascal D.; Fridrich, Cary; Grunenfelder, Denise; Ho, Samuel; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Keen, Nick; LaBonte, Laura R.; Larrow, Jay; Lenoir, Francois; Liu, Gang; Liu, Shumei; Lombardo, Franco; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Ramsey, Timothy; Sellers, William R.; Shultz, Michael D.; Stams, Travis; Towler, Christopher; Wang, Ping; Williams, Sarah L.; Zhang, Ji-Hu; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7773-7782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway.  SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1).  Because it is an oncoprotein assocd. with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest.  Recently in our labs., a small mol. inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2.  A high throughput screen was performed to identify progressable chem. matter, and X-ray crystallog. revealed the location of binding in a previously undisclosed allosteric binding pocket.  Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein-ligand interactions were characterized.  These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (SHP099, 1), a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6RT7zfZnvfLVg90H21EOLACvtfcHk0lg8RmbGgUpevw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP&md5=dfe43b5253e172576386f86797087f7b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%2BFortanet%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26aulast%3DChen%26aufirst%3DY.-N.%2BP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLaBonte%26aufirst%3DL.%2BR.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DJ.-H.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DAllosteric%2520Inhibition%2520of%2520SHP2%253A%2520Identification%2520of%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520Phosphatase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7773%26epage%3D7782%26doi%3D10.1021%2Facs.jmedchem.6b00680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Tyrosine Phosphatase SHP-2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">441</span>â <span class="NLM_lpage">450</span>, <span class="refDoi">Â DOI: 10.1016/S0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+Structure+of+the+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2FS0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Ã resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0lg8RmbGgUpevw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450%26doi%3D10.1016%2FS0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Revealing Mechanisms for SH2 Domain Mediated Regulation of the Protein Tyrosine Phosphatase SHP-2</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">249</span>â <span class="NLM_lpage">254</span>, <span class="refDoi">Â DOI: 10.1016/S0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+Mechanisms+for+SH2+Domain+Mediated+Regulation+of+the+Protein+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2FS0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0lg8RmbGgUpevw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520Mechanisms%2520for%2520SH2%2520Domain%2520Mediated%2520Regulation%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254%26doi%3D10.1016%2FS0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">Novartis SHP2 patent applications:</p></div><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Grunenfelder, D.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Stams, T. M.</span>; <span class="NLM_string-name">Williams, S.</span></span> <span> </span><span class="NLM_article-title">1 -Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine Derivatives and Compositions Thereof for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO15107493</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Chen&author=J.+G.+Fortanet&author=D.+Grunenfelder&author=R.+Karki&author=M.+Kato&author=M.+J.+LaMarche&author=L.+B.+Perez&author=T.+M.+Stams&author=S.+Williams&title=1+-Pyridazin-%2Ftriazin-3-yl-piper%28-azine%29%2Fidine%2Fpyrolidine+Derivatives+and+Compositions+Thereof+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3D1%2520-Pyridazin-%252Ftriazin-3-yl-piper%2528-azine%2529%252Fidine%252Fpyrolidine%2520Derivatives%2520and%2520Compositions%2520Thereof%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Williams, S.</span>; <span class="NLM_string-name">Sendzik, M.</span></span> <span> </span><span class="NLM_article-title">1-(Triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine Derivatives and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO15107494</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=R.+Karki&author=M.+Kato&author=M.+J.+LaMarche&author=L.+B.+Perez&author=S.+Williams&author=M.+Sendzik&title=1-%28Triazin-3-yl%2Fpyridazin-3-yl%29-piper%28-azine%29idine+Derivatives+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3D1-%2528Triazin-3-yl%252Fpyridazin-3-yl%2529-piper%2528-azine%2529idine%2520Derivatives%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Smith, T.</span>; <span class="NLM_string-name">Williams, S.</span>; <span class="NLM_string-name">Toure, B.
B.</span>; <span class="NLM_string-name">Sendzik, M.</span></span> <span> </span><span class="NLM_article-title">N-azaspirocycloalkane Substituted N-Heteroaryl Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO15107495</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+H.+Chen&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=R.+Karki&author=M.+Kato&author=M.+J.+LaMarche&author=L.+B.+Perez&author=T.+Smith&author=S.+Williams&author=B.%0AB.+Toure&author=M.+Sendzik&title=N-azaspirocycloalkane+Substituted+N-Heteroaryl+Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%2BH.%26atitle%3DN-azaspirocycloalkane%2520Substituted%2520N-Heteroaryl%2520Compounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Sarver, P. J.</span>; <span class="NLM_string-name">Shultz, M.</span>; <span class="NLM_string-name">Smith, T.
D.</span>; <span class="NLM_string-name">Williams, S.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO16203404</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+T.+Bagdanoff&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=M.+Kato&author=M.+J.+LaMarche&author=P.+J.+Sarver&author=M.+Shultz&author=T.%0AD.+Smith&author=S.+Williams&title=Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Tamez, V.</span>; <span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO16203405</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Z.+Chen&author=J.+G.+Fortanet&author=M.+J.+LaMarche&author=M.+Sendzik&author=V.+Tamez&author=B.+Yu&title=Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Jouk, A.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Liu, G.</span>; <span class="NLM_string-name">Palermo, M.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Sarver, P. J.</span>; <span class="NLM_string-name">Shultz, M. D.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Toure, B.
B.</span>; <span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO16203406</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Z.+Chen&author=J.+G.+Fortanet&author=A.+Jouk&author=R.+Karki&author=M.+J.+LaMarche&author=G.+Liu&author=M.+Palermo&author=L.+B.+Perez&author=P.+J.+Sarver&author=M.+D.+Shultz&author=M.+Sendzik&author=B.%0AB.+Toure&author=B.+Yu&title=Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Karki, R.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Majumdar, D.</span>; <span class="NLM_string-name">Perez, L. B.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Smith, T.
D.</span>; <span class="NLM_string-name">Yang, F.</span>; <span class="NLM_string-name">Yu, B.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO17216706</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Z.+Chen&author=J.+G.+Fortanet&author=R.+Karki&author=M.+J.+LaMarche&author=D.+Majumdar&author=L.+B.+Perez&author=M.+Sendzik&author=T.%0AD.+Smith&author=F.+Yang&author=B.+Yu&title=Compounds+and+Compositions+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Flemming, A.</span></span> <span> </span><span class="NLM_article-title">Allosteric Phosphatase Inhibitor Puts Brake on Cancer Cells</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">530</span>â <span class="NLM_lpage">531</span>, <span class="refDoi">Â DOI: 10.1038/nrd.2016.157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fnrd.2016.157" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=530-531&author=A.+Flemming&title=Allosteric+Phosphatase+Inhibitor+Puts+Brake+on+Cancer+Cells&doi=10.1038%2Fnrd.2016.157"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.157%26sid%3Dliteratum%253Aachs%26aulast%3DFlemming%26aufirst%3DA.%26atitle%3DAllosteric%2520Phosphatase%2520Inhibitor%2520Puts%2520Brake%2520on%2520Cancer%2520Cells%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D530%26epage%3D531%26doi%3D10.1038%2Fnrd.2016.157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Batth, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tollenaere, M. A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francavilla, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, J. V.</span></span> <span> </span><span class="NLM_article-title">Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2784</span>â <span class="NLM_lpage">2796</span>, <span class="refDoi">Â DOI: 10.1016/j.celrep.2018.02.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2Fj.celrep.2018.02.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29514104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktVKmsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2018&pages=2784-2796&author=T.+S.+Batthauthor=M.+Papettiauthor=A.+Pfeifferauthor=M.+A.+X.+Tollenaereauthor=C.+Francavillaauthor=J.+V.+Olsen&title=Large-Scale+Phosphoproteomics+Reveals+Shp-2+Phosphatase-Dependent+Regulators+of+Pdgf+Receptor+Signaling&doi=10.1016%2Fj.celrep.2018.02.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling</span></div><div class="casAuthors">Batth, Tanveer S.; Papetti, Moreno; Pfeiffer, Anamarija; Tollenaere, Maxim A. X.; Francavilla, Chiara; Olsen, Jesper V.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2784-2796</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Despite its low cellular abundance, phosphotyrosine (pTyr) regulates numerous cell signaling pathways in health and disease.  We applied comprehensive phosphoproteomics to unravel differential regulators of receptor tyrosine kinase (RTK)-initiated signaling networks upon activation by Pdgf-Î²Î², Fgf-2, or Igf-1 and identified more than 40,000 phosphorylation sites, including many phosphotyrosine sites without addnl. enrichment.  The anal. revealed RTK-specific regulation of hundreds of pTyr sites on key signaling mols.  We found the tyrosine phosphatase Shp-2 to be the master regulator of Pdgfr pTyr signaling.  Application of a recently introduced allosteric Shp-2 inhibitor revealed global regulation of the Pdgf-dependent tyrosine phosphoproteome, which significantly impaired cell migration.  In addn., we present a list of hundreds of Shp-2-dependent targets and putative substrates, including Rasa1 and Cortactin with increased pTyr and Gab1 and Erk1/2 with decreased pTyr.  Our study demonstrates that large-scale quant. phosphoproteomics can precisely dissect tightly regulated kinase-phosphatase signaling networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDY-Vxay_pvLVg90H21EOLACvtfcHk0lhhUpkcpF-zOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktVKmsbc%253D&md5=fbdaeb4de24e15a5a0e4d8db5e072a9e</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.02.038%26sid%3Dliteratum%253Aachs%26aulast%3DBatth%26aufirst%3DT.%2BS.%26aulast%3DPapetti%26aufirst%3DM.%26aulast%3DPfeiffer%26aufirst%3DA.%26aulast%3DTollenaere%26aufirst%3DM.%2BA.%2BX.%26aulast%3DFrancavilla%26aufirst%3DC.%26aulast%3DOlsen%26aufirst%3DJ.%2BV.%26atitle%3DLarge-Scale%2520Phosphoproteomics%2520Reveals%2520Shp-2%2520Phosphatase-Dependent%2520Regulators%2520of%2520Pdgf%2520Receptor%2520Signaling%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D22%26spage%3D2784%26epage%3D2796%26doi%3D10.1016%2Fj.celrep.2018.02.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. L.</span></span> <span> </span><span class="NLM_article-title">Scaffold-Based Novel SHP2 Allosteric Inhibitors Design Using Receptor-Ligand Pharmacophore Model, Virtual Screening and Molecular Dynamics</span>. <i>Comput. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">179</span>â <span class="NLM_lpage">188</span>, <span class="refDoi">Â DOI: 10.1016/j.compbiolchem.2018.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1016%2Fj.compbiolchem.2018.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29494926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsF2kurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2018&pages=179-188&author=W.+Y.+Jinauthor=Y.+Maauthor=W.+Liauthor=H.+L.+Liauthor=R.+L.+Wang&title=Scaffold-Based+Novel+SHP2+Allosteric+Inhibitors+Design+Using+Receptor-Ligand+Pharmacophore+Model%2C+Virtual+Screening+and+Molecular+Dynamics&doi=10.1016%2Fj.compbiolchem.2018.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamics</span></div><div class="casAuthors">Jin, Wen-Yan; Ma, Ying; Li, Wei-Ya; Li, Hong-Lian; Wang, Run-Ling</div><div class="citationInfo"><span class="NLM_cas:title">Computational Biology and Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-188</span>CODEN:
                <span class="NLM_cas:coden">CBCOCH</span>;
        ISSN:<span class="NLM_cas:issn">1476-9271</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SHP2 is a potential target for the development of novel therapies for SHP2-dependent cancers.  In our research, with the aid of the 'Receptor-Ligand Pharmacophore' technique, a 3D-QSAR method was carried out to explore structure activity relationship of SHP2 allosteric inhibitors.  Structure-based drug design was employed to optimize SHP099, an efficacious, potent, and selective SHP2 allosteric inhibitor.  A novel class of selective SHP2 allosteric inhibitors was discovered by using the powerful 'SBP', 'ADMET' and 'CDOCKER' techniques.  By means of mol. dynamics simulations, it was obsd. that these novel inhibitors not only had the same function as SHP099 did in inhibiting SHP2, but also had more favorable conformation for binding to the receptor.  Thus, this report may provide a new method in discovering novel and selective SHP2 allosteric inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzg1OlgVdJ5bVg90H21EOLACvtfcHk0lhhUpkcpF-zOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsF2kurc%253D&md5=327433bbc88dbce0bdbda3369648e797</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1016%2Fj.compbiolchem.2018.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.compbiolchem.2018.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DW.%2BY.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DR.%2BL.%26atitle%3DScaffold-Based%2520Novel%2520SHP2%2520Allosteric%2520Inhibitors%2520Design%2520Using%2520Receptor-Ligand%2520Pharmacophore%2520Model%252C%2520Virtual%2520Screening%2520and%2520Molecular%2520Dynamics%26jtitle%3DComput.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D73%26spage%3D179%26epage%3D188%26doi%3D10.1016%2Fj.compbiolchem.2018.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dardaei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fordjour, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langenbucher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainor, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friboulet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagogo-Jack, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruddy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cecca, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmaster, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caponigro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span> <span> </span><span class="NLM_article-title">SHP2 Inhibition Restores Sensitivity in ALK-Rearranged Non-Small-Cell Lung Cancer Resistant to ALK Inhibitors</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">512</span>â <span class="NLM_lpage">517</span>, <span class="refDoi">Â DOI: 10.1038/nm.4497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fnm.4497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29505033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVOlu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=512-517&author=L.+Dardaeiauthor=H.+Q.+Wangauthor=M.+Singhauthor=P.+Fordjourauthor=K.+X.+Shawauthor=S.+Yodaauthor=G.+Kerrauthor=K.+Yuauthor=J.+Liangauthor=Y.+Caoauthor=Y.+Chenauthor=M.+S.+Lawrenceauthor=A.+Langenbucherauthor=J.+F.+Gainorauthor=L.+Fribouletauthor=I.+Dagogo-Jackauthor=D.+T.+Myersauthor=E.+Labrotauthor=D.+Ruddyauthor=M.+Parksauthor=D.+Leeauthor=R.+H.+Di+Ceccaauthor=S.+Moodyauthor=H.+Haoauthor=M.+Mohseniauthor=M.+LaMarcheauthor=J.+Williamsauthor=K.+Hoffmasterauthor=G.+Caponigroauthor=A.+T.+Shawauthor=A.+N.+Hataauthor=C.+H.+Benesauthor=F.+Liauthor=J.+A.+Engelman&title=SHP2+Inhibition+Restores+Sensitivity+in+ALK-Rearranged+Non-Small-Cell+Lung+Cancer+Resistant+to+ALK+Inhibitors&doi=10.1038%2Fnm.4497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15dR"><div class="casContent"><span class="casTitleNuber">15d</span><div class="casTitle"><span class="NLM_cas:atitle">SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors</span></div><div class="casAuthors">Dardaei, Leila; Wang, Hui Qin; Singh, Manrose; Fordjour, Paul; Shaw, Katherine X.; Yoda, Satoshi; Kerr, Grainne; Yu, Kristine; Liang, Jinsheng; Cao, Yichen; Chen, Yan; Lawrence, Michael S.; Langenbucher, Adam; Gainor, Justin F.; Friboulet, Luc; Dagogo-Jack, Ibiayi; Myers, David T.; Labrot, Emma; Ruddy, David; Parks, Melissa; Lee, Dana; Di Cecca, Richard H.; Moody, Susan; Hao, Huaixiang; Mohseni, Morvarid; LaMarche, Matthew; Williams, Juliet; Hoffmaster, Keith; Caponigro, Giordano; Shaw, Alice T.; Hata, Aaron N.; Benes, Cyril H.; Li, Fang; Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">512-517</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Most anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung tumors initially respond to small-mol. ALK inhibitors, but drug resistance often develops.  Of tumors that develop resistance to highly potent second-generation ALK inhibitors, approx. half harbor resistance mutations in ALK, while the other half have other mechanisms underlying resistance.  Members of the latter group often have activation of at least one of several different tyrosine kinases driving resistance.  Such tumors are not expected to respond to lorlatinib-a third-generation inhibitor targeting ALK that is able to overcome all clin. identified resistant mutations in ALK-and further therapeutic options are limited.  Herein, we deployed a shRNA screen of 1,000 genes in multiple ALK-inhibitor-resistant patient-derived cells (PDCs) to discover those that confer sensitivity to ALK inhibition.  This approach identified SHP2, a nonreceptor protein tyrosine phosphatase, as a common targetable resistance node in multiple PDCs.  SHP2 provides a parallel survival input downstream of multiple tyrosine kinases that promote resistance to ALK inhibitors.  Treatment with SHP099, the recently discovered small-mol. inhibitor of SHP2, in combination with the ALK tyrosine kinase inhibitor (TKI) ceritinib halted the growth of resistant PDCs through preventing compensatory RAS and ERK1 and ERK2 (ERK1/2) reactivation.  These findings suggest that combined ALK and SHP2 inhibition may be a promising therapeutic strategy for resistant cancers driven by several different ALK-independent mechanisms underlying resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBbW-AAzZ-grVg90H21EOLACvtfcHk0lgr5-vVPezsCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVOlu78%253D&md5=e40334532f10444b2df350345add9d0e</span></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1038%2Fnm.4497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4497%26sid%3Dliteratum%253Aachs%26aulast%3DDardaei%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%2BQ.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DFordjour%26aufirst%3DP.%26aulast%3DShaw%26aufirst%3DK.%2BX.%26aulast%3DYoda%26aufirst%3DS.%26aulast%3DKerr%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DLangenbucher%26aufirst%3DA.%26aulast%3DGainor%26aufirst%3DJ.%2BF.%26aulast%3DFriboulet%26aufirst%3DL.%26aulast%3DDagogo-Jack%26aufirst%3DI.%26aulast%3DMyers%26aufirst%3DD.%2BT.%26aulast%3DLabrot%26aufirst%3DE.%26aulast%3DRuddy%26aufirst%3DD.%26aulast%3DParks%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DDi%2BCecca%26aufirst%3DR.%2BH.%26aulast%3DMoody%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DLaMarche%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DHoffmaster%26aufirst%3DK.%26aulast%3DCaponigro%26aufirst%3DG.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DHata%26aufirst%3DA.%2BN.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DSHP2%2520Inhibition%2520Restores%2520Sensitivity%2520in%2520ALK-Rearranged%2520Non-Small-Cell%2520Lung%2520Cancer%2520Resistant%2520to%2520ALK%2520Inhibitors%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D512%26epage%3D517%26doi%3D10.1038%2Fnm.4497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Leukemia-Associated SHP2E69K Mutant by the Allosteric SHP2 Inhibitor SHP099</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1246</span>â <span class="NLM_lpage">1249</span>, <span class="refDoi">Â DOI: 10.1038/s41375-018-0020-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41375-018-0020-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29568093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOmsrrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=1246-1249&author=X.+Sunauthor=Y.+Renauthor=S.+Gunawanauthor=P.+Tengauthor=Z.+Chenauthor=H.+R.+Lawrenceauthor=J.+Caiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Selective+Inhibition+of+Leukemia-Associated+SHP2E69K+Mutant+by+the+Allosteric+SHP2+Inhibitor+SHP099&doi=10.1038%2Fs41375-018-0020-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15eR"><div class="casContent"><span class="casTitleNuber">15e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099</span></div><div class="casAuthors">Sun, X.; Ren, Y.; Gunawan, S.; Teng, P.; Chen, Z.; Lawrence, H. R.; Cai, J.; Lawrence, N. J.; Wu, J.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1246-1249</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The article studies selective inhibition of leukemia-assocd. SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099.  Our findings here identify SHP2E69K as a SHP099-sensitive mutation, wherein three of four most common oncogenic SHP2 mutants studied here are resistant to SHP099.  Moreover, whether Noonan syndrome-assocd. SHP2 mutants are sensitive to SHP099 remained to be tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQzBW1E1YhLVg90H21EOLACvtfcHk0lgr5-vVPezsCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOmsrrK&md5=2cb9342a2e06eac4b9d9043163e4095c</span></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=10.1038%2Fs41375-018-0020-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41375-018-0020-5%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGunawan%26aufirst%3DS.%26aulast%3DTeng%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DSelective%2520Inhibition%2520of%2520Leukemia-Associated%2520SHP2E69K%2520Mutant%2520by%2520the%2520Allosteric%2520SHP2%2520Inhibitor%2520SHP099%26jtitle%3DLeukemia%26date%3D2018%26volume%3D32%26spage%3D1246%26epage%3D1249%26doi%3D10.1038%2Fs41375-018-0020-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kostallari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasnicka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaqoob, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongjarupong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, V. H.</span></span> <span> </span><span class="NLM_article-title">Hepatic Stellate Cell-Derived Platelet-Derived Growth Factor Receptor-Alpha-Enriched Extracellular Vesicles Promote Liver Fibrosis in Mice Through SHP2</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">333</span>â <span class="NLM_lpage">348</span>, <span class="refDoi">Â DOI: 10.1002/hep.29803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1002%2Fhep.29803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=29360139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Klu7zF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2018&pages=333-348&author=E.+Kostallariauthor=P.+Hirsovaauthor=A.+Prasnickaauthor=V.+K.+Vermaauthor=U.+Yaqoobauthor=N.+Wongjarupongauthor=L.+R.+Robertsauthor=V.+H.+Shah&title=Hepatic+Stellate+Cell-Derived+Platelet-Derived+Growth+Factor+Receptor-Alpha-Enriched+Extracellular+Vesicles+Promote+Liver+Fibrosis+in+Mice+Through+SHP2&doi=10.1002%2Fhep.29803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15fR"><div class="casContent"><span class="casTitleNuber">15f</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2</span></div><div class="casAuthors">Kostallari, Enis; Hirsova, Petra; Prasnicka, Alena; Verma, Vikas K.; Yaqoob, Usman; Wongjarupong, Nicha; Roberts, Lewis R.; Shah, Vijay H.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">333-348</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Liver fibrosis is characterized by the activation and migration of hepatic stellate cells (HSCs), followed by matrix deposition.  Recently, several studies have shown the importance of extracellular vesicles (EVs) derived from liver cells, such as hepatocytes and endothelial cells, in liver pathobiol.  While most of the studies describe how liver cells modulate HSC behavior, an important gap exists in the understanding of HSC-derived signals and more specifically HSC-derived EVs in liver fibrosis.  Here, we investigated the mols. released through HSC-derived EVs, the mechanism of their release, and the role of these EVs in fibrosis.  Mass spectrometric anal. showed that platelet-derived growth factor (PDGF) receptor-alpha (PDGFRÎ±) was enriched in EVs derived from PDGF-BB-treated HSCs.  Moreover, patients with liver fibrosis had increased PDGFRÎ± levels in serum EVs compared to healthy individuals.  Mechanistically, in vitro tyrosine720-to-phenylalanine mutation on the PDGFRÎ± sequence abolished enrichment of PDGFRÎ± in EVs and redirected the receptor toward degrdn.  Congruently, the inhibition of Src homol. 2 domain tyrosine phosphatase 2, the regulatory binding partner of phosphorylated tyrosine720, also inhibited PDGFRÎ± enrichment in EVs.  EVs derived from PDGFRÎ±-overexpressing cells promoted in vitro HSC migration and in vivo liver fibrosis.  Finally, administration of Src homol. 2 domain tyrosine phosphatase 2inhibitor, SHP099, to carbon tetrachloride-administered mice inhibited PDGFRÎ± enrichment in serum EVs and reduced liver fibrosis.  Conclusion: PDGFRÎ± is enriched in EVs derived from PDGF-BB-treated HSCs in an Src homol. 2 domain tyrosine phosphatase 2-dependent manner and these PDGFRÎ±-enriched EVs participate in development of liver fibrosis. (Hepatol. 2018;68:333-348).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofC4FQDJF6aLVg90H21EOLACvtfcHk0ljB6fTDNjrnlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Klu7zF&md5=f2a5e625ad4715f9b5be28370632d054</span></div><a href="/servlet/linkout?suffix=cit15f&amp;dbid=16384&amp;doi=10.1002%2Fhep.29803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.29803%26sid%3Dliteratum%253Aachs%26aulast%3DKostallari%26aufirst%3DE.%26aulast%3DHirsova%26aufirst%3DP.%26aulast%3DPrasnicka%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DV.%2BK.%26aulast%3DYaqoob%26aufirst%3DU.%26aulast%3DWongjarupong%26aufirst%3DN.%26aulast%3DRoberts%26aufirst%3DL.%2BR.%26aulast%3DShah%26aufirst%3DV.%2BH.%26atitle%3DHepatic%2520Stellate%2520Cell-Derived%2520Platelet-Derived%2520Growth%2520Factor%2520Receptor-Alpha-Enriched%2520Extracellular%2520Vesicles%2520Promote%2520Liver%2520Fibrosis%2520in%2520Mice%2520Through%2520SHP2%26jtitle%3DHepatology%26date%3D2018%26volume%3D68%26spage%3D333%26epage%3D348%26doi%3D10.1002%2Fhep.29803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemulapalli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span> <span> </span><span class="NLM_article-title">Structural Reorganization of SHP2 by Oncogenic Mutations and Implications for Oncoprotein Resistance to Allosteric Inhibition</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="NLM_elocation-id">4508</span> <span class="refDoi">Â DOI: 10.1038/s41467-018-06823-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41467-018-06823-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=30375388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A280%3ADC%252BB3cvkslelsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+R.+LaRochelleauthor=M.+Fodorauthor=V.+Vemulapalliauthor=M.+Mohseniauthor=P.+Wangauthor=T.+Stamsauthor=M.+J.+LaMarcheauthor=R.+Chopraauthor=M.+G.+Ackerauthor=S.+C.+Blacklow&title=Structural+Reorganization+of+SHP2+by+Oncogenic+Mutations+and+Implications+for+Oncoprotein+Resistance+to+Allosteric+Inhibition&doi=10.1038%2Fs41467-018-06823-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15gR"><div class="casContent"><span class="casTitleNuber">15g</span><div class="casTitle"><span class="NLM_cas:atitle">Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition</span></div><div class="casAuthors">LaRochelle Jonathan R; Vemulapalli Vidyasiri; Blacklow Stephen C; LaRochelle Jonathan R; Vemulapalli Vidyasiri; Blacklow Stephen C; Fodor Michelle; Mohseni Morvarid; Wang Ping; Stams Travis; LaMarche Matthew J; Chopra Rajiv; Acker Michael G</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4508</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Activating mutations in PTPN11, encoding the cytosolic protein tyrosine phosphatase SHP2, result in developmental disorders and act as oncogenic drivers in patients with hematologic cancers.  The allosteric inhibitor SHP099 stabilizes the wild-type SHP2 enzyme in an autoinhibited conformation that is itself destabilized by oncogenic mutations.  Here, we report the impact of the highly activated and most frequently observed mutation, E76K, on the structure of SHP2, and investigate the effect of E76K and other oncogenic mutations on allosteric inhibition by SHP099.  SHP2(E76K) adopts an open conformation but can be restored to the closed, autoinhibited conformation, near-identical to the unoccupied wild-type enzyme, when complexed with SHP099.  SHP099 inhibitory activity against oncogenic SHP2 variants in vitro and in cells scales inversely with the activating strength of the mutation, indicating that either oncoselective or vastly more potent inhibitors will be necessary to suppress oncogenic signaling by the most strongly activating SHP2 mutations in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRglXfZMl481dts4TFFB11gfW6udTcc2eaOPU4esnFkhLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvkslelsA%253D%253D&md5=ceac9384173a0439b945b51f7bc65ea1</span></div><a href="/servlet/linkout?suffix=cit15g&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06823-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06823-9%26sid%3Dliteratum%253Aachs%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DVemulapalli%26aufirst%3DV.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26atitle%3DStructural%2520Reorganization%2520of%2520SHP2%2520by%2520Oncogenic%2520Mutations%2520and%2520Implications%2520for%2520Oncoprotein%2520Resistance%2520to%2520Allosteric%2520Inhibition%26jtitle%3DNat.%2520Commun.%26date%3D2018%26doi%3D10.1038%2Fs41467-018-06823-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">PÃ¡dua, R. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitsawong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiller, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otten, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, D.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Activating Mutations and Allosteric Drug Inhibition of the Phosphatase SHP2</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="NLM_elocation-id">4507</span> <span class="refDoi">Â DOI: 10.1038/s41467-018-06814-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41467-018-06814-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=30375376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A280%3ADC%252BB3cvkslemsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+A.+P.+P%C3%A1duaauthor=Y.+Sunauthor=I.+Markoauthor=W.+Pitsawongauthor=J.+B.+Stillerauthor=R.+Ottenauthor=D.+Kern&title=Mechanism+of+Activating+Mutations+and+Allosteric+Drug+Inhibition+of+the+Phosphatase+SHP2&doi=10.1038%2Fs41467-018-06814-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15hR"><div class="casContent"><span class="casTitleNuber">15h</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2</span></div><div class="casAuthors">Padua Ricardo A P; Sun Yizhi; Marko Ingrid; Pitsawong Warintra; Stiller John B; Otten Renee; Kern Dorothee; Sun Yizhi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4507</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Protein tyrosine phosphatase SHP2 functions as a key regulator of cell cycle control, and activating mutations cause several cancers.  Here, we dissect the energy landscape of wild-type SHP2 and the oncogenic mutation E76K.  NMR spectroscopy and X-ray crystallography reveal that wild-type SHP2 exchanges between closed, inactive and open, active conformations.  E76K mutation shifts this equilibrium toward the open state.  The previously unknown open conformation is characterized, including the active-site WPD loop in the inward and outward conformations.  Binding of the allosteric inhibitor SHP099 to E76K mutant, despite much weaker, results in an identical structure as the wild-type complex.  A conformational selection to the closed state reduces drug affinity which, combined with E76K's much higher activity, demands significantly greater SHP099 concentrations to restore wild-type  activity levels.  The differences in structural ensembles and drug-binding kinetics of cancer-associated SHP2 forms may stimulate innovative ideas for developing more potent inhibitors for activated SHP2 mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRglXfZMl481eR_TJajKxJDfW6udTcc2eaOPU4esnFkhLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvkslemsg%253D%253D&md5=676e8c7d4c85cbb7ce2fa9f756106535</span></div><a href="/servlet/linkout?suffix=cit15h&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06814-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06814-w%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A1dua%26aufirst%3DR.%2BA.%2BP.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMarko%26aufirst%3DI.%26aulast%3DPitsawong%26aufirst%3DW.%26aulast%3DStiller%26aufirst%3DJ.%2BB.%26aulast%3DOtten%26aufirst%3DR.%26aulast%3DKern%26aufirst%3DD.%26atitle%3DMechanism%2520of%2520Activating%2520Mutations%2520and%2520Allosteric%2520Drug%2520Inhibition%2520of%2520the%2520Phosphatase%2520SHP2%26jtitle%3DNat.%2520Commun.%26date%3D2018%26doi%3D10.1038%2Fs41467-018-06814-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Czako, B.</span>; <span class="NLM_string-name">Jones, P.</span>; <span class="NLM_string-name">Cross, P.</span>; <span class="NLM_string-name">Leonard, P.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Inhibitors of PTPN11</span>. WO Patent <span class="NLM_patent">WO2017156397</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=B.+Czako&author=P.+Jones&author=P.+Cross&author=P.+Leonard&title=Heterocyclic+Inhibitors+of+PTPN11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCzako%26aufirst%3DB.%26atitle%3DHeterocyclic%2520Inhibitors%2520of%2520PTPN11%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span>; <span class="NLM_string-name">Gu, S.</span>; <span class="NLM_string-name">Si, X.</span>; <span class="NLM_string-name">Xie, J.</span>; <span class="NLM_string-name">Shen, J.</span></span> <span> </span><span class="NLM_article-title">N-Heterocyclic Ring Compound, and Intermediate, Preparation Method, Medicine Composition and Application Thereof</span>. Chinese Patent <span class="NLM_patent">CN107286150</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+Zhu&author=S.+Gu&author=X.+Si&author=J.+Xie&author=J.+Shen&title=N-Heterocyclic+Ring+Compound%2C+and+Intermediate%2C+Preparation+Method%2C+Medicine+Composition+and+Application+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DN-Heterocyclic%2520Ring%2520Compound%252C%2520and%2520Intermediate%252C%2520Preparation%2520Method%252C%2520Medicine%2520Composition%2520and%2520Application%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span>; <span class="NLM_string-name">Gao, P.</span>; <span class="NLM_string-name">Chu, J.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Wen, C.</span>; <span class="NLM_string-name">Kang, D.</span>; <span class="NLM_string-name">Bai, J.</span>; <span class="NLM_string-name">Pei, X.</span></span> <span> </span><span class="NLM_article-title">Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors</span>. WO Patent <span class="NLM_patent">WO2017211303</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+Ma&author=P.+Gao&author=J.+Chu&author=X.+Wu&author=C.+Wen&author=D.+Kang&author=J.+Bai&author=X.+Pei&title=Novel+Heterocyclic+Derivatives+Useful+as+SHP2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%26atitle%3DNovel%2520Heterocyclic%2520Derivatives%2520Useful%2520as%2520SHP2%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Jogalekar, A.</span>; <span class="NLM_string-name">Won, W.</span>; <span class="NLM_string-name">Koltun, E. S.</span>; <span class="NLM_string-name">Gill, A.</span>; <span class="NLM_string-name">Mellem, K.</span>; <span class="NLM_string-name">Aay, N.</span>; <span class="NLM_string-name">Buckl, A.</span>; <span class="NLM_string-name">Semko, C.</span>; <span class="NLM_string-name">Kiss, G.</span></span> <span> </span><span class="NLM_article-title">2,5-Disubstituted 3-Methyl Pyrazines and 2,5,6-Trisubstituted 3-Methyl Pyrazines As Allosteric SHP2 Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018013597</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+Jogalekar&author=W.+Won&author=E.+S.+Koltun&author=A.+Gill&author=K.+Mellem&author=N.+Aay&author=A.+Buckl&author=C.+Semko&author=G.+Kiss&title=2%2C5-Disubstituted+3-Methyl+Pyrazines+and+2%2C5%2C6-Trisubstituted+3-Methyl+Pyrazines+As+Allosteric+SHP2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJogalekar%26aufirst%3DA.%26atitle%3D2%252C5-Disubstituted%25203-Methyl%2520Pyrazines%2520and%25202%252C5%252C6-Trisubstituted%25203-Methyl%2520Pyrazines%2520As%2520Allosteric%2520SHP2%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span>; <span class="NLM_string-name">Aay, N.</span>; <span class="NLM_string-name">Mellem, K.</span>; <span class="NLM_string-name">Buckyl, A.</span>; <span class="NLM_string-name">Koltun, E. S.</span>; <span class="NLM_string-name">Semko, C.</span>; <span class="NLM_string-name">Kiss, G.</span></span> <span> </span><span class="NLM_article-title">Pyridine Compounds as Allosteric SHP2 Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018136264</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+Gill&author=N.+Aay&author=K.+Mellem&author=A.+Buckyl&author=E.+S.+Koltun&author=C.+Semko&author=G.+Kiss&title=Pyridine+Compounds+as+Allosteric+SHP2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DA.%26atitle%3DPyridine%2520Compounds%2520as%2520Allosteric%2520SHP2%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Blank, B. R.</span>; <span class="NLM_string-name">Pitzen, J.</span>; <span class="NLM_string-name">Wang, G.</span>; <span class="NLM_string-name">Won, W. S.</span>; <span class="NLM_string-name">Tzitzilonis, C.</span>; <span class="NLM_string-name">Li, J. J.</span>; <span class="NLM_string-name">Koltun, E. S.</span>; <span class="NLM_string-name">Aay, N.</span>; <span class="NLM_string-name">Buckyl, A.</span>; <span class="NLM_string-name">Mellem, K.</span>; <span class="NLM_string-name">Semko, C.</span>; <span class="NLM_string-name">Jogalekar, A.</span>; <span class="NLM_string-name">Kiss, G.</span>; <span class="NLM_string-name">Gill, A.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Compounds as Allosteric SHP2 Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018136265</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=B.+R.+Blank&author=J.+Pitzen&author=G.+Wang&author=W.+S.+Won&author=C.+Tzitzilonis&author=J.+J.+Li&author=E.+S.+Koltun&author=N.+Aay&author=A.+Buckyl&author=K.+Mellem&author=C.+Semko&author=A.+Jogalekar&author=G.+Kiss&author=A.+Gill&title=Bicyclic+Compounds+as+Allosteric+SHP2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlank%26aufirst%3DB.%2BR.%26atitle%3DBicyclic%2520Compounds%2520as%2520Allosteric%2520SHP2%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span>; <span class="NLM_string-name">Giordanetto, F.</span>; <span class="NLM_string-name">Greisman, J. B.</span>; <span class="NLM_string-name">Maragakis, P.</span>; <span class="NLM_string-name">Taylor, A. M.</span>; <span class="NLM_string-name">Walters, W. P.</span></span> <span> </span><span class="NLM_article-title">SHP2 Phosphatase Inhibitors and Methods of Use Thereof</span>. WO Patent <span class="NLM_patent">WO2018057884</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=B.+K.+Albrecht&author=F.+Giordanetto&author=J.+B.+Greisman&author=P.+Maragakis&author=A.+M.+Taylor&author=W.+P.+Walters&title=SHP2+Phosphatase+Inhibitors+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DSHP2%2520Phosphatase%2520Inhibitors%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span>; <span class="NLM_string-name">Greisman, J. B.</span>; <span class="NLM_string-name">Maragakis, P.</span>; <span class="NLM_string-name">Taylor, A. M.</span>; <span class="NLM_string-name">Dipietro, L. V.</span>; <span class="NLM_string-name">Kelley, E. H.</span>; <span class="NLM_string-name">Lescarbeau, A.</span>; <span class="NLM_string-name">Murcko, M. A.</span>; <span class="NLM_string-name">Pierce, L. C. T.</span>; <span class="NLM_string-name">Shortsleeves, K. C.</span>; <span class="NLM_string-name">Walters, W. P.</span>; <span class="NLM_string-name">Bhat, S.</span>; <span class="NLM_string-name">Therrien, E.</span>; <span class="NLM_string-name">Dahlgren, M. K.</span></span> <span> </span><span class="NLM_article-title">Pyrazolo[3,4-B]Pyrazine Derivatives as SHP2 Phosphatase Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018081091</span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=F.+Giordanetto&author=J.+B.+Greisman&author=P.+Maragakis&author=A.+M.+Taylor&author=L.+V.+Dipietro&author=E.+H.+Kelley&author=A.+Lescarbeau&author=M.+A.+Murcko&author=L.+C.+T.+Pierce&author=K.+C.+Shortsleeves&author=W.+P.+Walters&author=S.+Bhat&author=E.+Therrien&author=M.+K.+Dahlgren&title=Pyrazolo%5B3%2C4-B%5DPyrazine+Derivatives+as+SHP2+Phosphatase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26atitle%3DPyrazolo%255B3%252C4-B%255DPyrazine%2520Derivatives%2520as%2520SHP2%2520Phosphatase%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. M.</span>; <span class="NLM_string-name">Lescarbeau, A.</span>; <span class="NLM_string-name">Kelley, E. H.</span>; <span class="NLM_string-name">Shortsleeves, K. C.</span>; <span class="NLM_string-name">Dipietro, L. V.</span>; <span class="NLM_string-name">Walters, W. P.</span>; <span class="NLM_string-name">Murcko, M. A.</span>; <span class="NLM_string-name">Pierce, L. C.</span>; <span class="NLM_string-name">Tang, Y.</span>; <span class="NLM_string-name">Giordanetto, F.</span>; <span class="NLM_string-name">Greisman, J. B.</span>; <span class="NLM_string-name">Maragakis, P.</span>; <span class="NLM_string-name">Bhat, S.</span>; <span class="NLM_string-name">Dahlgeren, M. K.</span>; <span class="NLM_string-name">Therrien, E.</span></span> <span> </span><span class="NLM_article-title">Pyrazolo[3,4-B]Pyrazine Derivatives as SHP2 Phosphatase Inhibitors</span>. WO Patent <span class="NLM_patent">WO2018218133</span><span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=A.+M.+Taylor&author=A.+Lescarbeau&author=E.+H.+Kelley&author=K.+C.+Shortsleeves&author=L.+V.+Dipietro&author=W.+P.+Walters&author=M.+A.+Murcko&author=L.+C.+Pierce&author=Y.+Tang&author=F.+Giordanetto&author=J.+B.+Greisman&author=P.+Maragakis&author=S.+Bhat&author=M.+K.+Dahlgeren&author=E.+Therrien&title=Pyrazolo%5B3%2C4-B%5DPyrazine+Derivatives+as+SHP2+Phosphatase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26atitle%3DPyrazolo%255B3%252C4-B%255DPyrazine%2520Derivatives%2520as%2520SHP2%2520Phosphatase%2520Inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haderk, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzitzilonis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordec, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakely, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bivona, T. G.</span></span> <span> </span><span class="NLM_article-title">RAS Nucleotide Cycling Underlies the SHP2 Phosphatase Dependence of Mutant BRAF-, NF1- and RAS-Driven Cancers</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">1064</span>â <span class="NLM_lpage">1073</span>, <span class="refDoi">Â DOI: 10.1038/s41556-018-0169-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1038%2Fs41556-018-0169-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=30104724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsV2isLnP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=1064-1073&author=R.+J.+Nicholsauthor=F.+Haderkauthor=C.+Stahlhutauthor=C.+J.+Schulzeauthor=G.+Hemmatiauthor=D.+Wildesauthor=C.+Tzitzilonisauthor=K.+Mordecauthor=A.+Marquezauthor=J.+Romeroauthor=T.+Hsiehauthor=A.+Zamanauthor=V.+Olivasauthor=C.+McCoachauthor=C.+M.+Blakelyauthor=Z.+Wangauthor=G.+Kissauthor=E.+S.+Koltunauthor=A.+L.+Gillauthor=M.+Singhauthor=M.+A.+Goldsmithauthor=J.+A.+M.+Smithauthor=T.+G.+Bivona&title=RAS+Nucleotide+Cycling+Underlies+the+SHP2+Phosphatase+Dependence+of+Mutant+BRAF-%2C+NF1-+and+RAS-Driven+Cancers&doi=10.1038%2Fs41556-018-0169-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17hR"><div class="casContent"><span class="casTitleNuber">17h</span><div class="casTitle"><span class="NLM_cas:atitle">RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers</span></div><div class="casAuthors">Nichols, Robert J.; Haderk, Franziska; Stahlhut, Carlos; Schulze, Christopher J.; Hemmati, Golzar; Wildes, David; Tzitzilonis, Christos; Mordec, Kasia; Marquez, Abby; Romero, Jason; Hsieh, Tientien; Zaman, Aubhishek; Olivas, Victor; McCoach, Caroline; Blakely, Collin M.; Wang, Zhengping; Kiss, Gert; Koltun, Elena S.; Gill, Adrian L.; Singh, Mallika; Goldsmith, Mark A.; Smith, Jacqueline A. M.; Bivona, Trever G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1064-1073</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Oncogenic alterations in the RAS/RAF/MEK/ERK pathway drive the growth of a wide spectrum of cancers.  While BRAF and MEK inhibitors are efficacious against BRAFV600E-driven cancers, effective targeted therapies are lacking for most cancers driven by other pathway alterations, including non-V600E oncogenic BRAF, RAS GTPase-activating protein (GAP) NF1 (neurofibromin 1) loss and oncogenic KRAS.  Here, we show that targeting the SHP2 phosphatase (encoded by PTPN11) with RMC-4550, a small-mol. allosteric inhibitor, is effective in human cancer models bearing RAS-GTP-dependent oncogenic BRAF (for example, class 3 BRAF mutants), NF1 loss or nucleotide-cycling oncogenic RAS (for example, KRASG12C).  SHP2 inhibitor treatment decreases oncogenic RAS/RAF/MEK/ERK signalling and cancer growth by disrupting SOS1-mediated RAS-GTP loading.  Our findings illuminate a crit. function for SHP2 in promoting oncogenic RAS/MAPK pathway activation in cancers with RAS-GTP-dependent oncogenic BRAF, NF1 loss and nucleotide-cycling oncogenic KRAS.  SHP2 inhibition is a promising mol. therapeutic strategy for patients with cancers bearing these oncogenic drivers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2gVKE5Juu_LVg90H21EOLACvtfcHk0ljjS7c2me_7yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsV2isLnP&md5=05e84e5c0d51d501c229e118f44aa6cd</span></div><a href="/servlet/linkout?suffix=cit17h&amp;dbid=16384&amp;doi=10.1038%2Fs41556-018-0169-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41556-018-0169-1%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DHaderk%26aufirst%3DF.%26aulast%3DStahlhut%26aufirst%3DC.%26aulast%3DSchulze%26aufirst%3DC.%2BJ.%26aulast%3DHemmati%26aufirst%3DG.%26aulast%3DWildes%26aufirst%3DD.%26aulast%3DTzitzilonis%26aufirst%3DC.%26aulast%3DMordec%26aufirst%3DK.%26aulast%3DMarquez%26aufirst%3DA.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DHsieh%26aufirst%3DT.%26aulast%3DZaman%26aufirst%3DA.%26aulast%3DOlivas%26aufirst%3DV.%26aulast%3DMcCoach%26aufirst%3DC.%26aulast%3DBlakely%26aufirst%3DC.%2BM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DKiss%26aufirst%3DG.%26aulast%3DKoltun%26aufirst%3DE.%2BS.%26aulast%3DGill%26aufirst%3DA.%2BL.%26aulast%3DSingh%26aufirst%3DM.%26aulast%3DGoldsmith%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DBivona%26aufirst%3DT.%2BG.%26atitle%3DRAS%2520Nucleotide%2520Cycling%2520Underlies%2520the%2520SHP2%2520Phosphatase%2520Dependence%2520of%2520Mutant%2520BRAF-%252C%2520NF1-%2520and%2520RAS-Driven%2520Cancers%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2018%26spage%3D1064%26epage%3D1073%26doi%3D10.1038%2Fs41556-018-0169-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarver, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohseni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichkule, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">6-Amino-3-Methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01726</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01726" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=P.+Sarverauthor=M.+Ackerauthor=J.+T.+Bagdanoffauthor=Z.+Chenauthor=Y.+N.+Chenauthor=H.+Chanauthor=B.+Firestoneauthor=M.+Fodorauthor=J.+Garcia-Fortanetauthor=H.+Haoauthor=M.+Hentemannauthor=M.+Katoauthor=R.+Koenigauthor=L.+R.+LaBonteauthor=G.+Liuauthor=S.+Liuauthor=C.+Liuauthor=E.+McNeilauthor=M.+Mohseniauthor=M.+Sendzikauthor=T.+Stamsauthor=S.+Spenceauthor=V.+Tamezauthor=R.+Tichkuleauthor=C.+Towlerauthor=H.+Wangauthor=P.+Wangauthor=S.+L.+Williamsauthor=B.+Yuauthor=M.+J.+LaMarche&title=6-Amino-3-Methylpyrimidinones+as+Potent%2C+Selective%2C+and+Orally+Efficacious+SHP2+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01726"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01726%26sid%3Dliteratum%253Aachs%26aulast%3DSarver%26aufirst%3DP.%26aulast%3DAcker%26aufirst%3DM.%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%2BN.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DGarcia-Fortanet%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DH.%26aulast%3DHentemann%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DR.%26aulast%3DLaBonte%26aufirst%3DL.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMcNeil%26aufirst%3DE.%26aulast%3DMohseni%26aufirst%3DM.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DSpence%26aufirst%3DS.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DTichkule%26aufirst%3DR.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3D6-Amino-3-Methylpyrimidinones%2520as%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Efficacious%2520SHP2%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.8b01726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitch, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platzer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Moreno, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, L. P.</span></span> <span> </span><span class="NLM_article-title">Arginine: Its pKa Value Revisited</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">752</span>â <span class="NLM_lpage">761</span>, <span class="refDoi">Â DOI: 10.1002/pro.2647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=10.1002%2Fpro.2647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=25808204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVaht7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=752-761&author=C.+A.+Fitchauthor=G.+Platzerauthor=M.+Okonauthor=E.+B.+Garcia-Morenoauthor=L.+P.+McIntosh&title=Arginine%3A+Its+pKa+Value+Revisited&doi=10.1002%2Fpro.2647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Arginine: Its pKa value revisited</span></div><div class="casAuthors">Fitch, Carolyn A.; Platzer, Gerald; Okon, Mark; Garcia-Moreno E., Bertrand; McIntosh, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">752-761</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Using complementary approaches of potentiometry and NMR spectroscopy, we have detd. that the equil. acid dissocn. const. (pKa value) of the arginine guanidinium group is 13.8 Â± 0.1.  This is substantially higher than that of â¼12 often used in structure-based electrostatics calcns. and cited in biochem. textbooks.  The revised intrinsic pKa value helps explains why arginine side chains in proteins are always predominantly charged, even at pH values as great as 10.  The high pKa value also reinforces the observation that arginine side chains are invariably protonated under physiol. conditions of near neutral pH.  This occurs even when the guanidinium moiety is buried in a hydrophobic micro-environment, such as that inside a protein or a lipid membrane, thought to be incompatible with the presence of a charged group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOgRAuc6HbkLVg90H21EOLACvtfcHk0lh4-xKwNUisrA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVaht7k%253D&md5=e2144529f99b55edbb43306f17bbf152</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fpro.2647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2647%26sid%3Dliteratum%253Aachs%26aulast%3DFitch%26aufirst%3DC.%2BA.%26aulast%3DPlatzer%26aufirst%3DG.%26aulast%3DOkon%26aufirst%3DM.%26aulast%3DGarcia-Moreno%26aufirst%3DE.%2BB.%26aulast%3DMcIntosh%26aufirst%3DL.%2BP.%26atitle%3DArginine%253A%2520Its%2520pKa%2520Value%2520Revisited%26jtitle%3DProtein%2520Sci.%26date%3D2015%26volume%3D24%26spage%3D752%26epage%3D761%26doi%3D10.1002%2Fpro.2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">The synthesis of spirocyclic amines is included in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_001.csv" class="ext-link">SI</a> for this manuscript. They may also be found at:</p></div><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuoliang, C.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Sendzik, M.</span>; <span class="NLM_string-name">Tamez, V.</span>; <span class="NLM_string-name">Bing, Y.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted Pyrimidinones for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO2016203405</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=C.+Zhuoliang&author=J.+G.+Fortanet&author=M.+J.+LaMarche&author=M.+Sendzik&author=V.+Tamez&author=Y.+Bing&title=Preparation+of+Substituted+Pyrimidinones+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhuoliang%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520Substituted%2520Pyrimidinones%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagdanoff, J. T.</span>; <span class="NLM_string-name">Chen, Z.</span>; <span class="NLM_string-name">Dore, M.</span>; <span class="NLM_string-name">Fortanet, J. G.</span>; <span class="NLM_string-name">Kato, M.</span>; <span class="NLM_string-name">LaMarche, M. J.</span>; <span class="NLM_string-name">Sarver, P. J.</span>; <span class="NLM_string-name">Shultz, M.</span>; <span class="NLM_string-name">Smith, T. D. S.</span>; <span class="NLM_string-name">Williams, S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted Pyrazolopyrimidinones and Pyrrolopyrimidinones for Inhibiting the Activity of SHP2</span>. WO Patent <span class="NLM_patent">WO2016203404</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+T.+Bagdanoff&author=Z.+Chen&author=M.+Dore&author=J.+G.+Fortanet&author=M.+Kato&author=M.+J.+LaMarche&author=P.+J.+Sarver&author=M.+Shultz&author=T.+D.+S.+Smith&author=S.+Williams&title=Preparation+of+Substituted+Pyrazolopyrimidinones+and+Pyrrolopyrimidinones+for+Inhibiting+the+Activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26atitle%3DPreparation%2520of%2520Substituted%2520Pyrazolopyrimidinones%2520and%2520Pyrrolopyrimidinones%2520for%2520Inhibiting%2520the%2520Activity%2520of%2520SHP2%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP','PDB','2SHP'); return false;">PDB: 2SHP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR','PDB','5EHR'); return false;">PDB: 5EHR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD9','PDB','6MD9'); return false;">PDB: 6MD9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDA','PDB','6MDA'); return false;">PDB: 6MDA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB','PDB','6MDB'); return false;">PDB: 6MDB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDD','PDB','6MDD'); return false;">PDB: 6MDD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDC','PDB','6MDC'); return false;">PDB: 6MDC</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01725">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26652"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01725">10.1021/acs.jmedchem.8b01725</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings with SHP2 IC<sub>50</sub>, % inhibition @40mM, <i>p</i>-ERK IC<sub>50</sub>, antiproliferation IC<sub>50</sub>, hERG (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_001.csv">CSV</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig2">Figure <a id="rightTab-" class=" internalNav" href="#fig2">2</a></a>a, pharmacophore model from <b>2</b>, <b>3</b>, and <b>4</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig3">Figure <a id="rightTab-" class=" internalNav" href="#fig3">3</a></a>, docking model of <b>15</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Related to <a id="rightTab-" class=" internalNav" href="#fig4">Figure <a id="rightTab-" class=" internalNav" href="#fig4">4</a></a>, X-ray structure of <b>24</b> and docking model of <b>19</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_004.pdb">PDB</a>)</p></li><li><p class="inline">X-ray data tables, selectivity panel data for 1; PK profiles for 1, 5, 14; synthetic procedures; molecular formula strings, docking models (<a id="rightTab-" class=" internalNav" href="#fig2">Figures <a id="rightTab-" class=" internalNav" href="#fig2">2</a></a>â<a id="rightTab-" class=" internalNav" href="#fig4">4</a>) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_005.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_001.csv">jm8b01725_si_001.csv (2.01 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_002.pdb">jm8b01725_si_002.pdb (6.11 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_003.pdb">jm8b01725_si_003.pdb (305.96 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_004.pdb">jm8b01725_si_004.pdb (301.91 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01725/suppl_file/jm8b01725_si_005.pdf">jm8b01725_si_005.pdf (290.82 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MD9">6MD9</a> for SHP2 in complex with compound <b>3</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDA">6MDA</a> for SHP2 in complex with compound <b>4</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDB">6MDB</a> for SHP2 in complex with compound <b>5</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDD">6MDD</a> for SHP2 in complex with compound <b>24</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6MDC">6MDC</a> for SHP2 in complex with compound <b>1</b>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01725&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01725%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-4%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01725" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996c4eef623d06","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
